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Epidermal Growth Factor Receptor (EGFR) as a prototypical receptor tyrosine kinase 
is intensively studied due to its important role in aberrant cancer signalling. This study 
investigated the dynamics and organization of EGFR on live CHO-K1 cell membrane 
both at its resting and ligand-bound states. The development of imaging Fluorescence 
Correlation Spectroscopy (FCS), a quantitative bioimaging tool, enables measuring 
both the dynamics and organization of EGFR with single molecule sensitivity. 
Implementation of FCS diffusion law analysis provides information of nanoscale 
organization of membrane molecules.  
Chapter 1 reviews on EGFR especially its activation on membrane, endocytosis and 
the biological significance. This follows with current knowledge on cell membrane 
including its chemical composition, physical properties, dynamics and organization 
principles. An introduction into the common biophysical tools to study the membrane 
dynamics and organization is given. The last section discusses the main topic of EGFR 
membrane dynamics and localization.  
Chapter 2 describes the materials and methods used in this study. Cell culture and 
treatments are described and the instrumentation information is provided. 
Chapter 3 introduces the theory of FCS and its extension of imaging total internal 
reflection (ITIR)-FCS. The FCS diffusion law analysis is discussed and its application 
on membrane studies is reviewed. 
Chapter 4 covers the results of Imaging FCS diffusion law analysis with various 
membrane probes by ITIR-FCS. Free diffusing, raft partitioning and actin cytoskeleton 
compartmentalized molecules exhibit distinct membrane behaviours and the sub-




Chapter 5 presents the results of resting EGFR diffusion and localization on membrane. 
Drug perturbations on resting EGFR is carried out. 
Chapter 6 focuses on the EGFR membrane dynamics and localization after ligand 
stimulation. The two doses ligand stimulation induces different response of EGFR on 
the membrane and the subsequent endocytosis process. The relationship of EGFR 
membrane diffusion, confinement and internalization is further discussed. Lastly, the 
EGFR clustering on the membrane is studied by modulating cholesterol level, actin 
cytoskeleton integrity and culture temperature.  
Chapter 7 summarizes up the main findings in this thesis and presents an outlook into 





1.1 Epidermal growth factor receptor (EGFR) 
The study of EGFR can be dated back to more than half century ago when Cohen and 
colleagues first reported the purification of a ‘tooth-lid’ factor (later renamed as 
epidermal growth factor (EGF)) [1, 2]. It was found to be capable of stimulating 
epidermal cell proliferation. This isolated polypeptide is composed by 53 amino acids, 
which contains a consensus sequence of six spatially conserved cysteine residues [2]. 
Research on EGF has progressed at a prodigious rate expanding to many other similar 
growth factors and the characterization of its membrane receptor Epidermal Growth 
Factor Receptor (EGFR) [3]. This leads to the discovery of the receptor tyrosine kinase 
(RTK) super-family. 
All currently known human RTKs share a similar molecular architecture which 
includes a ligand-binding extracellular region, a single transmembrane helix and a 
cytoplasmic region [4]. The tyrosine kinase (TK) locates in the cytoplasmic region, 
which contains juxtamembrane (JM) regulatory regions and an additional C terminal 
tail. The structure of RTK family proteins and their activation mechanism are highly 
conserved in evolution. The essential regulatory functions triggered by this family of 
proteins mainly include proliferation, differentiation, cell migration and survival [5, 6]. 
The alteration of the RTK activities or misregulation of RTKs will result in numerous 
diseases include cancers, diabetes, angiogenesis and many more [4].  
1.1.1 EGFR Structure  
Since discovery, EGFR has become the prototypical system to study the RTK family. 
However, the crystallographic analysis of full-length EGFR remained a challenge due 
to the technical issues of solubilizing the transmembrane proteins as well as the high 
flexibility of the full-length receptor [7]. 
EGFR is a 1186 amino acid transmembrane glycoprotein [3]. It contains the 




619), a transmemebrane (TM) domain (residues 620-642), a JM domain (residues 643-
684), a tyrosine kinase (TK) domain (residues 685-952) and the C-terminal tail (also 
known as regulatory region, residues 953-1186) [8]. On a side note, the 24 residues of 
the signal sequence are not counted in this numbering [9]. The extracellular domain 
comprises of four domains: domain I (L1, residues 1-164), domain II (CR1 or S1, 
residues 165-309), domain III (L2, residues 310-479) and domain IV (CR2 or S2, 
residues 480-619) [10]. The extracellular domain is linked to the intracellular region 
by the single membrane spanning ɑ-helix (TM domain) [11]. The JM domain which 
comprises two major parts of JMA (residues 645-663) and JMB (residues 664-682) is 
adjacent to the TM domain and proximal to the inner leaflet of the cell membrane [12]. 
The TK domain contains two lobes called the N-lobe and C-lobe which are reported to 
be intrinsically autoinhibited and activated by intermolecular interactions [13]. The C-
terminal tail serves as the docking sites for effector proteins with SH2 (Src Homolog 
2) or PTB (phosphotyrosine binding) domains. It is a long tail segment containing 
seven tyrosine residues [9]. 
Ligand binding to the transmembrane ErbB (originally named because of the homology 
to the erythroblastoma viral gene product, v-erbB) family protein (equal to EGFR 
family protein) leads to their conformational changes with receptor homo- or hetero-
oligomerization. This oligomerization in turn activates the tyrosine kinase, with 
transphosphorylation of multiple cytoplasmic tail tyrosine residues [14]. The 
phosphorylated tyrosines provide recruiting sites for the SH2 and PTB domains 
presented in various cytoplasmic adaptor proteins, thus initiating an array of signalling 
[15].  
Early EGFR studies suggested that the receptors existed as monomers at their resting 
states and dimerization was induced by ligand binding [16]. In the canonical view of 
EGFR activation, monomeric receptors converted to dimeric form after the addition of 




dimerization: a ligand-mediated mechanism and a receptor-mediated mechanism [17]. 
With the crystal structure of the extracellular region of the 2:2 ligand-receptor dimer 
solved, the traditional EGFR activation model was modified as physical interaction 
between extracellular domains instead of ligand induce EGFR dimerization [8]. 
Compared with the unbound structure, the ligand-bound receptor exhibited a large 
rotation in domain I which formed binding pocket together with domain III [8, 21]. 
Domain II contained the so-called dimerization arm which interacted with each other 
in a dimer [22]. The compact unit of domain I, II and III formed was often referred to 
as the extracellular head module while domain IV formed the elongated leg part. The 
extracellular domains adopted a tethered conformation in the absence of ligand and the 
dimerization arm was buried inside the head-leg part in this autoinhibited conformation 
[23]. Ligand interaction with the binding pocket triggered the concurrent rotation of 
domain I, which followed with the subsequent rearrangement of domain II. This 
rearrangement exposed the dimerization loop to the other EGF-bound EGFR with 
extended conformation, inducing formation of the back-to-back dimer [8, 24]. 
Moreover, binding of the first ligand reduced the binding affinity between the second 
ligand and the receptor dimer. Such negative cooperativity was proposed to explain the 
the high and low affinity of EGF-EGFR binding properties inferred from concave-up 
curves observed in the Scatchard plot [25]. The high EGF-binding affinity population 
with Kd = 10-100 pM represented 2-5% of the receptors while the low affinity species 
with Kd = 2-5 nM accounted for the majority of receptors (95-98%) [26]. 
The extracellular back-to-back dimer resulted in the formation of enzymatically active 
asymmetric dimers in the intracellular side, in which one kinase served the other kinase 
domains as a cyclin-like activator [13]. The C-lobe of one kinase which was regarded 
as activator interacted with the N-lobe of the other kinase known as receiver, which 
formed a tight interface in stabilizing the active form of the receiver [13]. Jura et al. 




kinase domains. Their model proposed the JM region as an essential positive 
component in stabilizing the asymmetric kinase dimer [27, 28]. Most recent studies 
suggested that the interactions between the EGFR intracellular module and the cell 
membrane played a critical role in dimer formation and EGFR activation [29, 30]. The 
N-terminal interaction in the dimerized transmembrane helices promoted the formation 
of antiparallel JM segments, which would release the receptor from the inhibition by 
the membrane [30]. It was also reported that cyclic side-by-side orientated receptor 
dimers were the active phosphorylated species that played the predominant role in 
signalling outputs [31]. The most recent study reported that EGFR multimerization 
formed by self-association of ligand-bound dimers could boost the tail phosphorylation 
by cooperatively activating the kinase domains. The residues in Domain IV identified 
in affecting multimerization instead of dimerization led to uncovering the role of 
multimerization in EGFR activation [32]. 
1.1.2 Biological significance 
1.1.2.1 Activation of EGFR in the cell membrane 
Ligand-induced receptor dimerization with the conversion from an inactive monomer 
conformation to the active dimer configuration has long stood as the original model for 
the EGFR activation [6, 19, 33, 34]. It was believed that receptor dimerization induced 
by EGF binding acted as the first step of receptor activation [35]. However, as evidence 
on the preformed dimer emerged, the ligand-induced dimerization model was 
questioned. For example, single molecule imaging suggested that before ligand binding 
EGFR dimers existed in the cell membrane of A431 cells [36]. Soon many studies were 
taken to examine the dimerization issues of EGFR. 
Many groups put effort into quantifying the pre-formed dimerization ratio, but reported 
differently about the pre-formed dimer percentage by using various methods with their 




reported 40% EGFRs formed dimers in absence of ligand by homo-fluorescence 
resonance energy transfer (FRET) measurements [37]. Meanwhile, Pike’s group 
showed that around half EGFR were either dimer or oligomer with Live Cell 
Fluorescence Intensity Distribution Analysis (FIDA) [38].  
FRET and Fluorescence Lifetime Imaging (FLIM) study also revealed that at least 65% 
of the EGFR within the subpopulation of high affinity receptors in the A431 cell 
membrane existed as preformed dimers [39]. Another study has reported that the 
original preformed dimer would interact with a new non-phosphorylated receptor to 
form new dimers and initiated the activation upon ligand treatments [40]. By chemical 
cross-linking, Maruyama’s group reported that the surface EGFR dimer was around 80% 
[41]. Our group quantified the pre-formed dimer ratio to ~64% on CHO-K1 cells with 
Single Wavelength-Fluorescence Cross Correlation Spectroscopy (SW-FCCS) [42]. 
The reason for the different reported dimer ratios could be attributed to several factors: 
specific methods and techniques used in those studies, different cell lines, and even 
various temperature conditions [43]. Pre-formed dimers existed on the cell membrane 
even before ligand binding was substantially documented [44]. Albeit EGFR 
dimerization was not sufficient for the kinase activation, receptor dimerization was 
necessary for EGFR activation and commonly accepted as a critical step.  
Despite the different reported dimer ratios, pre-formed dimers existing on the cell 
membrane before ligand binding are assumed to exist although the fraction was under 
discussion. Many of the aforementioned studies discussed the activation of EGFR 
based on the transition from monomer to dimer. However, some studies suggested that 
the existence of tetramer and high order oligomers played an important role in EGFR 
activation [31, 45, 46]. The general consideration of EGFR activation as the result of 
ligand-induced dimerization was gradually revised when more evidence emerged to 
show that tetramer or higher order oligomers played a major role in the receptor 




cell membrane as oligomers before ligand binding. These oligomers would dissociate 
after ligand binding, with the slow emergence of oligomerization from EGFR 
monomers. Another FRET study of EGFR oligomers showed that average molecule 
number changed from 2.2 to 3.7 per cluster before and after ligand treatment [48]. 
Tyrosine kinase inhibitors (TKIs) were shown to partially disperse the submicron 
preformed clusters, which suggested the nanoscale EGFR high order organization was 
controlled by the kinase domains to some extent [46]. Based on the homo-FRET results, 
EGFR was also proposed to form oligomers with the structure of head-to-head dimers 
before ligand binding [49]. Quantitative FRET-FLIM imaging demonstrated the 
mechanism of ligand-independent lateral propagation of EGFR activation in the 
membrane [50]. The dynamic EGFR clustering was proposed to induce signal 
amplification and variation, as the observed phosphorylated EGFR exceeded the bound 
ligands [51]. In addition, receptor overexpression was also reported to activate EGFR 
signalling without the ligand [43]. The binding kinetics were shown to be altered with 
different expression levels of EGFR during ligand binding activation processes [52]. 
Recent studies revealed that overexpression of EGFR released the receptor from the 
membrane inhibition effect, thus sufficed the ligand-free activation [30].   
Inactive EGFR forming oligomers with different sizes and percentages on the cell 
membrane has also been reported in many studies [38, 53, 54]. The increased 
aggregation level of EGFR after ligand binding was suggested as a crucial step related 
to the signalling outputs [43, 55]. For example, Clayton and colleagues [31, 46, 48] 
reported that the average molecule number in the cluster increased with ligand binding 
and higher order receptor complexes augment the receptor phosphorylation. Associated 
with clathrin structures, the formation of higher-order oligomers was reported with 
almost complete EGFR homo-dimerization after ligand stimulation [56]. High 
expression level of EGFR was noticed to increase the fraction of homodimers even in 




hyperactive EGFR signalling. It was also reported that upon EGFR activation the cell 
membrane lipid environment was remodelled with induced nanocluster formation [57]. 
Unliganded receptors were also reported to form higher order oligomers on some cell 
lines within individual microdomains [46]. Regardless of the diverse nature of these 
reported high order oligomerization and clustering, the dynamic high order complexes 
and clustering of EGFR were believed to play crucial roles in the amplification the EGF 
signalling upon receptor activation [51, 58].  
1.1.2.2 EGFR endocytosis 
Binding with its cognate ligand EGF, the ligand-EGFR complexes are internalized by 
both chathrin-mediated and clathrin-independent endocytosis pathways. The clathrin-
mediated endocytosis (CME) with the rate constant Ke up to ~ 0.6 min-1 was considered 
to be the fastest internalization pathway [59]. Increased localization of liganded-EGFR 
complexes in clathrin coated pits (CCPs) has been observed and was regarded as one 
of the crucial internalization pathways [60]. The EGF-EGFR complexes were able to 
interact with clathrin binding protein AP-2 both on the cell membrane and early 
endosomes (EEs). The interaction procedure was considered to be similar to the 
constitutive proteins in CCP such as transferrin receptors (TfRs) [61, 62]. The CCPs 
sorting mechanism post EGF stimulation was shown to involve the EGFR kinase 
activity as well as many other interacting partners [63]. The most well-known 
interacting proteins were SH2 adaptor Grb2 and the ubiquitin ligase Cbl which bind to 
the phosphorylated tyrosine residuals [64-66]. The binding of Cbl via Grb2 was 
reported to regulate EGFR internalization and subsequent sorting, although EGFR 
ubiquitination was not necessary for its internalization [67]. 
The EGF-EGFR complexes were reported to be present in the early endosomes (EEs) 
2-5 min post ligand binding [68-70]. These complexes may remain intact or the ligand 
EGF dissociates from the receptor in the acidic environment. The activated EGFR 




heterodimers in EEs [71]. Both ligands bound and unbound EGFR could rapidly 
recycle back to the cell membrane via back fusion of peripheral early endosomes or 
retroendocytosis with tubular carriers typically within minutes [59, 72]. When the EEs 
developed into multivesicular bodies (MVBs) or sorting endosomes(SEEs), the inward 
membrane invagination incorporates EGF-EGFR complexes into intraluminal vesicles 
which are recycled at a slower rate ranging from minutes to hours [59]. Or the 
complexes may be targeted for degradation as the further development of these MVBs 
and SEEs gradually loses EE marker proteins such as Rab5 but increases in the amount 
of late endosomal proteins such as Rab7. The complexes would get degraded when the 
late endosomes with low pH got fused with primary lysosomes which contain the 
growth factor proteolytic enzymes [73].  
Meanwhile, the CME reaches saturation as revealed by kinetic analysis if a large 
number of cell membrane EGFR was bound with EGF [63]. The up-regulation of non-
clathrin mediated endocytosis (NCE) was reported with the increase of EGF 
concentration and EGFR expression levels [74]. The NCE could be either 
micropinocytosis-like endocytosis [63] or cholesterol sensitive domains [75, 76]. The 
micropinocytosis endocytosis was first reported for A431 cells expressing high levels 
of EGFR [77] and later discovered in many other cell lines [78, 79]. It was also reported 
that the micropinocytosis-like endocytosis is involved in the rearrangement of actin 
cytoskeleton and membrane ruffling [80].  
EGFR activation and its signalling cascades were controlled by endocytosis, with 
termination the signal initiated from the cell membrane [4]. However, subsequent 
studies have demonstrated the capability of EGFR to recruit signalling molecules in 
EEs and to maintain- the signal output [81, 82]. The CME of EGFR was proposed to 
regulate the sustained activation of the MAPK/ERK signalling pathway and stimulate 
the Akt pathway [83, 84]. The activated EGFR could induce and transmit signals both 




CME largely impaired the MAPK response and Akt activation, which argued for a 
primary role of EGFR signalling at the cell membrane [85]. Besides MAPK and Akt 
signalling pathways, EGFR activation may regulate many other signalling pathways, 
such as the STAT pathway. 
1.1.2.3 EGFR and cancer 
The aberrant activity of EGFR was found closely related to several types of cancer 
including glioma, non-small-cell lung cancer (NSCLC), head and neck cancer, 
esophageal cancer and colorectal cancer [86]. The EGFR mutation with the deletion of 
exons 2-7 (EGFRvIII) in the extracellular region was reported to associate with glioma 
[87].  The enhanced tumorgenecity of this mutation resulted from the constitutive 
dimerization of EGFR, which impaired the EGFR downregulation and leaded to 
aberrant receptor tyrosine kinase activity [88]. Other commonly documented mutations 
often found in NSCLC were reported as substitutions like leucine-to-arginine 
substitution at position 858 (L858R) or deletions in exon 19 [89]. Genetic alteration 
induced amplification of EGFR was also reported in various cancer types including but 
not limited to head and neck, glioma, and colorectal cancer [90]. Mutations and 
alterations in EGFR were reported to be transforming in laboratory models and resulted 
in carcinomas covering a wide spectrum [86].   
Given the great contribution of EGFR in modulating cancer cell growth, signalling, 
differentiation, migration and survival, EGFR has become an attractive therapeutic 
candidate [91]. The two currently common anticancer therapies targeting EGFR 
include monoclonal anti-EGFR antibodies which bind to the extracellular region and 
small-molecule tyrosine kinase inhibitors (TKIs) which target the intracellular tyrosine 
kinase domains [64].  
Monoclonal antibodies (mAbs) were specifically designed against the extracellular 




prevented receptor dimerization and autophosphorylation but preserved its 
internalization, ubiquitination and degradation, thus downregulating the EGFR 
signalling [14, 93]. Although the mAbs were specifically designed for EGFR activation 
inhibition, the exact interaction mechanism was still elusive [94, 95]. The clinically 
applied mAbs were usually recombinant immunoglobulin of type IgG1 (Cetuximab) 
and IgG2 (Panitumumab), both of which bind to human EGFR and downregulate 
EGFR signalling [64]. 
TKIs interacting on the intracellular tyrosine kinase domains were usually small 
synthetic molecules by nature either reversible or irreversible acting as ATP analogs 
[96]. Reversible TKIs competed with ATPs in a way of recognizing the kinase-active 
conformation while irreversible TKIs bound to those sites covalently with the specific 
reaction to nucleophilic cysteine residues [64]. Binding of TKIs to the receptors could 
prevent their autophophorylation, thus inhibiting the activation of downstream 
signalling pathways. The approved TKIs included Gifitinib, Erlotinib, Lapatinib and 
Canertinib, which were applied to different cancer types accordingly. 
Other novel therapeutic approaches involved the so-called chemo preventive agents 
such as Genistein, Curcumin and Caspacin, functioning in down regulating EGFR 
transcription. In addition, combinations of different therapies involving several 
components were often applied to enhance the overall treatment outcomes [64]. 
1.2 Physicochemical properties of cell membranes 
Cell membranes not only confer cells their spatial identity defining the boundary 
between interior and exterior spaces but also play an essential role in supporting and 
retaining the cytoplasm. Cell membranes also participate in the transportation of 
nutrients, molecular recognition, cell-cell communication and many other cellular 
processes. The versatile functions of cell membranes rely largely on their diverse 




1.2.1 Chemical composition of cell membrane 
The physicochemical properties of cell membranes were studied intensively to better 
understand the membrane composition and organization. This chemical composition is 
known to be diverse and cell membranes are constituted by over a thousand different 
lipids species, various proteins and different kinds of carbohydrates [97, 98]. Among 
all the constituents, lipids are the most abundant component across almost all biological 
membranes. Cells use about 5% of their genes in producing these different kinds of 
lipids [98]. The proteins can be categorized into either integral membrane proteins 
which are embedded inside the lipid bilayer or peripheral proteins which are thought 
to be loosely associated with the cell membrane surface via different lipid anchors. The 
integral membrane proteins represent about one-third of the human genome encoded 
proteins [99]. Moreover, the post translational modifications such as glycosylation, 
phosphorylation and nitrosylation add another layer of complexity to the cell 
membrane associated proteins. As for carbohydrates on the cell membrane, they are 
usually recognized as carbohydrate chains associated with either lipids or proteins to 
form glycolipids or glycoproteins which play important roles in cell-cell recognition 
and cell response [100]. 
Lipids classically defined as chemical components insoluble in water generally can be 
sectioned into a small hydrophilic polar head and a non-polar hydrophobic long acyl 
chain tail. The amphiphilic property, as the hydrophilic head tends to face towards the 
aqueous medium while the hydrophobic tail is shielded against the polar water 
molecules, becomes the intrinsic basis of the formation of lipid bilayer in aqueous 
environment. The planar lipid bilayer structure forms the basic skeleton which holds 
the whole assembly of all the lipids, proteins and carbohydrates. Cell membrane lipids 
utilize glycerophospholipids such as phosphatidylcholine (PC), phosphatidylserine (PS) 
and phosphatidylethanolamine (PE) as the major structural lipids [98]. Another class 




class of sphingolipids with ceramide as their hydrophobic backbone including 
sphingomyelin (SM) and the glycosphingolipids (GSLs) [98]. The major non-polar 
lipids in the cell membranes are sterols such as cholesterol which regulate membrane 
fluidity [101].   
The diverse lipid composition differs across different cell lines and even between the 
two leaflets of the cell membrane of some cells. Lipid asymmetry, i.e. the unequal 
distribution of lipids between the inner and outer leaflets, is been intensively studied 
[102]. The outer leaflet mainly includes phosphatidylcholines and sphingolipids while 
the inner leaflet contains more negatively charged lipids such as 
phosphatidylethanolamines, phosphatidylserines and phosphoinositides, with 
cholesterol found in both leaflets with different ratios [103]. The asymmetric 
distribution of cell membrane lipids was initiated with the study of erythrocytes which 
lack internal membranes [104, 105]. Later it was reported that the lipid composition 
differs between the apical and basolateral membranes in epithelial cells, with identical 
lipid composition in both outer and inner leaflets [106]. This bilayer asymmetry is 
further complicated by the embedded integral proteins, various peripheral proteins and 
the wide spectrum of lipid anchored proteins. Besides the transbilayer asymmetry, the 
inhomogeneous lipid distribution also contributes to the lateral membrane 
heterogeneity, forming membrane microdomains. The membrane heterogeneity is also 
recognized from specialized membrane structures such as caveolae and CCPs [107]. 
The membrane heterogeneity plays important roles in many membrane functions.  
1.2.2 Physical properties of cell membrane 
The chemical composition of the cell membrane affects its physical properties such as 
rigidity, surface charge and fluidity, which are important in maintaining its 
morphological structure as well as carrying out certain membrane functions. The 
membrane physical properties often modulate the function of membrane lipids as well 




and activity were reported to be regulated by the membrane thickness, curvature, 
fluidity and surface charge [109, 110]. 
The three-dimension nature of the cell membrane is constituted by the lipid bilayer with 
a thickness about 4 nm containing numerous lipids and various proteins which have 
different protrusions into the neighbouring environment [111]. The cell membrane 
presents different morphologies even within the same cell. For instance, in polarized 
cells the apical membrane is distinct from the basal membrane not only in the 
composition but also in the activity. Specific structures such as caveolae, podosomes 
and many others can exist on the cell membrane to carry out particular functions. 
Moreover, the two leaflets of the cell membrane are also known to be asymmetric, 
which differ in their composition, structure and local surface charge [112]. The outer 
leaflet contains more lipids with large glycosylated headgroups while nearly all anionic 
lipids are found in the inner leaflet in eukaryotic cells [113].  
The fluidity of the cell membrane is an important feature which attracts much attention. 
It is affected by several factors including membrane composition, temperature and lipid 
phase behaviour. Lipids as the most abundant component in the cell membrane mainly 
can be classified into three groups according to their phase behaviours [98]. 
Unsaturated fatty acyl chain lipids such as PC are usually fluid at room temperature, 
which form the liquid disordered or fluid phase (Ld). Lipids with saturated tails 
generally adopt the so-called solid gel or solid ordered (So) phase at room temperature. 
The third group is the non-polar cholesterol which is quite unique in the phase diagram 
[114]. The physical properties such as interacting forces and fluidity of lipids were 
thought to contribute to membrane microdomains [115]. The acyl chain saturation level 
and chain lengths also contribute to the lipid phase transition and determine the lipid-




Substantial studies have described the lipid phase behaviour caused by temperature 
effects and lipid compositions. Model membrane systems with defined composition 
assist in understanding the phase transition behaviour [116]. In the single component 
system, the So phase to Ld phase transition occurs when temperature increases beyond 
a certain value, which is defined as the melting temperature (Tm) [117]. In two-
component lipid bilayers, high melting saturated and low melting unsaturated lipids 
can coexist between So and Ld phases or form liquid ordered (Lo) domains. In high- and 
low-melting lipids and cholesterol ternary systems, Ld and Lo can coexist and differ in 
their lateral diffusion [118]. The lateral diffusion in the Ld phase is reported to be more 
than twice faster than that of the Lo phase. Similar diffusion differences are also 
reported as lipids diffuse slower in the So compared to the Ld phase [119]. Cholesterol 
is reported to rigidify the Ld phase but cause fluidization of the So phase [120]. It was 
often found enriched in the detergent resistant membrane (DRM) fraction in membrane 
biochemical studies, thus confirming the notion that cholesterol-dependent phase 
segregation observed in artificial membranes somehow resemble lipid raft formation 
in live cell membranes [121-123]. However, membrane lipid rafts cannot be assumed 
to be the result exclusively of the lipid phase segregation or simply regarded as the 
DRMs [124]. These three originally distinct concepts often get confused and should be 
clarified when referring to some early membrane extraction studies. The lipid and 
protein interactions in the cell membrane are much more complex than in artificial 
systems. The misled identification of rafts with DRMs should be carefully evaluated 
given the artefacts during the extraction [125]. The approach of chemically well-
defined lipid mixtures is used to clarify the physical-chemical mechanism behind the 
behaviour of biological membranes. This approach has helped unravel much 




1.3 Cell membrane dynamics and organization 
Biochemical and molecular studies suggest that diverse membrane functions require 
interactions among the various membrane molecule species [126-128]. The highly 
organized structures with heterogeneity in lateral structures and asymmetry between 
inner and outer leaflets play critical roles in generating various functions [123, 129, 
130]. It has been shown that signal transduction [35], endocytosis [131] and exocytosis 
[132], cell adhesion [133], cell spreading [134] and many other important membrane 
functions [135, 136] depend critically on the unique membrane dynamics and molecule 
interactions which are spatiotemporally strictly regulated. These intricate regulations 
include not only the lateral interactions of membrane molecules but also the coupling 
of the intracellular and extracellular leaflets [111]. The complicated interplay between 
membrane components spans over a broad range both in length and time scales, which 
leads to a unique and complex membrane organization [123, 137]. 
Understanding of cell membrane organization has evolved extensively  from the classic 
fluid mosaic model first introduced in 1972 [138]. According to this model, the cell 
membrane is formed by a homogeneous lipid bilayer in a fluid state including globular 
assemblies of various proteins. Both the lipids and proteins can diffuse laterally in the 
membrane. Many new insights have been continuously updated and modifications were 
made to this model accordingly.  
1.3.1 Lipid raft model  
Lipid rafts were proposed to explain the more complex structure of the cell membrane 
[139]. They were first described as membrane lipid assemblies that were organized into 
microdomains with specific composition to function as sorting platforms mediating 
membrane trafficking and cell signalling [139]. However, the mechanism and 
biophysical basis of lipid raft formation, structure, dynamics and function are not 
clearly understood at that stage. Several models for lipid rafts have been proposed to 




Soon after, another model proposed that lipid complexes composed of self-assembled 
cholesterol and phospholipids would associate with certain proteins, forming molecular 
complexes on the membrane [140]. In this model, each condensed complex, also called 
a lipid shell, is usually formed by 15 to 30 molecules with a 2:1 stoichiometry of 
sphingolipid:cholesterol. These lipid shells may or may not exist as discrete phases that 
differ from the surrounding membranes. They can target the protein-lipid assembly to 
preexisting caveolae/lipid rafts and their aggregation forms larger domains. They also 
account for the distribution of both clustered and non-clustered proteins found in lipid 
raft [140].  
Later a third model was proposed describing lipid rafts as small, unstable membrane 
complexes [141]. The main difference of this small/unstable reserve raft model from 
the previous lipid shell model is the lifetime of the rafts as well as the molecule numbers 
or in another term the raft diameters. The lipid rafts can merge into larger stabilized 
rafts by stimulation induced clustering of raft-philic molecules.  
In the same year, Mayor and Rao suggested that conventional approaches treating 
membrane as passive, thermally equilibrated systems should be refined in 
understanding the raft-organization in vivo [142]. They suggested that lipid rafts are 
small, dynamic, pre-existing lipid assemblies, which can be induced to form large-scale 
and more stable lipid rafts. The rafts are considered to be actively players in cell 
functions such as membrane protein sorting [143].  
The large body of lipid rafts research mentioned above reflects the diversity of the raft 
composition, size and stability. However, those proposed models describing the nature 
of the lipid rafts are not mutually exclusive.  
A consensus definition for the membrane rafts was brought up during the Keystone 
Symposium on Lipid Rafts and Cell Function in 2006. The definition reads: 




sphingolipid-enriched domains that compartmentalize cellular processes. Small rafts 
can sometimes be stabilized to form larger platforms through protein-protein and 
protein-lipid interactions” [144]. In this context, the membrane rafts are considered one 
kind of membrane domains with certain compositional and functional properties. It 
should be noted that DRMs and the Lo phase were not used in this definition as an 
agreement was achieved that in complex cell membranes no evidence was found for 
the presence of ordered phases. Moreover, this definition has been continuously revised 
with more evidence provided by theoretical and experimental studies. 
Based on the consensus of membrane rafts definition, Jacobson et al. discussed about 
the hierarchical organization of lipid–protein composites in biological membranes 
[145]. Given the high density of transmembrane proteins, the membrane should be 
treated as lipid-protein composites instead of proteins floating in the lipid ‘sea’. The 
membrane proteins are supposed to impose order to the lipids surrounding nearby [145] 
and the membrane-cytoskeleton (MSK) interactions will affect the organization of the 
microdomains [146, 147]. It was reported that membrane rafts contain actin binding 
proteins and actin regulating lipids, which will regulate the F-actin arrangement [147]. 
At the same time, cytoskeleton also plays a role in stabilizing the membrane rafts. 
However, many questions such as the size, shape, composition, density, lifetime and 
function of the rafts remain to be elusive [145]. 
Analysing the functionalized condition of rafts can be one way of assessing the 
molecular organization of rafts, as chemical specificities with phase segregation will 





Figure 1.1 Raft based membrane heterogeneity. 
(a) Nanoscale assemblies of sterols such as cholesterol, sphingolipids such as 
sphingomyelin and glycosphingolipids (GSLs), and proteins in the cell membrane 
fluctuate in composition. GPI-anchored proteins, transmembrane raft proteins and 
acylated cytosolic proteins are postulated constituents of these assemblies, which can 
be modulated by actin filaments. Not much is known about the state of nanoscale 
assemblies in the cytosolic leaflet of the membrane. Transmembrane non-raft proteins 
are excluded from these assemblies. (b) In response to external signals or the initiation 
of membrane trafficking events, raft platforms are formed from fluctuating assemblies 
through lipid–lipid, lipid–protein and protein–protein oligomerizing interactions. 
These platforms are important for membrane signalling and membrane trafficking. (c) 
Micrometer-sized raft 'phases' can be induced at equilibrium. This figure is adapted 
from [148] under copyright permission (doi:10.1038/nrm2977).  
Membrane proteins with specific lipid modification such as palmitoylation were 




allows membrane rafts function as signalling platforms, facilitating protein-protein 
interaction by concentrating some proteins and excluding others.  
The revised raft model proposed that proteins may function in organizing the lipids 
distribution [123].  It works together with sphingolipid-cholesterol specific assembly 
in forming raft-based membrane heterogeneity. In addition, the fluctuating nanoscale 
assemblies with preferential interactions between specific proteins, sphingolipids and 
cholesterol will be stabilized into larger structures functioning as signalling platforms 
[148]. The raft based heterogeneity is depicted in Figure 1.1. The size, lifetime, 
composition and stability of the rafts are of crucial importance in regulating the 
functions of cell membranes [123]. The main functions of these lipid rafts include the 
rearrangement and trafficking of membrane associated proteins as well as membranes 
[150], facilitating signal transduction [151, 152] and cell polarization [153]. Proteins 
enriched in lipid rafts are inherently linked to cell membrane functions and different 
types of proteins get concentrated in rafts, such as the most prominent 
glycosylphosphatidylinositol anchored proteins (GPI-APs) [154]. 
The enrichment with sphingolipids and cholesterol makes lipid rafts more rigid than 
the surrounding fluid matrix, which is considered as obstacles of free diffusion [155, 
156]. Other membrane activities such as endocytosis signal transduction and membrane 
intracellular tracking are also regulated by the lipid rafts [153, 157, 158].  
Recent studies have shown that cell membrane organization is also influenced by 
cellular levels of cholesterol and sphingolipids [159]. An alternative membrane 
sphingolipid-enriched domain in different sizes was proposed with the accumulating 
evidence of biophysical studies [160-162]. These sphingolipid-enriched domains were 
shown to interact with cholesterol indirectly with a complex mechanism involving the 




organizing to the membrane rafts organization should be evaluated with more care to 
include other factors such as actin cytoskeleton.  
1.3.2 Picket-fence model 
The role of the actin cytoskeleton in cell membrane organization has been recognized 
for a long time [163]. The actin filaments in close spatial association with the cell 
membrane inner leaflet were observed to provide both confining and binding effects 
on membrane proteins, affecting membrane domain formation [164]. Another model 
emphasizing the pivotal role of the cytoskeleton and transmembrane proteins in 
membrane compartmentalization is the picket-fence model based on single-particle 
tracking (SPT) [165, 166].  
The long neglected fact for membrane lipids and proteins is that the diffusion 
coefficients in cell membranes are usually 5 to 50 times (20 is a good round number as 
an estimate) slower than the values obtained from artificial membranes in Single 
Particle Tracking (SPT) studies [111, 137]. This high retardation in membrane 
diffusion cannot be explained by protein crowding or the presence of cholesterol [167, 
168]. Even if crowding and cholesterol effects are combined, only a 20% difference 
can be explained [111]. This enigma was addressed by introducing actin filament 
fences and transmembrane (TM) proteins pickets into the membrane organization. 
In this model, TM proteins were supposed to associate with the actin cytoskeleton by 
their cytoplasmic protruding domains. The collision or the direct connectivity of the 
TM protein cytoplasmic domain with the actin skeleton could induce temporary 
confinement or immobilize the TM proteins along the cytoskeleton. These TM protein-
membrane skeleton (MSK) interaction would function in corralling TM proteins by 
MSK. Meanwhile, the immobilized TM proteins along the MSK serve as pickets 
hindering protein and lipid diffusion. The dimension of the membrane confinement 




mainly caused by MSK imbedded beneath the membrane [169]. The immobilized TM 
proteins aligned to the MSK not only act as steric obstacles or pickets for free diffusion 
but also cause hydrodynamic friction-like effects increasing the viscosity of the 
membrane nearby. The great decrease of molecule diffusion caused by friction-like 
effects was supported by the observation of faster lipid diffusion along polarized 
membrane skeleton axial directions compared to the circumferential direction [170].  
 
Figure 1.2 The membrane skeleton fence model and the anchored protein picket model. 
Schematic side view of the cell membrane, showing the membrane skeleton (MSK), 
the diffusing transmembrane (TM) protein (red), and a TM protein anchored to the 
MSK, acting as a picket (blue). The cell membrane can be partitioned into closely 
apposed domains (compartments) for the translational diffusion of membrane 
molecules. All of the membrane constituent molecules undergo short-term confined 
diffusion within a compartment and long-term hop movement between these 
compartments (hop diffusion). The compartment boundaries are made of actin-based 
membrane skeleton (fence) and TM proteins anchored to and aligned along the actin 
fences (pickets, including the TM proteins transiently bound to the actin fences). The 
figure is adapted from [171] under copyright permission. 
The motion of the membrane molecules was characterized by the hop diffusion 
between the confined meshes with two diffusion rates, i.e. micro- and macroscopic 
diffusion rates. The molecules diffuse freely inside the cytoskeleton mesh (microscopic 
diffusion) while intermesh hopping results in the macroscopic diffusion. The TM 




been reported to exhibit such diffusion, with an average spatial confinement of 30-230 
nm and rare hops of 1-50 ms [169, 171-173]. The free diffusion rate inside the meshes 
is comparable to what was observed in artificial membranes while the macroscopic 
diffusion in the long-range is greatly retarded. This short-range and long-range 
diffusion rates explain the enigma of the 20 times difference in the diffusion coefficient 
of artificial and cell membranes [111]. In addition, both lipid rafts and protein 
oligomers can move as entire assemblies within the cytoskeleton mesh with a slow 
diffusion rate and they also get confined by the picket fences. A most recent 
computational work demonstrated that less than ~22% immobile particles in the 
membrane can cause the ~20 times reduction in the diffusion coefficient [174]. 
The role of the picket-fences in membrane receptor clustering and signalling is 
controversial. Some studies reported that the picket fences posited inhibitory effect on 
cell signalling [175, 176], while other evidence suggested that the actin cytoskeleton 
facilitated the receptor clustering and would promote the downstream signalling [177, 
178]. 
1.3.3 Active composite model 
The picket-fence model addressed the cortical actin as a major regulator in the 
membrane organization mainly based on SPT study results. Early SPT studies have 
also shown that GPI-anchored proteins would be trapped in the transient confinement 
zones (TCZ) and the confinement was sensitive to cholesterol extraction [179, 180]. 
Many biochemical studies have revealed that GPI-anchored proteins (GPI-APs) enrich 
in the DRM fractions together with cholesterol and were often used as a raft marker on 
cell membranes [123, 139]. However, the relationship between the TCZ confinement 
and the cholesterol sensitive lipid raft-like domains has not been fully revealed yet. The 
dynamics and distribution of GPI-APs on the membrane by biophysical and 




organization [181]. The active composite model was proposed to explain the dynamics 
of GPI-APs on cell membrane [135].  
Early homo- and hetero-Fluorescence Resonance Energy Transfer (FRET) study 
revealed that GPI-APs existed as monomers on the membrane and at least 20–40% 
GPI-APs from the membrane pool formed cholesterol-sensitive sub-resolution 
nanoscale clusters [182]. These clusters were found to be constituted by two to four 
molecules and undergo continuous remodelling by intermixing multiple GPI-AP 
species. Further study reported that these clusters were immobile and presented a 
constant ratio against monomers independent of total expression levels [183]. The 
highly dynamic nanoclusters and monomers involved in the continuous aggregation-
fragmentation process with rates at ~0.1 s, which was insensitive to temperature change 
from 24-37 °C [183]. The correlation between the clusters dynamics and the 
remodelling of cortical actins has shown that the activity of the cortical actin would 
drive the lipid-tethered protein dynamics.  
 
Figure 1.3 Active composite model. 
Short filaments organize into aster like configurations which template the organization 
of membrane proteins that have actin-binding capacity, and lipid anchored components 
that couple across the bilayer, connecting to the actin filaments at the inner leaflet. The 
consequences of this active actin engagement are the key for the active composite 




The active actin treadmilling and myosin contractility was suggested to found the 
physical basis for the membrane surface molecule nanoclustering. GPI-APs and a 
variety of cell-surface molecules which directly or indirectly interact with the cortical 
actin would bind transiently onto the cortical actin. The transiently-bound molecules 
were supposed to be actively driven by the actin filaments via control of actomyosin 
contractile forces and tread-milling, which resulted in local molecule clustering [184]. 
This local naoclustering of the active complexes would greatly enhance the chemical 
reaction rates at the nanoscale smaller than 10 nm [185].  
The active composite model presented new insights into the membrane organization 
taking chemical processes into consideration. These chemical processes mainly 
included the interactions between cell surface molecules with the cortical actin and 
inter-molecule interactions [135]. The local engagement of the cortical actin machinery 
accounted for the cellular regulation and a classification criterion of membrane 
molecules was proposed based on this engagement. According to the molecule 
interaction with the actin filaments, membrane molecules in this model were defined 
into three classes, namely inert, passive and active. The inert molecules like short-chain 
lipid on the outer leaflet would couple hydrodynamically with the static mesh but not 
the dynamic actin. The passive molecules such as GPI-APs were supposed to couple to 
the dynamic actin filaments by direct or indirect interactions without affecting the actin. 
As shown in the Figure 1.3, they could be transiently clustered in nanocluster enriched 
domains, which were created by actomyosin contractility. The active molecules were 
assumed to represent surface components like integrins and T cell receptors, which 
would affect either the dynamic actin filaments or myosin motor activity (or both) [184]. 
In addition, the localized focusing platforms brought up in this model addressed the 
key step of constructing regulatable microdomains, else known as active rafts in the 




1.3.4 Three-tiered architecture of the cell membrane 
The aforementioned three models are not mutually exclusive and the different 
principles may all contribute to the cell membrane organization. The major difference 
between the active composite model and previous models is the new perspective of 
viewing the cell surface as an energy-consuming system [135]. The compartmentalized 
view of the cell membrane was earlier proposed to describe the hierarchical three-tiered 
architecture of the cell membrane. Three types of mesoscale domains were summarized 
by Kusumi’s group [111]. The term mesoscale refers to the spatial scale greater than a 
nanometer but smaller than micrometer (typically 2-300 nm), which covers the spatial 
range of many membrane molecule and domain dynamic activities [111]. The actin 
membrane-skeleton-induced compartments are thought to be the most basic and 
essential domains, creating the first tier of the cell membrane architecture. They usually 
span over the dimension of 40-300 nm. The raft domains enriched in cholesterol, 
glycosphingolipids and GPI-APs are regarded as the second-tier domains in the 
hierarchy. Generally, the size of the raft domains is between 2 nm to 20 nm. The third-
tier mesodomains take the dynamic protein complex domains into account. These 
domains are often composed of membrane protein dimers, oligomers and inter-species 
complexes. They are generally on the scale of 3-10 nm in diameter [111]. The key 
feature to distinguish between protein complex domains and raft domains is the 
involvement of lipid-lipid interaction. The lipid interactions are not found in the protein 





Figure 1.4 Three-tiered hierarchical mesoscale-domain architecture of the cell 
membrane. 
(1) Membrane compartments, generated by the partitioning of the entire cell membrane 
by the membrane-associated actin-based membrane skeleton (MSK fence) and 
transmembrane (TM) proteins anchored to the MSK fence (pickets, not shown in this 
figure). (2) Raft domains enriched in cholesterol, glycosphingolipids, and 
glycosylphosphatidylinositol (GPI)-anchored proteins, with sizes limited by the 
membrane compartments. (3) Dynamic protein complex domain composed of dimers 
and greater oligomers of integral membrane proteins, which may exist only transiently. 
This type of domain also includes coat-protein-induced and scaffolding-protein-
induced protein assemblies. Adapted from [111] under copyright permission. 
As shown in Figure 1.4, the first-tier actin-based membrane skeleton formed the base 
scaffold for the membrane structure and carried out membrane functions together with 
the other two tiers synergistically. The sizes of the lipid rafts were limited by the 
membrane actin skeleton compartments. Meanwhile, the association of actin meshwork 
with the membrane leaflets enhances the microdomain formation and generate 
membrane subdiffusion. Both experimental and theoretical studies have shown that this 
increases the membrane reaction efficiencies and signalling outputs [183, 186]. The 
third-tier dynamic protein complex domains were also coupled with the first-tier 
membrane actin meshwork. The membrane pickets and fences were believed to 
facilitate the protein oligomerization and protein complexes formation. The 
oligomerization-induced trapping dictated the enhanced confinement. Binding of 
protein complexes to the membrane actin meshwork could be due to the avidity effect. 
The actin polymerization could also be initiated at the oligomerization site. The 




communication between meshes. Protein complex formation was regulated by the size 
and number of actin meshes. If the protein complex formation was raft-associated on 
top of oligomerization, the regulating mechanism could be multi-faceted. The coupling 
of the raft domains and protein complexes was critical in connecting the second and 
third tiers of membrane organization mesodomains together. Protein-protein 
interactions were crucial in the formation of raft domains and recruitment of the 
molecules into raft domains. It was also important in the function of raft domains for 
signalling pathways by exemplifying the signal or transporting molecules. Meanwhile, 
the assembly of molecules in the rafts within one meshwork could either enhance or 
suppress the related signalling pathways. The coupling of the three-tier mesodomains 
worked cooperatively to regulate the molecule behaviours and tune the signalling on 
the cell membrane [111, 137]. 
1.4 Biophysical approaches to membrane study 
1.4.1 Diffusion based techniques 
Early membrane biochemical studies have accumulated much information about 
membrane compositions. However, dynamic membrane behaviour together with its 
nanoscale organization was not possible to observe due to technical limitations. The 
implementation of diffusion based biophysical techniques opened up the way to 
investigate membrane dynamics in live cell membranes. Several diffusion based 
biophysical approaches have been adopted in studying cell membrane dynamics and 
organization. The most commonly utilized experimental methods include Fluorescence 
Recovery After Photobleaching (FRAP), Single Molecule or Particle Tracking (SMT 
or SPT) and Fluorescence Correlation Spectroscopy (FCS).  
1.4.1.1 Fluorescence Recovery After Photobleaching (FRAP) 
FRAP dates back to the 1970s and was initially utilized to measure diffusion in 




with the progress in genetic engineering in fluorescent proteins (FPs) and the 
development of new microscope modalities like the confocal microscope [188, 189]. 
The working principle of FRAP depends on the property of fluorophore photobleaching. 
In a typical FRAP cell membrane measurement as depicted in Figure 1.5, fluorophores 
within a specified region of interest (ROI) are irreversibly photobleached by a transient 
high-intensity laser. After bleaching, the fluorescence recovery inside the bleached ROI 
is recorded over time applying a low-intensity laser. The recovery originates from 
dynamic processes including diffusion, binding, dissociation and/or  transport from 
neighbouring regions [190]. The information embedded in the recovery needs careful 
interpretation and various kinetic models may need to be tested and verified [191, 192]. 
Sometimes a complementary technique named fluorescence loss in photobleaching 
(FLIP) was also employed, which monitored the fluorescence loss in the unbleached 
region during photobleaching. 
 




(A) Cell membrane is photobleached by high laser power and slowly recovered after 
bleach. (B) The fluorescence intensity inside ROI is plotted against time.  
The fractional recovery in fluorescence was recorded and plotted against time to 
quantitatively analyse the experimental data (Figure 1.5 B). The mobile fraction (Mf) 
was determined by the ratio of maximal recovery intensity to the pre-bleach intensity. 
It represented the fraction of fluorophores that could participate in the exchange 
between the bleached region and non-bleached region. The time 1/2 denoted the time 
required to reach half the maximum of full recovery. The shorter time (smaller 1/2) was 
expected for faster fluorescence recovery, hence a faster diffusion rate [193]. The exact 
value of the diffusion coefficient is obtained by fitting the recovery curve with 
theoretical models. 
FRAP is commonly used in recovering the protein diffusion in cell membranes and 
helped answering protein regulation principles in membranes. For example, Ganguly 
et al. reported that the mobile fraction of the serotonin 1A receptor increased when the 
actin cytoskeleton was destabilized [176]. FRAP measurements were also applied to 
reveal the regulation of cholesterol-dependent domains and their relation to G protein-
coupled receptors(GPCRs) [194]. 
1.4.1.2 Single Molecule Tracking (SMT) 
Single molecule tracking is an alternative method to recover molecular mobilities 
quantitatively by tracking individual or small groups of fluorophores over time [195]. 
Antibody-coated colloidal gold was commonly used in the tracking. It represents a 
strong Rayleigh scatter, which gives a typically detectable diameter of 30-40 nm [195, 
196]. The specific attachment of fluorophores to the molecule of interest was the first 
critical step for single molecule tracking. The most popular probes used up to date 
include gold nanoparticles, quantum dots (QDs) and cyanine dyes (Cy) [197, 198]. 
These probes provide better photostability than fluorescent proteins and stronger signal 




resolution microscopy single particle tracking (SPT) has been realized. With the 
development of single-emitter super-resolution techniques such as photoactivation 
localization microscope (PALM) and stochastic optical reconstruction microscopy 
(STORM), SPT conducted with nanometer precision [199, 200]. 
The spatial resolution of SPT is restricted by the labelling fluorophore size while the 
temporal resolution is dependent on the frame rate of the detector. With video rate 
temporal resolution ~ 2 nm precision was achieved by colloidal gold for membrane 
receptors and motor proteins on live cells [163, 196]. Higher temporal resolution of 25 
s was reported before for lipid measurements on cell membranes [166]. By operating 
a camera at fast and slow acquisition rates, the fast microscopic diffusion within the 
cytoskeleton mesh and the long range macroscopic diffusion could be registered, 
respectively [171, 201]. Employment of this video rate SPT led to establishment of the 
‘picket-fence model’ in the hierarchical organization of membranes [171]. 
 
Figure 1.6 Schematics of SPT measurement. 
(A) Molecule coordinates on the images were recorded with time gap T. The 




displacement (MSD) plot. The net displacement of the molecule was plotted with lag 
time. If the MSD = 4Dt, it was pure diffusion. Otherwise non-Brownian diffusion 
modes existed on the membrane. Different from FRAP which mainly relied on 
fluorophore photobleaching, SMT required a stable fluorophore over the time of 
detection. The dynamic moving behaviour of the molecule was recorded as an 
individual trajectory on the membrane surface. As shown in Figure 1.6, the molecule 
coordinates at each time on the surface was recorded, generating a single molecule 
trajectory [202]. The Mean Square Displacement (MSD) plot is often used to quantitate 
the trajectory. By analyzing the trajectories, the rates and modes of the diffusion were 
determined for the particular molecule with nanometer precision [198]. Several modes 
of motion could be recovered from the MSD plot, including free diffusion, anomalous 
diffusion, flow and confined diffusion [197].  
1.4.1.3 Fluorescence Correlation Spectroscopy (FCS) 
Another prevalent method for membrane dynamics is fluorescence correlation 
spectroscopy (FCS) [203]. Analysing the fluctuations in the fluorescence signal, FCS 
can resolve the underlying molecular processes by extracting the quantified parameters 
such as diffusion coefficients and concentrations [204]. Fluorescence correlation 
spectroscopy (FCS) has become a commonly tool in biophysics [205].   
The first implementation for FCS was achieved more than four decades ago and was 
used to address chemical kinetics in solution [206, 207]. The signal-to-noise ratio (S/N) 
and accuracy of measurements have been improved very remarkably with the 
technological advances since its inception. The introduction of confocal microscopy 
and fluorescent proteins (FPs) significantly contributed to the application of FCS in 
cell measurements [208-211]. Conventional confocal-FCS measurements took 
advantage of the small observation volume generated by the pinhole, which rejected 
the out-of-focus light. The fluorescence fluctuations inside the focal volume are 
recorded and are analysed via their autocorrelation function (ACF). The detailed 
mathematical deduction regarding the data analysis will be further discussed in the FCS 
theory chapter. The two critical parameters extracted from the ACFs are the diffusion 
time D and the number of particles N. Diffusion time D represents the characteristic 
time the molecule takes to transit through the focal volume while the particle number 
N denotes the average number of particles within the detection volume. This enable 




the membrane molecule interaction can be indicated by the quantified change of 
diffusion time [212-214]. Binding of ligands to membrane receptors was also resolved 
by FCS measurements [215]. The membrane viscosity or the membrane lipid packing 
was probed by monitoring fluorescent lipid analogs in the membrane [216].  
Early studies on model membranes employed FCS to detect fluidity differences and 
distinguish various phases between lipid domains [119, 217]. Lipid mobility measured 
by confocal FCS was proven to serve as a good fingerprint for the model membrane 
phase compositions [218]. The role of cholesterol concentration in determining phase 
separation and curvature was revealed by FCS monitoring the dynamic lipids 
redistribution between phases in the model membrane [219]. After replacing the 
unsaturated phospholipids with saturated ones, the role of cholesterol in sorting was 
further characterized by the same approach [220]. The measured lipid diffusion 
coefficient (D) by confocal FCS changes as a function of unsaturated 
glycerophospholipid chain length [120]. Confocal FCS combined with other 
techniques is often employed in exploring model membranes. For example, the lipid 
lateral diffusion and membrane phase structure modulation by protein binding was 
characterized by the combination of confocal FCS and infrared absorption 
spectroscopy [221]. The structure and dynamics of DOPC/SM/cholesterol model 
membranes were measured by applying the combined atomic force microscope (AFM) 
and confocal microscope [222]. The membrane lateral organization and mechanical 
properties were probed by AFM imaging and force measurements while the lipid 
phases with the partition coefficients and diffusion coefficients were detected with two-
focus scanning FCS [222]. This combined approach also reveals the reorganization of 
raft domains, whose formation was driven by short- and long-chain ceramide [223].  
Confocal FCS and its derivatives also greatly contributed in revealing the cell plasma 
membrane dynamics and organization. Early FCS measurements with lipids analogs in 




motion, different from results on giant unilamellar vesicles (GUVs) [224]. The 
diffusion behaviours in the heterogeneous cell membrane were suggested to be more 
complicated compare to the model membrane systems. The raft marker cholera toxin 
B subunit and nonraft marker 1,1'-dioctadecyl-3,3,3'3'-tetramethylindocarbocyanine 
(DiI) can be distinguished in the cell membrane simply by the different diffusion 
coefficients (D) measured by FCS [225]. FCS measurements also showed that the 
diffusion behaviours in the model and cell membranes are different after raft 
perturbation [225]. Furthermore, the combination of confocal FCS and other methods 
also shed light on investigating proteins on the live cell membranes. For instance, FCS 
measurements associated with fluorescent intensity distribution analysis (FIDA) 
demonstrated that EGFR on live CHO cells exist as monomers together with clusters 
of dimer and higher order oligomers [38]. 
Moreover, the single molecule sensitivity of FCS allows it to detect membrane 
molecules at their physiological expression levels which are usually quite low in the 
pM to nM range. The investigation of C-peptide binding to GPCRs was conducted to 
show specific binding at single-molecule sensitivity [226]. It was also shown to be able 
to detect the lateral mobile fraction of membrane receptor among receptors clusters at 
high expression level (~3,000-4,000 receptors/m2) [227]. Membrane sub-resolution 
organization [228, 229], peptide-membrane interaction [230], receptor-antagonist 
complexes formation [231], receptor and downstream signalling molecule interactions 
[232] are among the important membrane parameters provided by FCS. 
1.4.2 Imaging techniques 
1.4.2.1 Super-resolution approaches 
Light microscope imaging has a fundamental limitation in spatial resolution inherent 
from the diffraction limit determined by the wave nature of light. The diffraction limit 




is larger than half the wavelength of light. For a given set-up, the point spread function 
(PSF) is usually taken to quantify the spatial resolution with its full width at half 
maximum (FWHM). Practically, both the wavelength of the light (λ) and the numerical 
aperture (NA) of the objective will affect the spatial resolution of the images. The 
Rayleigh criterion (R = 0.61 λ/NA) is a manual of the resolution and determines the 
minimal resolvable distance in light microscopes, which is about 200 nm. For many 
biological structures and processes, however, higher resolution is required. Different 
imaging techniques were developed to overcome the diffraction limit and super-
resolution imaging has become a powerful imaging tool in biological studies during the 
last two decades. 
The most commonly available super-resolution techniques nowadays include Single 
Molecule Localization Microscopy (SMLM), Stimulated Emission Depletion (STED) 
microscopy and Structured Illumination Microscopy (SIM). Each of these techniques 
has their specific ways bypassing the theoretical optical resolution limit [233-235]. 
Theoretical studies discussing their individual strengths are well documented [236, 
237]. A recent experimental study also compared the imaging performance of these 
three techniques and provided practical suggestions in choosing specific method for 
particular biological samples [238].  
Total internal reflection (TIR) was employed in single molecule localization 
microscopy to reduce the background noise [237, 239, 240]. Thus, SMLM, including 
the PhotoActivation Localization microscopy (PALM) and STochastic Optical 
Reconstruction Microscopy (STORM), is a powerful tool for membrane measurements. 
These two methods rely on localizing the fluorophore more accurately and primarily 
differ in the fluorophores used for the labelling. PALM originally employs the 
fluorophore of endogenously expressed photoactivatable fluorescent protein such as 
photoactivatable-GFP (PA-GFP) while STORM is performed by tagging the samples 




between fluorescent on-state and off-state either by photobleaching or by reversible 
fluorophore activation, SMLM achieved higher spatial resolution by localizing 
molecules at different time [241-243]. Only a subset of the membrane fluorophores 
will be exited and emit photons at each imaging cycle. A few thousand to tens of 
thousands of images will be taken and fluorophores on the membrane will be recorded 
in the image series. When the molecule is sparsely separated from the individual frame, 
each fluorophore can be determined by pinpointing their localization with improved 
accuracy typically smaller than the optical resolution. The images recording different 
molecule localizations can be reconstructed into the super-resolution image. The higher 
accuracy of the localization improves the image resolution to a much better level than 
the diffraction limit. Nowadays, the SMLM can reach a spatial resolution of ~20-30 
nm [244, 245] or even 10 nm with further optimization [246].  
1.4.2.2 Super-resolution membrane studies 
SMLM imaging has provided previously unattainable images of membrane 
organization including lipid domains, lipid-protein complexes and protein-protein 
complexes [247]. The complex lipids and protein distribution in the membrane has 
important implications in carrying out certain cell functions [123, 148]. The 
heterogeneous membrane arrangement may arise from the specific lipid segregation, 
protein-protein interactions and cytoskeleton imposed physical barriers on the 
membrane [165, 248]. By imaging at nanometer scales, SMLM technique has enabled 
unravelling the membrane sub diffraction structures which often have pivotal 
physiological relevance.  
The early work in living cell membranes used fluorescence photo-activation 
localization microscopy (FPALM) to image the hemagglutinin (HA) protein clustering 
at ~40 nm resolution [249]. The membrane distribution of nanoscale clustering of HA 
was demonstrated and more recent work had revealed the dynamic relationship 




characterized various membrane proteins such as T cell receptor (TCR), paxillin and 
many others [251, 252]. SMLM can also combine with other techniques in revealing 
membrane protein nanoscale information. For instance, SMLM imaging together with 
fluorescence cross-correlation spectroscopy (FCCS) and transmission electron 
microscopy (TEM) has recovered that TCR exist as protein clusters on the T cell 
membrane and will concatenate with the adaptor molecule Lat after activation. The so-
called sptPALM combines PALM with live cell SPT to monitor the single molecule 
motions with spatially resolved maps. The membrane protein Gag and VSVG was 
previously probed by this approach [199].  
The membrane clustering is of particular interest in SMLM studies, which offer 
insights in sub-resolution membrane organization. Several methodologies have been 
brought up in analysing clusters in the super-resolution images.  One commonly used 
methodology in cluster quantification is the Ripley’s K-function (Ripley.1977). The 
non-random distribution of membrane proteins such as Src proteins was shown to be 
recovered by this approach [253]. Gaus’s group employed this method to identify the 
conformational states of Lck kinase in clustering and how Lck kinase links the 
intramolecular distribution with intermolecular patterning [254]. Recently, a model-
based Bayesian approach based on Ripley’s K-function analysis was proposed to 
evaluate the molecule cluster assignment [255]. This new approach was validated by 
both simulation and experiments with CD3 protein in resting and activated T cells.  
Another prevalent approach to decipher the membrane protein clusters is quantification 
by pair-correlation analysis. For example, GPI-APs were shown to form nanoclusters 
on COS-7 cell membranes and these clusters were sensitive to the cellular cholesterol 
and sphingomyelin [256]. The study also reported that the GPI-APs clusters cross-
correlate with the actin cytoskeleton after antibody cross-linking. The tracking and 
localization microscopy imaging and pair correlation analysis were also applied to 




was shown to recruit its effector protein signal transducer and activator of transcription 
2 (STAT2) into the signalling complexes. These transient protein complexes were 
suggested to serve as platforms for signalling. However, the over-counting of signals 
in SMLM were also discussed in literature and a new analytical method was proposed 
to overcome this problem [258]. 
SMLM has been recently applied to study the EGFR membrane distribution and 
regulation [259-261]. The ligand EGF induced receptor dimer has been verified by 
combining SMLM with single-molecule Fluorescence Resonance Energy Transfer 
(smFRET) [260]. The membrane distribution of the EGFR on the intact cell was 
obtained and the preferential cell-edge sub-resolution localization was also revealed for 
EGFR dimers at high density at the same time. Wild-type and mutant EGFR was 
demonstrated to exhibit different time-dependent diffusion maps in COS-7 cells. More 
and larger EGFR clusters on the apical surface compared to the basal surface was 
reported, independent of the EGFR activation state [261]. While a moderate state and 
homogeneous distribution for the suspended cells was also registered for COS-7 cells. 
A significant fraction of EGFR was also reported to colocalize with lipid rafts. The 
amount of EGFR clusters together with their sizes decreased significantly after mCD 
treatment no matter whether measured on the apical or basal membrane.  
Super-resolution imaging can also be applied to elucidate the activation of EGFR. The 
co-localization of EGFR and clathrin changed before and after EGF addition, which 
was visualized by sequential super resolution imaging adopting dSTORM [262]. This 
result was consistent with a previous biochemical study which reported clathrin-
mediated endocytosis (CME) for activated EGFR  [83]. In contrast to wild type EGFR, 
mutant EGFR was reported to form stable and ligand-independent dimers by two-
colour single quantum dot tracking super resolution SMLM [263]. The EGFR 
dimerization kinetics on live cells was quantified and the ligand-independent clustering 




colour SMLM combined with live cell FRET has addressed the importance of 
coordination between kinase and extracellular domain in regulating receptor 
dimerization and activation. In addition, the EGFR nanocluster and activation were also 
reported to be regulated by ionic protein-lipid interactions by SMLM [259].  
1.5 Aims of the study  
Better EGFR-targeted therapeutic outcomes require a more comprehensive 
understanding of EGFR especially its activation and initiation of downstream 
signalling cascades in the membrane. The efficient activation of EGFR in the 
membrane is determined by its spatiotemporal dynamics on the native cell membrane, 
including its dynamic interactions with membrane environment and downstream 
effector proteins. The initiation of EGFR signalling depends strongly on the dynamic 
formation of the signalling platforms in the cell membrane, which contributes to the 
receptor activation and internalization. The formation of such signalling platforms is 
closely related to EGFR inhomogeneous membrane distribution. The receptor 
membrane lateral diffusion, oligomerization and molecule interactions significantly 
affect the EGFR membrane distribution as well as the receptor activation process. 
The EGFR in membranes was reported to cluster into distinct populations within or 
outside different microdomains such as lipid rafts and caveolae. Besides, the 
cytoskeleton was also demonstrated to affect the diffusion of EGFR higher-order 
clusters [54]. Receptor clustering in membranes was commonly observed in EGFR 
expressing cells at both normal and oncogenic levels, which also contributed to the 
receptor inhomogeneous distribution. Fully understanding the mechanism and 
functional roles of this clustering under physiological conditions was of great 
importance. Not much information on the nature of the EGFR membrane 
heterogeneous distribution has been obtained. The selective localization of EGFR on 





Previous studies suggested the coexistence of EGFR clusters with varying number of 
receptors as well as the existence of monomer, dimers on the live cell membrane. The 
existence of inhomogeneous EGFR distribution and receptor clustering were 
influenced by many factors such as ligand treatment, local membrane composition and 
even the cluster composition itself [56, 57, 264]. The properties of the clusters such as 
receptor numbers, cluster densities and compositions were influenced by cell-types, 
receptor expression levels, experimental temperatures, technical approaches as well as 
the experimental conditions such as fixation or live cell experiments [56]. This partially 
explained the discrepancies existed in the literature about the EGFR preformed dimer 
ratios, oligomerization states and its activation behaviours. The exact mechanism of 
EGFR activation remains controversial, especially given the complex environment 
receptors are embedded in.   
Although previous studies in our lab have quantified the pre-formed EGFR dimer ratio 
in live cells [42, 265], the higher order receptor oligomers remained untested, which 
were supposed to play important roles in efficient EGFR activation. In addition, the 
oligomerization and clustering of EGFR under physiological condition before and after 
ligand stimulation were not clearly addressed in the literature. The concurrent dynamics 
and distribution of EGFR on live cell membranes appeared to be an interesting question 
to be answered. Because the dynamics and localization of EGFR together with its 
clustering have significant implications in the receptor activation, a non-invasive and 
quantitative study on the lateral diffusion and organization of EGFR on live cell 
membranes is required to study the exact EGFR activation mechanism. The resting and 
ligand-bound EGFR dynamic and localization should be investigated for a better 
understanding of EGFR regulation and activation. 
Hence, this study focus on elucidating the membrane EGFR lateral diffusion 
behaviours, clustering status together with its endocytosis before and after ligand 




various membrane probes under different membrane perturbation conditions. 
Membrane dynamics and heterogeneity are monitored with live cell membrane 
measurements. The EGFR mobility and distribution are measured at its resting state to 
depict how the resting EGFRs are regulated. Both low and high doses ligand 
stimulations will be added to investigate the EGFR membrane redistribution together 
with its endocytosis. Remaining membrane EGFR lateral mobility will also be 
measured to elucidate the link between EGF induced EGFR endocytosis and 
modulation of its membrane diffusion, confinement and clustering. The factors 
affecting EGFR membrane clustering will also be investigated, including ligand doses 






2 Materials and Methods 
2.1 Cell culture 
2.1.1 Adherent cell lines 
The adherent cell lines used in the thesis include epithelial cell CHO-K1 (Chinese 
hamster ovary), epithelial-like cell Hela, fibroblast-like tumour mast cell RBL-2H3 
(Rat Basophilic Leukemia) and Lifeact cells (CHO-K1 cells stably expressing GFP-
labelled actin). CHO-K1 and Hela cells were obtained from ATCC (Manassas, VA, 
USA). Lifeact cells were a kind gift from Prof. Rachel S. Kraut’s lab (NTU, Singapore). 
CHO-K1, Hela and Lifeact cells were cultivated in DMEM medium (Dulbecco's 
Modified Eagle Medium, Gibco) adding 10% FBS (Fetal Bovine Serum, Hi-clone, 
Invitrogen), and 1% PS (penicillin G and streptomycin, PAA, Austria). RBL-2H3 cell 
was a kind gift from Dr. Min Wu’s lab (NUS, Singapore), which was cultured in MEM 
(Minimum Essential Medium, Thermo Fisher Scientific, Singapore) supplemented 
with 20% FBS (Sigma, Singapore). All the three cell lines under culture were 
maintained in monolayer cultures and kept at 310 K cell culture incubator with 5% (v/v) 
CO2 and humidified atmosphere. Cells before experiments were harvested with trypsin-
EDTA (0.25%) (Thermo Fisher Scientific, Singapore) and seeded onto 35-mm glass 
bottom Petri dishes (P35G-1.0-20-C, MatTek, USA) or 8-well chamber slides (MatTek, 
USA). 
2.1.2 Suspension cell line 
The Jurkat cell line (T lymphocyte) used in this thesis was a generous gift from Prof. 
Alexander Bershadsky (MBI, Singapore). It was subcultured in RPMI-1640 Medium 
(Roswell Park Memorial Institute-1640, Sigma-Aldrich, Singapore) supplemented with 




Attachment of the cells onto the coverslip was required for TIRF measurement. In order 
to get the suspension Jurkat cells into adhesion, the cover glass should be precoated. 
The glass bottom dishes or 8-well chambers were sterilized with pure ethanol followed 
with 70% (vol/vol) ethanol. They were left at room temperature for air-dry. The glass 
was coated with poly-L-lysine (PLL) before use. For PLL coating, 0.1% (wt/vol) of 
PLL solution was prepared in double deionized water (dd H2O). PLL was deposited on 
the dish (1 mL) or on chamber well (200 μl) overnight at 37 °C. The dish or chamber 
was rinsed with 1× PBS three times. The dishes or chambers were pre-warmed before 
seeding.  
For Jurkat cell adhesion, the critical factor was demonstrated to be the presence of 
serum in the culture medium [266]. In short, cells after transfection or staining which 
were still cultured in suspension should be harvested by centrifuge to remove the 
normal culture medium. The cells were resuspended with serum-free pheno-red free 
Opti-MEM (Thermo Fisher Scientific, Singapore). The cells were seeded onto the pre-
coated glass holders and incubated back to the cell culture incubator. The attachment 
generally took about 30 min. The measurements were carried out when most of the 
cells got attached and the adhesion process was reversible. The experiments were 
typically done within cell adhesion period within 0.5-4 h post seeding. This 
manipulation was reported not to alter the diffusion of membrane proteins [267]. 
For all the cell lines, cells with passage number higher than 25 were discarded to ensure 
the cell membranes were in their native states for experiments [268, 269]. 
2.2 Cell labelling 
2.2.1 Live cell staining 
DiI-C18 (1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate, M.W. 
933.9) (Molecular Probes, Invitrogen, Singapore) solid was dissolved in dimethyl 




the stocks were kept in fridge avoiding light. The concentration was determined using 
ultraviolet (UV) spectrophotometer (NanoDrop, Thermo Fisher Scientific, Singapore). 
Before staining, the stock solution was sonicated at room temperature for half an hour 
and diluted into 100 nM with 1× PBS buffer. The working solution was sonicated at 
room temperature for another half an hour to avoid aggregates. The cells were rinsed 
three times with 1× PBS before the working solution was added. Right before adding 
to the cells, the working solution was also mixed well by vibrating for one minute. 
After adding the staining solution, cells were incubated back to 37 , 5% CO2 incubator 
for 10-15 minutes. At the end of the incubation, the cells were gently rinsed with 1× 
PBS for three times before adding the imaging buffer (phenol-red free DMEM 
(Invitrogen, Singapore) with 10 % FBS) for measurements. For different cell lines, 
different staining concentration and incubation time were tested to optimize the 
staining protocol. For the stained cells, no significant morphology or adhesion 
difference was seen. 
2.2.2 Immunostaining 
The antibody used for immunostaining was Anti-EGFR conjugated with Alexa647. 
Glass slides coated with gold (Au) nanoparticles were used to seed the cells. Before 
cell seeding, the slides were washed three times with 1× PBS and exposed to UV light 
for 10 min. CHO-K1 cells transfected with EGFP-EGFR were seeded back to the glass 
slides and maintained in cell incubator. The cells were washed with 1× PBS twice 
before fixation. The cells were incubated with 3.7% (vol/vol) paraformaldehyde (PFA) 
in PBS pH 7.4 for 10 min at room temperature. The cells were washed with 1× PBS 
three times and incubated with 1% BSA (Bovine serum albumin), 22.52 mg/mL glycine 
in PBST (PBS + 0.1% Tween 20) for 30 min. Incubation of BSA was used to block 
unspecific binding of the antibodies. The fixed sample was kept with 1× PBS 




Before experiments, the antibody diluting ratio and labelling amount for the fixed cells 
were optimized. The embedding solution for the fixed cell storage was decanted. The 
cells were washed with 1× PBS twice. The fixed cells were covered with labelling 
antibody for half an hour avoiding light. The antibody solution was discarded and the 
sample was incubated in 1× PBS in dark for 5 minutes. The PBS buffer was changed 
every 5 minutes for two more rounds. Before taken for imaging, the sample was 
changed to the imaging buffer. 
2.2.3 Cell transfection 
Electroporation by Neon Transfection System (Invitrogen, Singapore) was used for 
transient transfection of CHO-K1, Hela, and RBL-2H3 cells. Cells with ~90% 
confluency in a 75 cm2 flask were washed twice with 5 ml 1× PBS, trypsinized with 
trypsin-EDTA (0.25%) for ~1.5 min at 310 K. The trypsinized cells were resuspended 
with normal culture medium and the cell number was counted with BioRad cell counter. 
The required number of cells were taken accordingly and precipitated by centrifugation. 
The cells were resuspended with either 100 µl or 10 µl resuspension R buffer (Neon, 
Life Technologies) according to manufacturer’s protocol. The resuspended cells were 
mixed with a certain amount of the plasmids and transfered into the electroporation tip 
(2-mm wide, Bio-Rad, Hercules, CA). During transferring the mixture into the 
transfection tip, bubbles should be avoided inside the tip as it was critical for the 
electroporation pulse. According to different experiments requirements, the amount of 
cells and plasmids were optimized. At the same time, the electroporation programs with 
different cell viability and transfection efficiency were also optimized. After the 
electroporation, the cells were seeded back to the culture dish or chamber slides with 
required density. The culture medium after transfection was normal cell culture 
medium without antibiotics. The transfected cells were incubated in the incubator for 




Before EGFR measurements cells were starved for 4-8 hrs by DMEM without FBS/PS. 
The cells were washed twice with 1×PBS before changing to the imaging buffer. 
During measurements the cells were incubated with imaging buffer (phenol-red free 
FBS-free DMEM for EGFR measurements). To avoid fast internalization during 
measurements, cells were incubated with endocytosis inhibitors half an hour before 
measurements. The mixture of endocytosis inhibitors added was determined to a final 
concentration of NaN3 (Sigma-Aldrich, St Louis, MO, US), 10 mM; NaF (Sigma), 2 
mM; 2-deoxy-D-glucose (Sigma), 5 mM, respectively [270-272] 
Harvested by centrifugation, the certain amount of Jurkat cells was taken for 
electroporation which was similar to the adherent cells. The electroporation program 
and other parameters including plasmids quantity were optimized. After transfection, 
the cells were seeded back to normal cell culture dish with medium free of antibiotics 
and incubated at 37, 5% CO2 incubator overnight. Only before the measurements, 
transfected Jurkat cells were centrifuged for cell seeding. The cells were resuspended 
in serum-free medium and transferred required amount cells to the pre-coated glass 
bottom dish or glass slides. The seeding density was optimized. The cells were 
incubated in cell incubator for at least half an hour before taking to TIRF measurements.  
2.3 Plasmids 
2.3.1 EGFR 
The sequence of the EGFR constructs was reported before [272] and the same 
constructs were used in this study. 
2.3.2 GFP-GPI (Glycophosphatidylinositol from CD55) 







TGTACAAGCACCAC (incomplete GFP sequence and the primer used for this 
















Amino acid sequence for this part: 
PNKGSGTTSGTTRLLSGHTCFTLTGLLGTLVTMGLLT 
(DNA to protein translator was used and then ran Blastp against CD55 full amino acid 
sequence gotten from UniProt database, this part resulted in 100% positive match for 
the 37 AA sequence) 
2.3.3 PMT-GFP (Plasma membrane targeting sequence from RP2) 





The RP2 protein amino acid sequence for this part: MGCFFSKRRKADKES 
2.4 Drug treatment 
Methyl-β-cyclodextrin (mβCD, SigmaAldrich, Singapore) was reported to have high 
affinity for inclusion complexes with cholesterol and was often used to extract 
cholesterol from model and live cell membranes [273]. MβCD solid was dissolved in 
1× PBS buffer at 100 mM as the stock solution and it was kept in 4 °C for no more than 
30 days. For cholesterol depletion experiments, the stock was diluted into 3 mM, 5 mM 
and 10 mM with the imaging buffer which were used to incubate the cells during 
measurements. Before replacing the imaging buffer, the medium contained the working 
concentration of mβCD was pre-warmed to the required temperature.  
Latrunculin A (Lat A, Calbiochem) was produced by sponges including Red Sea 
sponge Latrunculia magnifica [274] and known to bind with G-actin monomer to 
inhibit actin polymerization [275]. It was commonly used to disrupt the actin 
cytoskeleton in live cells. Lat A was dissolved in DMSO make a stock solution in mM 
range, aliquoted avoiding light and stored in -20 °C. The stock was diluted by imaging 
buffer into the final concentration of 3 µM for cell treatment.  
Epidermal Growth Factor (EGF, Merck Millipore, Germany) is a polypeptide growth 
factor containing 53 amino acid residues which binds to EGFR [276]. The EGF was 
reconstituted by HEPES (50 mM, pH7.2, BSF, Singapore) into 1 mg/ml stock and 
aliquoted into small portion before storing back to -20 °C fridge. The EGF stock was 
diluted with imaging buffer into desired concentration (10 ng/mL, 100 ng/mL, 500 
ng/mL) and required temperature (T = 310 K or 298 K). The remaining stock was 
subsequently stored back at 4 °C and used up within one week.  
2.5 Instrumentation 




The instrument for confocal FCS is depicted in Figure 2.1. This instrument was 
modified for FCS measurements by coupling two avalanche photodiode detectors 
(APDs) (SPCM-AQR-14; Pacer, Berkshie, UK) and a hardware correlator (Flex02-
01D; Correlator.com, Bridgewater, NJ, USA) to a customized Olympus FV 300 
confocal microscope. Four laser lines 488/514 nm Argon, 543 nm and 633 nm 
(Olympus, Tokyo, Japan) were equipped to provide specific wavelength excitation 
based on different requirements. As shown in the figure, when the laser travelled 
through the beam expansion lens, it was reflected by an excitation long-pass dichroic 
mirror (DM) (560 DCLP; Omega, VT) and focused on the sample by a water-
immersion objective (60×, NA 1.2; Olympus, Tokyo, Japan). The laser power was 
measured before the objective and adjusted to 25 µW for confocal FCS measurements. 
The fluorescence from the sample was collected by the same objective and passed 
through an internal 3× magnification stage and a 150 µm pinhole in the image plane. 
To eliminate the afterpulsing of the detectors [277], a 50/50 beam splitter (Thorlabs, 
Newton, NJ) was added into the system and used to split the fluorescence signal into 
two channels. The intensity signal from the APD was recorded and got computed online 
by the hardware correlator to provide the auto correlation function (ACF). The ACF 
fitting was performed by a self-written program plugged in Igor Pro 6.0 platform 
(WaveMetrics, Lake Oswego, OR). For the cell measurements on the confocal set-up, 
the additional temperature control system was applied which was composed by an on-
stage incubator (TempControl 37-2, Pecon, Erbach, Germany) and an objective heating 





Figure 2.1 The Confocal-FCS set-up. 
(Adapted from Ma.X. Ph.D thesis 2014, NUS) 
2.5.2 Total Internal Reflection Fluorescence (TIRF) Microscopy 
With the total internal reflection (TIR) illumination scheme, imaging total internal 
reflection (ITIR)-FCS measurements were performed on two TIRF set-ups in our lab. 
Both of the TIRF microscope were modified from commercial Olympus 
epifluorescence microscope (IX-71, Olympus; IX-83, Olympus) with a high NA oil 
immersion objective and an array detector Electron Multiplying charge-coupled device 
(EMCCD). The schematic of the light path together with the TIR illumination interface 





Figure 2.2 The ITIR-FCS set-up. 
TIRF microscope is coupled with array detector like EMCCD here to record the 
membrane signal. The FCS processing is done in computer software. For the two set-
ups used in our lab, the details are provided in Table 1. 





Olympus, IX-83, Japan 
Objective 
Oil, PlanApo, 100×, NA 
1.45, Olympus, 
Singapore 
Oil, Apo N, 60×, NA 1.49, 
Olympus, Japan 
Oil, Apo N, 100×, NA 1.49, 
Olympus, Japan 
Laser 
λem= 488, 514 nm, Dual 
color air-cooled ion, 
Spectra-Physics, 185-
F02, CA, USA, 
λem= 532 nm, Cabolt 
Samba, Sweden 
λem = 405, 491, 514 and 561 
nm, 
LAS/405/100, LAS/491/100, 





Singapore (for 488 nm) 
524DRLP, Olympus, 


























































Combination of 2 tilting 
mirrors, Maximum angle 
72.5˚ 





































































Table 1 Characteristics of TIRF instruments. 
In addition, the TIRFM-II set-up is capable of doing dual color imaging by 
implementing image splitter (TwinCam and OptoSplit II, Cairn research). The 




individual cameras enabled us to measure different membrane lipids or proteins with 
distinct labelling at the same time.  
Furthermore, both set-ups were equipped with on-stage incubators (Live cell 
instrument, LCI, Korea) and a CO2/Air gas chamber (Live Cell Instrument, LCI, Korea) 
for live cell measurements, providing the precise experimental temperature and optimal 
CO2 concentration during experiments.  
For the TIRF-I set-up, the laser power was controlled by the remote control device 
(Spectra-Physics lasers, 377G, CA. USA). This remote control device provided the 
current count reading directly which enabled the remote laser power control 
quantitatively. For the TIRF-II set-up, the lasers were controlled by the implemented 
software. The laser power for most of the measurements on cells was used in the range 
of 100 µW to 500 µW without damaging the samples. 
The performance of different array detectors in imaging FCS has been systematically 
compared in a recent study [278]. In this thesis, Andor electro multiplying charge 
couple detector (EMCCD) was used to record the signal from the membrane. One 
pivotal feature which makes EMCCD outperforms CCD in reducing the read-out noise 
is the extra step of amplifying the signals by impact ionization. Another process in 
EMCCD to reduce the noise is the thermoelectric cooling of the camera to -80 ℃ which 
largely suppress the noise introduced by the thermal fluctuation. Besides, EMCCD 
works better than sCMOS regarding the quantum efficiency (QE) and single molecule 
sensitivity.  
Before each measurement, camera cooling was initiated upon open the control software 
Andor Solis. The temperature of the camera should be cooled down to -80  ℃. The 
acquisition mode was set as kinetic which was able to run at a speed of 1,800 fps for a 
2121 ROI. The vertical and horizontal shift speeds were set to 0.25 µs/row and 10 




C18 and 2 ms for other molecules. The preamplifier gain was used to increase the camera 
sensitivity, which was set to the highest value of 4.7. The electron multiplication (EM) 
gain was set to highest with a value of 300 in the software setting, which provided the 
single molecule sensitivity. In addition, during the measurements the baseline clamp 
mode available in EMCCD was always on to avoid the fluctuation of the camera. 
Generally, a stack of more than 30,000 images was taken for a 2121 ROI on the cell 
membrane and saved as 16-bit tiff. file. It was shown that images more than 10,000 
frames were sufficient for the membrane dynamics [279].  
As shown in the Figure 2.2, when the excitation light travelled through two optical 
media with different refraction indexes, it will get both reflected and refracted at the 
boundary. The refraction angle can be predicted by the Snell’s law: 
𝑛1 sin 𝜃1 = 𝑛2 sin 𝜃2 (2.1) 
𝑛1 and 𝑛2 represent the refractive indices of the two media respectively, 𝜃1 is the angle 
between incident light and the interface while 𝜃2 is the angle between the interface and 
the emitted light. When the light travels from a medium with larger 𝑛1 to one with a 
smaller 𝑛2, the light deviates away from the boundary normal with 𝜃2 larger than 𝜃1. 
If the incident angle 𝜃1becomes large enough, the light will not be refracted in the other 
medium anymore but rather get totally reflected back to the same medium. The angle 
which starts to see such total internal reflection is defined as the critical angle 𝜃𝑐 and 
meets the criteria: 







The excitation light gets totally internally reflected under this situation but leaves a thin 




continuous on the other side of the interface. This thin layer of illumination is termed 
as evanescent wave and decays exponentially as shown by the equation: 
𝐸𝑧 = 𝐸0𝑒
−𝑧 𝑑⁄  (2.3) 
Where 𝐸𝑧  is the electromagnetic field along the direction of the interface with a 
distance of z. 𝐸0 is the electromagnetic field at the interface with z distance of 0. The 
penetration depth (d) into the other medium is given by [280]: 









The parameter 𝜆  is the excitation wavelength and 𝑛1 sin𝜃1 is determined by the 
illumination objective known as numerical aperture (N.A). Typically, TIRF 
measurements performed on live cells which are assumed to have a refractive index 
similar to water (1.33) requires a numerical aperture greater than 1.33. In this thesis, 
most of the experiments carried out by using an oil immersion objective with 1.45 N.A. 
Any mismatches in the refractive index of the oil with the glass in the objective lens 
will result in the spherical aberration. The penetration depth achievable by the oil-
immersion objective TIRF set-up is usually around 100 nm, which is capable of lighting 





3 FCS theory and diffusion law 
3.1 Fluorescence Correlation Spectroscopy (FCS) theory 
Since the first experimental realization of FCS by Magde et al. [207], FCS has become 
a versatile tool for detecting various chemical dynamics with single molecule 
sensitivity. Later it was applied to biological studies and turned out to be a useful 
technique in providing physicochemical information in vivo. In FCS, revealing such 
information relies on the fluorescence signal recorded from the fluorophore with high 
temporal resolution. The fluorescence signal will have certain variations caused by 
biological processes with time lapse. The temporal characteristics of these fluctuations 
caused by equilibrium physical processes can be resolved quantitatively by the 
autocorrelation analysis. 
3.1.1 Auto-Correlation Function (ACF) 
In statistics, correlation describes the dependence between pairs of variables and its 
mathematic meaning in FCS was well explained in an earlier published work [282]. 
The Auto-Correlation Function (ACF) is used to depict the self-similarity of a signal at 
different points in time. In FCS the temporal ACF is generated to perform the statistical 
analysis of quantifying the fluorescence fluctuations (Figure 3.1). 
The observation volume here is usually very small on the order of femtoliters (fL) and 
fluorescence signal inside this small volume will be recorded. The shape and size of 
the observation volume are determined by the illumination and detection schemes of 
the individual set-ups. Molecular processes such as translational and rotational 
diffusions, flow or other changes in the fluorescence properties such as blinking, 
chemical reactions or bleaching will result in the temporal fluorescence F(t) fluctuating 
around the average of < F(t)>.  
These fluctuations δF(t) contain the information of the characteristic time of the 
molecular process as well as the frequency of the occurrence. The δF(t) represents the 




𝛿𝐹(𝑡)  =  𝐹(𝑡) − ˂ 𝐹(𝑡) ˃ (3. 1) 







 (3. 2) 
For the temporal autocorrelation analysis, the fluorescence signal F(t) is used to 
calculate the overlap with itself at different lag times .  
𝐺() =  
< 𝐹(𝑡 + )𝐹(𝑡) >
< 𝐹(𝑡 + ) >< 𝐹(𝑡) >
=






Figure 3.1 Principles of autocorrelation (ACF) analysis. 
(A) Particle diffuses through the observation volume with the size of ~ fL. (B) Particle 
diffuses through the TIRF illumination and images by array detector. (C) Fluorescence 
Intensity Trace F(t) along time t. δF(t) is the deviation of the fluorescence intensity 
from the average <F(t)>. (D) Autocorrelation process by shifting the auto-replica with 
different time delay 1, 2, 3, 4. (E) A typical fluorescence correlation function for 
four processes at different lag times: ① Anti-bunching represents an anti-correlation 
curve as the molecule can only emit one photon at each excitation cycle; ② Rotational 
fluctuation: For the linearly polarized excitation light, the rotation of the fluorescence 
transition dipoles will lead to fluctuations; ③ Triplet state: A forbidden transition 
which has a long lifetime typically in the microsecond range; ④ Diffusion: The process 
of the molecule diffuses through the observation volume. 
The equation holds true for an equilibrium system since the fluorescence statistical 
properties are independent of time shift (i.e.  < 𝐹(𝑡 + ) > = < 𝐹(𝑡) >  ). The 




value can be obtained at  = 0 and it converges to 1 when approaches to infinity. The 
fluorescence autocorrelation function can be rewritten in terms of fluorescence 
fluctuation as: 
𝐺() =
< 𝐹(𝑡 + )𝐹(𝑡) >
< 𝐹(𝑡) >2
=
< (𝛿𝐹(𝑡 + )+< 𝐹 >)(𝛿𝐹(𝑡)+< 𝐹 >) >
< (𝛿𝐹(𝑡)+< 𝐹 >) >)2
=
< (𝛿𝐹(𝑡 + )𝛿𝐹(𝑡) >) +< 𝐹 >2
< 𝐹 >2
= 




It should be noted that ACF analysis not only recovers the diffusion dynamics but also 
detects the dynamic processes which will cause fluctuations in the intensity trace such 
as triplet blinking. The multiple dynamic processes contribute simultaneously to the 
fluorescence fluctuations, resulting the occurrence of multiple decay components in the 
ACF. However, only diffusive processes will be concentrated on in this thesis.  
3.1.2 Imaging total internal reflection (ITIR)-FCS 
ITIR FCS as a new modality of FCS which uses array detectors such as 
EMCCD/sCMOS has the power of recording the signal from multiple points 
simultaneously into an image format and performing correlation analysis for each pixel 
on the image. The xy dimension defined by the pixel along with the special illumination 
schemes which provide z-sectioning serves as the observation volume (Figure 3.1 B) 
which is similar to the focal volume defined in the confocal set-up (Figure 3.1 A). ITIR-
FCS can be conducted on almost all the commercial TIRF microscopes implemented 
with a fast enough camera. By only exciting the fluorophores close to the surface, the 
TIR illumination largely decreases the background contribution from the cytosolic part 
of the cells, thus increasing the signal-to-noise (S/N) ratio. Besides the TIR illumination 
critical for the membrane fluorophore excitation, the detector acquisition properties 
also play an important role in the membrane imaging FCS measurements. Both 




fluorescence signal will be recorded and further processed. The theoretical derivation 
for ACF is sketched in the following section. 
For a given observation volume, the fluorescence intensity F(t) and its temporal 
fluctuation 𝛿𝐹(𝑡) can be calculated by integrating over space (𝑟 = (𝑥, 𝑦, 𝑧)) as: 
𝐹(𝑡) = 𝑄 ∫ 𝐼(𝑟
∞
−∞
)𝑆(𝑟)𝐶𝐸𝐹(𝑟)𝐶(𝑟, 𝑡)𝑑𝑟 (3.5) 
𝛿𝐹(𝑡) = 𝑄 ∫ 𝐼(𝑟
∞
−∞
)𝑆(𝑟)𝐶𝐸𝐹(𝑟)𝛿𝐶(𝑟, 𝑡)𝑑𝑟 (3.6) 
Q denotes the molecular brightness which depends on the fluorophore quantum yield, 
the absorption coefficient and the overall instrumental detection efficiency. In practice, 
increasing excitation intensity or using high quantum yield fluorophores result in a 
higher Q which provides better S/N ratio [283]. The definition for Q is expressed in 
photon counts per particle and second (cps). 
𝐼(𝑟) represents the spatial illumination intensity profile determined by the focused laser 
excitation. 
𝑆(𝑟) is a function describing the extension of the sample volume. 
𝐶(𝑟, 𝑡) and 𝛿𝐶(𝑟, 𝑡) describe the concentration of the fluorophore at certain position 𝑟 
and time t and its fluctuations, respectively.  
𝐶𝐸𝐹(𝑟) = ∫𝑇(𝑟)𝑃𝑆𝐹(𝑟)𝑑𝑟 (3.7) 
The spatial intensity profile of the exciting laser beam 𝐼(𝑟)  and the fluorescence 
detection probability which is determined by 𝑆(𝑟)and 𝐶𝐸𝐹(𝑟)   constitute the spatial 
distribution of the molecular detection efficiency MDE(r⃗) . 





Since the sample volume is much larger than the observation volume in all the 
measurements in this thesis, 𝑆(𝑟)  can be assumed to be 1 to reduce further the 
complexity of the derivation.  
Hence, the fluctuation 𝛿𝐹(𝑡) can be then rewritten as: 










< 𝛿𝐶(𝑟, 𝑡)𝛿𝐶(𝑟′, 𝑡 + 𝜏) > 𝑑𝑟𝑑𝑟′







The function < 𝛿𝐶(𝑟, 𝑡)𝛿𝐶(𝑟′, 𝑡 + 𝜏) > is called diffusion propagator (Weidemann et 
al. 2002). In ITIR-FCS, only 2D diffusion process is considered and the expression of 
this function can be rewritten as: 





4𝐷𝜏  (3.11) 
For the 2-D detection scheme, both diffusion propagator and the collection efficiency 
function can be separated into x- and y- dimension. The distribution of the excitation 
light along the sample plane which is perpendicular to the optical axis (𝐼(𝑟)) can be 
approximated by a 2-D Gaussian function. This 2-D Gaussian function is also separable 
in two dimensions. Hence, the 𝑀𝐷𝐸(𝑟) can be separated into x- and y-dimensions. The 
normalized autocorrelation function 3.10 can be rewritten into: 
𝐺(𝜏) = 𝐺𝑥(𝜏)𝐺𝑦(𝜏) + 1 (3.12) 
here,  
𝐺𝑥(𝜏) =








2 + 1 (3.13) 
Correspondingly, 𝐺𝑦(𝜏) can be written in a similar form substitute x position into y. 




calculation can be applied to 𝐺𝑦(𝜏) . The mathematical expression of 𝑀𝐷𝐸(x⃗)  is 
presented in Eq. 3.8.  
The image of a molecule in this situation is determined by the PSF. Hence, a Gaussian 








In the detector plane, the square pixel with side length 𝑎 determines the (?⃗?) , which 








0;     𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒
] (3.15) 
This represents the everywhere inside the pixel it equals to 1 and outside the pixel it is 
always treated into 0.  















Incorporating the above equation and the diffusion propagator 3.11 (for the x-direction) 




















Using the symmetric geometry of the camera pixel and eqs.3.12, the correlation 
































































+ 1 (3.20) 


















Note that both the pixel size and the dimensions of the PSF contribute to the 𝐴𝑒𝑓𝑓. The 
PSF of a microscope system is determined by the N.A of the objective and the emission 





The numerical value for the PSF in our TIRF set-up was determined experimentally to 
be about 0.4 by lipid bilayer experiments and described in details elsewhere [285]. 




For the imaging FCS curve fitting, a home-written fitting programs ImFCS was used 
either based on Igor Pro or Image J platform. The ImFCS software was described in 
detail before [286] and is available online 
(http://staff.science.nus.edu.sg/~chmwt/imfcs_software.html or 
http://staff.science.nus.edu.sg/~chmwt/imfcs_image_j_plugin.html). For each pixel 
recorded in the image, the individual ACF was calculated from each intensity trace 
along time by a multi-tau correlation scheme [214]. For the measurements on this thesis, 
a (16,8) correlator was used.  
Photobleaching during measurements would happen due to the photochemical 
destruction of the fluorophore and was seen for fluorescent protein labeled samples as 
an irreversible decrease in the fluorescence intensity. This problem was more general 
for 2D FCS measurements compare to 3D measurements as the replenishment of the 
fluorophore in the membrane was limited [287]. One way to minimize the 
photobleaching effects was to optimize the laser power and acquisition time. For the 
measurements inevitable showing photobleaching, bleach correction is another strategy 
to obtain accurate results. Different bleach correction methods were implemented in 
ImFCS. For Igor pro platform, exponential correction and sliding window correction 
were available to extract unbiased results. For the ImageJ plugin, 5 modes of bleaching 
correction were implemented, namely single exponential, double exponential, sliding 
window, polynomial and line segment.  
The single/double exponential and sliding window bleach corrections were similar to 
what is used in Igor Pro. Briefly, the exponential bleach correction assumes that the 
fluorescence intensity decays exponentially and can be modeled by a bi-exponential 
curve [288]. The raw intensity for each pixel was normalized by the exponential fitting 
function and the corrected data was kept to the same level of the average intensity. The 
polynomial bleach correction will first normalize the intensity trace by fitting it with 




effect. The sliding window was based on dividing the intensity trace into short time 
windows and averaging the final results from correlating each window. It assumes that 
the intensity decay in each window is relatively weak and the corresponding ACF was 
not biased significantly by the photobleaching [288].  
Each pixel in the image was fitted individually by the following model implemented in 





































+ 𝐺∞ (3.23) 
From the stacks of the images, the map of diffusion coefficient (D) and the map of 
particle numbers (N) were obtained for further analysis.  
It’s worthy to note that the amplitude of the ACF is inversely proportional to the 
number of particles in the observation volume (Figure 3.2 A). The width of the ACF 
increases with diffusion time (Figure 3.2 B), corresponding to a smaller D. 
 
Figure 3.2 Amplitude and width of the ACF. 
(A) The amplitude of the ACF is inversely proportional to the number of particles in 
the observation volume. With increasing N, the amplitude decreases. (B) The wider 






3.2 FCS Diffusion law 
3.2.1 FCS diffusion law theory 
The FCS diffusion law, known also as spot-variation FCS (sv-FCS), was first proposed 
by Lenne’s group [229] and has become a novel biophysical tool to probe the dynamic 
molecular confinement mode in live cell membrane. It describes the dependence of the 
molecule transit time (D) over the size of the observation area, by plotting apparent 
diffusion time on the area in the FCS diffusion law plot. The extrapolation of the transit 
time against the observation area results is the so-called diffusion law intercept (0), 
which will provide the information on the different diffusion confinement modes 
(Figure 3.3). The mathematical expression of this extrapolation is given by the equation: 
𝜏𝐷






Figure 3.3 FCS diffusion law plot and three different diffusion modes on membrane. 
Three modes on the membrane: Free diffusion (Red line), intercept 0 = 0. Transient 
trapping (Green line), extrapolation to y-axis (Dash green line), intercept 0 > 0. 
Meshwork compartmentalization (Blue line), extrapolation to y-axis (Dash blue line), 
intercept 0 < 0. 
For free diffusion, the molecule diffuses through the observation area at the same rate 
D and D is independent of the Aeff. In other words, the diffusion time increases linearly 
with the observation area, which results in a straight line passing through the origin in 
the diffusion law plot (red solid line, Figure 3.3). However, this linearity relationship 




diffusion is hindered by obstacles in the form of either transient trapping sites or 
diffusive barriers. For the transient trapping, the molecule can dynamically partition 
into the trapping sites and diffuses slower compared to the free diffusion outside. This 
transit trapping results in a non-linear transition region in the diffusion law plot and 
produces a positive intercept (0 ˃  0, green line in Figure 3.3). While in another scenario 
as meshwork hindered diffusion, the molecule can diffuse freely inside a meshwork 
compartment and will get obstructed at the boundary. It has to undergo hop-diffusion 
to transit between the separated compartments, which results in a slower D in the long 
range. In the diffusion law plot, the hindering effect by the physical 
compartmentalization will alter the slope and produces a negative intercept (0 ˂  0, blue 
line in Figure 3.3). The FCS diffusion law simulation and proof-of-principle 
experiment were first demonstrated in a confocal set-up and helped in revealing the 
sub-resolution information which was unachievable due to the diffraction limit. From 
the sign of the intercept, the two different diffusion modes can be easily deduced as 
positive intercept for transient trapping while negative intercept for meshwork 
hindering. On the cell membrane, such non-free diffusion modes can stem from several 
factors. The transient trapping effect mainly originates from the molecule partitioning 
into the micro-domains such as lipid rafts or molecule clustering on the cell membrane. 
The hop diffusion is largely due to the actin cytoskeleton which is embedded 
underneath the plasma membrane.  
3.2.2 FCS Diffusion law on live cells 
Since the inception of diffusion law, it has become a useful tool to probe the nanoscale 
membrane organization with diffraction limited measurements. According to various 
instrumentation set-ups, FCS diffusion law has been recently implemented on to 
different FCS modalities and played important roles in obtaining sub-resolution 




The conventional FCS diffusion law analysis is realized on the standard confocal 
microscope by varying the focal volume sizes. In order to create different sizes of 
confocal volume, a diaphragm or a variable telescope is used to control the lateral 
extension of the excitation laser beam, which falls onto the back-aperture of the 
microscope objective [289]. In the pioneering FCS diffusion law study, Wawrezinieck 
and co-workers first reported the experimental diffusion law results for one putative 
raft marker FL-GM1 and one cytoskeleton-hindered transmembrane protein TfR-GFP. 
They simulated different diffusion processes to explain their experimental results and 
proposed different models which included isolated microdomains confinement and 
actin meshwork for the two distinct behaviors on the membrane [289].  Based on 
extensive studies on the confined diffusion modeling, the FCS diffusion law intercept 
(0) is established to be the indicator of membrane organization, which is positive for 
the dynamic partitioning into microdomains and negative for actin-based cytoskeleton 
corrals. The same group of researchers extended the study into different groups of 
membrane components including specific membrane lipids and proteins to characterize 
their diffusion behaviors [290]. They first identified three subsets of molecules based 
on the 0 value as 1) the glycerophospholipid analogs for free diffusion; 2) the 
sphingolipid and GPI-AP for the dynamic partitioning into microdomains; 3) the 
transmembrane TfR-GFP for the actin-based cytoskeleton meshwork effects. By 
external perturbation as drug treatment or enzyme catalyzing, they further revealed that 
as proposed in the lipid rafts model cholesterol and sphingomyelin were the two factors 
contributing to the microdomain confinement. In addition, the isolated microdomain 
confinement was not affected by the compartmentalization meshwork as disruption of 
actin cytoskeleton did not alter the molecule confinement. The results also indicated 
that discrete microdomains and actin cytoskeleton contribute concomitantly to the 
molecule membrane diffusion behavior. This experimental approach constituted the 




FCS diffusion law strategy was employed to analyze the membrane organization of 
various membrane molecules. For example, the Fas ligand (FasL) as a member of the 
tumor necrosis factor (TNF) protein family which involves in inducing cell death upon 
activating its receptor Fas, was depicted to partially localize in rafts by adopting FCS 
diffusion law analysis [291]. The amount of FasL partitioning into rafts increased upon 
its interaction with the receptor. The raft partitioning diminished after cholesterol 
oxidase treatment which depleted the raft organization, leading to an important change 
of less FasL killing. This indicated the crucial role of lipid raft in maximizing the 
ligand-receptor interaction which induced the cell death. Further studies revealed that 
palmitoylation was required for the localization of FasL in rafts [292]. 
This FCS approach also enabled to identify the existence of highly dynamic 
nanodomains in both inner and outer leaflets of the live cell plasma membranes [293]. 
Corroborating the nature of lipid raft, cholesterol and sphingolipids were assessed to 
involve in nanodomain formation. More importantly, accumulation of 
phosphatidylinositol-3,4,5-triphosphate (PIP3) in the plasma membrane nanodomains 
was found to play a crucial role in facilitating Akt recruitment and activation during 
the PI3K/Akt signalling pathway initiation. Thus, directly monitoring of rafts 
involvement in the cell signalling pathway activation was achieved by confocal FCS 
diffusion law analysis. Another interesting finding by confocal FCS diffusion law was 
that the confinement of both activating and inhibitory receptors played pivotal roles in 
the self-tolerance of NK cells [294]. 
Although commonly applied into biological membrane studies, confocal FCS diffusion 
law approach suffers from several limitations including: 1) calibration-dependence for 
each measurement makes it cumbersome 2) multiple sequential measurements required 
for one plot results in the loss of simultaneous information 3) photophysical damage to 





An alternative FCS module called z-scan FCS was introduced to perform the diffusion 
law analysis by moving the divergent excitation laser beam along the z-direction [295]. 
This calibration-free technique simplifies the prior calibration every time after 
changing the size of the illumination spot, which is realized without addition of extra 
optical components. The first implementation of this approach was carried out to test 
the membrane marker 1,1’-dioctadecyl-3,3,3’,3’-tetramethylindodicarbocyanine 
perchlorate (DiD) in both supported phospholipid bilayers (SPBs) and the OLN-93 cell 
plasma membranes. The results revealed that in live OLN-93 cells DiD undergoes 
hindered diffusion caused by microdomain confinement. Another application of the z-
scan FCS diffusion law was the Serotonin1A receptor organization on the plasma 
membrane which exhibited confinement by actin cytoskeleton meshwork hindering 
[296]. The depletion of cholesterol was revealed to reduce the confinement of the 
receptor in a similar manner of cytoskeleton destabilization.  
Both the conventional and z-scan FCS diffusion law analysis are realized on the 
confocal micsroscope set-up and still limited by the optical diffraction limit. The 
application of FCS diffusion law on STED microscope was realized by Eggeling’s 
group, which was shown to be a powerful technique to obtain information well below 
the diffraction limit [248]. The STED-FCS diffusion law provided information about 
the sphingolipids (SM) and GPI-APs, which were trapped in domain sizes smaller than 
20 nm and with confinement time ~10-20 ms. The same group also reported that GM1 
transiently incorporated into complexes by diffusion law analysis [297]. Most recently 
combination of STED microscopy with scanning FCS was achieved to characterize the 
interaction of lipids and proteins on cell membrane [298]. Transient molecular 
interaction hotspots with size smaller than 80 nm and trapping time for several 
milliseconds were reported for the fluorescent sphingolipid analogue under 
investigation. The results demonstrated the presence of nanodomains caused by lipid 




3.2.3 Imaging FCS diffusion law and previous studies in our group 
The above mentioned techniques have obtained much information about the cell 
membrane but all suffered from their respective limitations which have been recently 
reviewed [299]. Conventional confocal set-up based FCS diffusion law analysis 
requires sequential measurements which is time consuming and loses the real-time 
information. STED-FCS is still restricted to specific membrane markers, thus 
technically more demanding. In addition, it also requires sequential measurements 
which is cumbersome and causes possible damage to the sample. 
Our group recently implemented the FCS diffusion law to our imaging FCS modality. 
As introduced in chapter 2, imaging FCS acquires information from the membrane 
simultaneously and records it in the imaging format. The real-time spatial multiplexing 
scheme of FCS measurements is achieved with the fast camera. From the same set of 
images performing FCS analysis, post-acquisition binning of the camera pixels 
generates the different observation area for diffusion law analysis. Without additional 
optical elements in the system, imaging FCS eliminates the requirement of multiple 
measurements for the diffusion law analysis.  
The effective observation area (Aeff) is determined by the convolution of the respective 
binning pixel size with the PSF of the system. The PSF determination was earlier 
experimentally determined for our Imaging total internal reflection FCS (ITIR-FCS) 
set-up [285].The original confocal diffusion law equation was modified accordingly: 




The 0 is still used as the indicator of different diffusion modes. Every pixel performs 
as the smallest observation area (Aeff). The 1×1 to 5×5 offline pixel binning creates the 
variable sizes of Aeff. At each binning, ACFs are computed followed by curve fitting, 
generating different D values. Since D values are directly obtained from the fitting, 




the y-axis will be labelled with D for the consistency with literature in the FCS 
diffusion law plot. The plot of D (Aeff/D) against Aeff constructs the FCS diffusion law 
plot, which is fitted with a straight line to obtain the intercept (0). The integration of 
the entire data analysis is implemented in our home-written software ImFCS. 
Our group have earlier reported imaging FCS diffusion law on probing the organization 
in supported lipid bilayers and cell membranes [285, 300, 301]. Three different lipid 
bilayers, i.e 1,2-dilauroyl-sn-glycero-3-phosphocholine (DLPC) on glass, phase 
separated DLPC: 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC) (1:1) on glass, 
and DLPC on Polydimethylsiloxane (PDMS) grids were employed to emulate the 
different organizational scenarios. RhoPE was incorporated into all bilayers to monitor 
the diffusion behaviours. Patterned bilayers were reported to study diffusion barriers 
induced non-Brownian dynamics [302]. From the TIRF images, isolated domains are 
visible in phase-separated bilayers while patterned bilayers show adjacent 
compartments. The intercept (0) of RhoPE obtained from DLPC bilayer was -0.02 ± 
0.03 s, which shows the free diffusion behaviour. While in DLPC:DSPC bilayers and 
patterned DLPC bilayers, it shows strictly positive and negative value, respectively (0 
= 1.87 ± 0.32 s for DLPC: DSPC bilayer and -1.65 ± 0.54 s for patterned DLPC bilayer). 
Moreover, a clear inflection point is presented in the FCS diffusion law plot for the 
patterned DLPC bilayer, which indicates the molecule switching diffusion mode from 
free diffusion inside a mesh compartment to hop diffusion occurred at the mesh 
boundary. This bilayer results corroborate well with the FCS diffusion law theory and 
pave the way of applying imaging FCS diffusion law analysis onto live cell membrane 
studies. Considering the complexity of the live cell plasma membrane, the FCS 
diffusion law experiments needs to be verified on live cells as well and careful 





4 Imaging FCS diffusion law on live cells 
4.1 Non-raft phase marker DiI 
Lipid-mimetic DiI is a commonly used lipid marker for liquid-disordered diffusion on 
cell membrane [303]. It is weakly fluorescent in water but highly fluorescent and quite 
photostable when incorporated into membranes. The free diffusion variant 1,1′-
dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate (DiI-C18) was chosen to 
probe the free diffusion on live CHO-K1 cells first.  
DiI-C18 homogeneously stains CHO-K1 cell plasma membrane (Figure 4.1 A, inset) 
and serves as a putative free diffusion marker. At T = 310 K, the diffusion coefficient 
(D) of DiI-C18 from fitting the ITIR-FCS curves (Figure 4.1 A) was 1.34 ± 0.20 µm2/s. 
The result was consistent with the typical D reported by the previous study (1.4 ± 0.3 
µm2/s for HEK293 cell line) [225]. In addition, the D and N correlation showed no 
particular trend, which represented homogeneous membrane diffusion above 
diffraction-limit (Figure 4.1 B).  
To monitor various diffusion behaviours regarding different membrane organization 
principles, drug perturbations to cell plasma membrane were employed. Here, the 
integrity of the DiI-C18 stained cell membrane was perturbed by different drug 
treatments. Upon 3 mM mCD treatment, the distribution of DiI-C18 did not change 
much with averaged value D of 1.28 ± 0.30 µm2/s (before) and 1.21 ± 0.31 µm2/s (after) 
(Figure 4.1 C). The FCS diffusion law intercept (0) remained zero after removing 
cholesterol (before 0 = 0.07 ± 0.01 s, after mCD 0 = 0.06 ± 0.01 s) which implied 
that cholesterol did not have any effect of the localization of DiI-C18 in the membrane. 
In addition, the time modulation of membrane diffusion and organization was also 
monitored for DiI-C18 upon cholesterol removal. Both D and 0 fluctuated around its 
initial value overtime (Figure 4.1 G). This indicates that adoption of mCD onto live 




partitioning. The preferential partitioning of DiI-C18 into non-raft phase in model and 
cell membrane is well documented in the literature [225, 303].  
 
Figure 4.1 ITIR-FCS on CHO-K1 cells labelled with DiI-C18.  
(A) Representative cell ACFs for each pixel in Region of Interest (ROI). Grey: raw 
data, Red: fitted curves. Inset: DiI-C18 labelled cell TIRF image with highlighted ROI 
in red square. (B) D vs N correlation plot of DiI-C18 dynamics. (C) Distribution of D 
before and 30 min after 3 mM mCD treatment averaged from 5 cells from different 3 




FCS diffusion law plots before and after 3 mM mCD treatment. (E) Distribution of D 
before (Red bars) and 10 min after 3 µM Lat A treatment (Black bars) averaged from 
3 sets. Inset: Cumulative frequency plot of the D distribution. (F) Representative cell 
FCS diffusion law plots before (Red bars) and after 3 µM Lat A treatment (Black bars). 
(G) Time dependent change D and 0 after 3 mM mCD treatment (H) Time dependent 
change D and 0 after 3 µM Lat A treatment. Note that for the time dependent 
monitoring, cells should not be the ones morphologically rounded after treatment.  
Other than lipid rafts disruption, actin cytoskeleton destabilization by Lat A treatment 
was also monitored. Lat A showed no change on the DiI-C18 lateral mobility (D before: 
1.38 ± 0.34 µm2/s, after: 1.25 ± 0.26 µm2/s) (Figure 4.1 E). Similarly, the FCS diffusion 
law intercept 0 did not change upon Lat A treatment (before: 0.05 ± 0.02 s, after: 0 = 
0.06 ± 0.02 s, Figure 4.1 F). Regarding the D value, both drug treatments had no 
significant change. Thus, free diffusion on the cell membrane is neither perturbed by 
lipid rafts nor by the cytoskeleton.  
The membrane localization of DiI-C18 on CHO-K1 is in concordance with the previous 
reports for free diffusion [228, 304] and these results are consistent with most of the 
previous studies [305, 306]. However, several studies have reported a reduced D of 
DiI-C18 in mCD treated RBL and HEK cell membranes [225]. It’s worthy to note that 
in those studies a very high concentration of mCD (~ 12 mM) was used. As suggested 
by other work, high concentration mCD (>10 mM) may have detrimental effects on 
live cell membranes and possibly will reorganize the cytoskeleton structures [273, 307, 
308]. 
In Lifeact stably transfected cells, low concentration mCD (3 mM) showed marginal 
change on the cytoskeleton organization (Figure 4.2 A) while high concentration 
mCD (10 mM) affected the organization of cytoskeleton significantly (Figure 4.2 B). 
This would possibly be one of the reasons that addition of mCD yielded the different 
outcomes in literature.  
At the same time, the effect of 3 µM Lat A on cell actin cytoskeleton was also verified 




within two minutes of incubation the structure of cytoskeleton changed dramatically 
(Figure 4.2 C). Incubation of Lat A with ten minutes was sufficient to completely 
reorganize the actin cytoskeleton.  
 
Figure 4.2 Lifeact stably transfected cells in demonstrating the concentration effect of 
mCD.  
(A) Moderate concentration (3 mM) mCD treatment hardly changed the actin 
cytoskeleton organization in Lifeact transfected cells. (B) High concentration (10 mM) 
mCD treatment had side effects on cytoskeleton organization with increased time of 
incubation. (C) Time dependent imaging of Lifeact cells incubated with 3 µM Lat A. 
The effect of Lat A was quite fast as 10 minutes incubation leaded to a large portion of 
actin cytoskeleton destabilization and significant morphological change was visible. 
Scale bar: 20 µm. 
4.2 Raft partitioning of GPI-AP 
4.2.1 Raft phase marker GPI-AP 
Glycosylphosphatidylinositol-anchored proteins (GPI-APs) are reported to associate 
with cholesterol and sphingolipid enriched domains and has been used as membrane 
raft phase marker in many studies [139, 289, 309]. GFP-GPI-AP was expressed on live 




The membrane image of cell expressing GPI proteins presented rather homogeneous 
under TIRF microscope (Figure 4.3 A). The diffusion coefficient (D) map and number 
of particles (N) map were also homogeneous throughout the entire ROI. The D & N 
correlation map (Figure 4.3 B) showed no particular trend which revealed the 
homogeneity above diffraction-limit.  
The diffusion coefficient of GFP-GPI-AP was 0.31 ± 0.22 m2/s before any treatment. 
The FCS diffusion law intercept 0 of GPI-AP was 1.26 ± 0.02 s (Figure 4.3 D), the 
positivity of which was much higher compared to the margin error (± 0.1 s) for the 
ITIR-FCS diffusion law intercept proposed by previous study [279]. Therefore, the 
reduced D was deduced to be caused by the confinement of GFP-GPI-AP protein inside 
rafts.  
The mCD incubation was used to further confirm the raft confinement effects. The 
distribution of D shifted to the larger value with averaged D changed from 0.31 ± 0.22 
m2/s to 0.44 ± 0.22 m2/s ~30 minutes of mCD addition (Figure 4.3 C). The overall 
shift in diffusion was observed in the D cumulative frequency distribution plot (Figure 
4.3 C inset). The organization of GFP-GPI-AP in the membrane rafts addressed by FCS 
diffusion law changed dramatically as shown in the FCS diffusion law plot. The 
intercept (0) decreased from 1.26 ± 0.02 s to 0.19 ± 0.02 s as shown in the Figure 4.3 
D. This drop indicated the abolishment of domain confinement upon disruption of rafts 
for GFP-GPI-AP, which was expected as GFP-GPI-AP was reported to preferentially 
localize in cholesterol-rich rafts.  
It has also been documented that actin cytoskeleton plays an important role in the 
hierarchical architecture of plasma membrane and membrane organization will be 
largely affected upon actin removal [111]. The increased size of lipid rafts in absence 
of actin cytoskeleton was reported before in plasma membrane blebs [166]. It was also 




[111]. In this context, the role of actin cytoskeleton in regulating the raft phase marker 
GPI-AP was also investigated. 
 
Figure 4.3 CHO-K1 cells expressing GFP-GPI-AP with 3 mM mCD and 3 M Lat A. 
(A) TIRF image of GFP-GPI-AP transfected CHO-K1 cell plasma membrane. ROI: 
Region of Interest (ROI) from live cell membrane. D: Diffusion coefficient (D) map of 
the ROI. N: Number of particles (N) map of the ROI. (B) D vs N correlation plot of 
GFP-GPI-AP dynamics. The cell membrane is homogeneously expressing GFP-GPI-
AP proteins as shown in the TIRF image. In addition, the D and N correlation plot 
showed no particular trend, which represented homogeneity above diffraction-limit. (C) 
Distribution of D before (Red bars) and ~30 min after 3 mM mCD treatment (Black 
bars). (Number of ACFs = 2205 and Number of cells = 5). Inset: Cumulative plot of 
the D distribution before and ~30 min after treatment. (D) Representative cell FCS 
diffusion law plot for GFP-GPI-AP before (Red line) and ~30 min after 3 mM mCD 
(Black line). Inset: Cell image before and after treatment. From the TIRF images, no 




intensity. However, the FCS diffusion law intercept 0 value reduced from positive to 
zero, which clearly indicated a sub-resolution raft partitioning to free diffusion. (E) 
Distribution of D before (Red bars) and ~15 min after 3 M Lat A treatment (Black 
bars). (Number of ACFs = 2205 and Number of cells = 5). Inset: Cumulative plot of 
the D distribution before and ~15 min after treatment. (F) Representative cell FCS 
diffusion law plot for GFP-GPI-AP before (Red line) and ~15 min 3 M Lat A 
treatment (Black bars). Inset: Cell image before and after treatment. 
The D distribution showed marginal change with averaged D value from 0.31 ± 0.22 
m2/s to 0.33 ± 0.24 m2/s after Lat A (Figure 4.3 E). Before and after treatment, the 
cumulative frequency distribution of D could not be clearly discriminated (Figure 4.3 
E, inset). The disruption of cytoskeleton showed limited alteration as the 0 value 
changed from 1.34 ± 0.15 s to 1.31 ± 0.16 s (Figure 4.3 F), which meant no change in 
GFP-GPI-AP membrane organization with Lat A treatment. This can be explained as 
the GFP-GPI-APs are supposed to have little spatial interaction with actin cytoskeleton. 
The GFP-GPI-AP anchors into the outer leaflet of the membrane while the actin 
cytoskeleton is known to directly associate with the inner leaflet of the plasma 
membrane. So the marginal effect of cytoskeleton disruption on GFP-GPI diffusion is 
somehow expected. The same effect was also observed for DiI-C18 stained cells with 
Lat A as shown in Figure 4.1 E, F &H. 
Therefore, the dependence of both GFP-GPI and DiI-C18 is weak on actin cytoskeleton 
as anticipated. Lenne et al. also reported that the actin-based skeleton alterations by 
latrunculin B did not have any effect on the GPI-anchored proteins regarding their 
molecular confinement [228]. They proposed an identical hypothesis describing the 
concomitant contribution from cytoskeleton meshwork and discrete raft domains to the 
membrane organization. Both cytoskeleton and raft domains were expected to affect 
the dynamic diffusion and compartmentalization of the membrane molecules 
simultaneously.  
However, it should be noted that previous studies also described an actin cytoskeleton 




leaflet [166, 310]. The membrane organization paradigm proposed based on those 
findings described the non-random diffusion of membrane proteins and lipids. Their 
compartmentalization on the membrane is proposed in a compartmentalized fluid 
model rather than the two-dimensional continuum model. The so-called picket-fence 
model invokes the notion that non-random diffusion is caused by the transmembrane 
protein pickets and cytoskeleton fences [201]. With this consideration, the actin-
cytoskeleton disruption will somehow affect the overall membrane organization and 
alter the membrane molecule behaviours.  
However, I observed that the diffusion of outer membrane raft-phase marker GFP-GPI 
was not affected greatly by cytoskeleton disruption on CHO-K1 cells. The similar 
marginal change of membrane organization for GPI-AP results was also documented 
in other previous studies [311]. 
4.2.2 Raft phase marker GPI under membrane perturbation 
For the above experiments, cholesterol depletion from the plasma membrane was 
achieved by adopting 3 mM mCD drug treatment. Although mCD was one of the 
most commonly used drugs to modulate the membrane raft organization, the side 
effects should be kept in mind. For instance, it might reorganize the actin cytoskeleton 
at high dose of incubation, as shown in 10 mM treatment for Lifeact cells (Figure 4.2 
B). Similar results as the overall modulation in both membrane dynamics and 
organization were reported before by other groups [312]. Moreover, high dose (> 5 
mM) mCD extracting phospholipids and proteins from membranes was also 
documented [273]. The various effects of mCD treatment were strongly dependent on 
cell types, concentrations, incubation time and temperature [273]. Owing to the 
capability of ITIR-FCS in continuous monitoring the membrane dynamics and 
organization, I took a step further to follow the diffusion of GFP-GPI-AP on plasma 




and 5 mM) without disturbing the cytoskeleton structure at T = 310 K. Firstly the 
effects of 3 mM mCD in CHO-K1 were explored monitoring the diffusion of GFP-
GPI-AP with time. Interestingly, a time dependent modulation of the live cell 
membrane dynamics and organization was observed as shown in the Figure 4.4.  
 
Figure 4.4 GFP-GPI-AP membrane dynamics and organization modulated with various 




(A) Change of diffusion coefficient (D, black) and FCS diffusion law intercept (0, red) 
with 3 mM mCD treatment. The time in x-axis represented the time course post drug 
treatment.  (B) Extent of percentage change of D and 0 compared to its initial value 
before treatment over time with 3 mM mCD incubation. (C) Change of diffusion 
coefficient (D, black) and FCS diffusion law intercept (0, red) with 5 mM mCD 
incubation. (D) Extent of percentage change of D and 0 compared to its value before 
any treatment over time incubated with 5 mM mCD. (E) Change of diffusion 
coefficient (D, black) and FCS diffusion law intercept (0, red) with the incubation time 
course after 3 mM mCD treatment on Hela cells. (F) Extent of percentage change of 
D and 0 compared to its value before any treatment over time. (G) Distribution of D 
before and ~30 min after treatment on Hela cells expressing GFP-GPI. Inset: 
Cumulative plot of the D distribution before and ~30 min after 3 mM mCD treatment. 
The results were similar to what was observed for CHO-K1 cells, which indicated that 
GFP-GPI-AP membrane diffusion and localization were similar in these two cell lines. 
(H) Representative Hela cell FCS diffusion law plot for GFP-GPI before (Red line) and 
~20 min after 3 mM mCD (Black line). 
As can be seen, the D of GFP-GPI-AP increased monotonically from 0.31 ± 0.22 m2/s 
to 0.44 ± 0.22 m2/s within 32 minutes of mCD addition and then it decreased towards 
the initial value of D = 0.36 ± 0.17 m2/s after 60 minutes of incubation. The plotted 
percentage decrease of 0 value (Figure 4.4 B) reflected the gradual loss of raft 
confinement for GFP-GPI-AP with time within ~30 minutes. At time point of 32 min, 
the intercept value decreased more than 90% which meant GPI-AP diffused almost 
freely at this moment. The loss of membrane heterogeneity is mirrored by the 
percentage decrease in the 0 values as 0 is directly proportional to all the confinement 
on the membrane. 
Previous studies have shown that cholesterol depletion by mCD will affect the 
distribution of cholesterol in both intracellular and plasma membrane pools [313]. A 
recent study by the same group reported that total cellular cholesterol concentration 
was decreased about 45% by incubating with 2.5 mM mCD for 30 minutes while 
about 25% cholesterol was depleted from the membrane [314]. They also stated that 
using 5 mM mCD incubation could achieve the similar levels of cholesterol removal. 
Importantly, earlier study has proposed that complete disruption of cholesterol and 
sphingolipid enriched rafts required about 20% depletion of cholesterol from the live 




corresponds well with the regime of complete disruption of GPI-AP containing 
domains.  
After the observed lowest 0 around 30 minutes in CHO cells, besides the decrease 
trend of D, the membrane organization probed by diffusion law intercept value 0 also 
followed a similar trend of recovery. The 0 was measured to elevate to 1.03 ± 0.26 s 
after 60 min incubation, which recovered back to about 80% of its initial value (Figure 
4.4 A). As can be seen Figure 4.4 B, the time dependence of both diffusion and 
membrane heterogeneity was similar regarding the change trend after 3 mM mCD 
treatment. However, compared to the membrane diffusion the change in membrane 
organization was sharper regarding the rate of change for GFP-GPI-AP.  
The membrane lateral dynamics and organization can be deduced not to be exclusively 
correlated. The way how mCD disrupted raft is reported to form cholesterol-mCD 
complex during the incubation [273]. Thus, the rate of raft disruption by mCD is 
governed by the rate of cholesterol extraction by formation of cholesterol-mCD 
complex. However, the rate of GFP-GPI-AP diffusion change is determined by the rate 
of its release to non-raft phase from the raft phase. These two somewhat independent 
processes mediate the change in GFP-GPI-AP diffusion and overall membrane 
localization. As documented in literature [315], GFP-GPI-AP was shown to have more 
affinity to localize in rafts which results in its partitioning into the non-raft phase 
thermodynamically less feasible. Thus, the rate of GPI-AP released on raft disruption 
is presumably slower compared to the change of membrane heterogeneity.  
In addition, membrane perturbation at 5 mM mCD was also carried out as earlier 
study had shown that similar level of cholesterol depletion could be achieved at this 
concentration without causing changes in cytoskeleton [314]. Interestingly, as shown 
in Figure 4.4 C, GFP-GPI-AP diffusion value reached highest earlier at about 15 




of membrane heterogeneity as diffusion law intercept 0 reached the lowest value at 
about 15 minutes. The D changed from 0.31 ± 0.16 m2/s to 0.45 ± 0.15 m2/s and the 
intercept decreased from 1.30 ± 0.22 s to 0.36 ± 0.06 s. Moreover, although the 
membrane fluidity of GFP-GPI-AP where this molecule partition into was recovered 
almost completely, the membrane organization represented by the diffusion law 
intercept recovered only about 50% (Figure 4.4 D). Compared to 3 mM mCD 
incubation, the process of restoration of membrane dynamics and heterogeneity was 
much slower for 5 mM mCD incubation. In addition, the same behaviour was 
observed for GFP-GPI-AP on Hela cells (Figure 4.4 E&F&G&H) besides the lowest 
0 was registered ~20 min after treatment.  
From this point of view, it can be concluded that cholesterol extraction is dose-
dependent and further confirm that the raft disruption effect by mCD will reach the 
maximum at relatively short time within half an hour. The recovery process of 
membrane diffusion and organization is probably resulted from restoration of 
membrane cholesterol from intracellular cholesterol pools. It has been reported before 
that plasma membrane cholesterol replenishment from the intracellular cholesterol 
stores will happen upon cholesterol depletion by mCD [316]. A new equilibrium state 
of plasma membrane is achieved by this resurgence with the similar fluidity but 
relatively weaker raft organization. This also implies that the mCD treatment for raft 
disruption experiment should be taken carefully and observed only at specific dose-
dependent manners, in a narrow time window of about 5-10 minutes. 
These observed unique GFP-GPI-AP results during cholesterol extraction pose an 
intriguing question on the origin of such time and dose dependent behaviour of the live 
cell membrane organization. In principle, the recovery of membrane heterogeneity by 
cholesterol depletion can be achieved by recruiting cholesterol back into the plasma 




hypotheses are proposed. The first is cholesterol biosynthesis or cholesterol 
replenishment from the intracellular pools. The other possibility is cholesterol 
supplementing to the membrane by cholesterol-mCD complex formed during 
cholesterol extraction. To further distinguish from these two possible mechanisms and 
find out the major controlling factor, experiment that refreshing the 3 mM mCD 
during measurements were carried out. All the cholesterol-mCD complexes formed 
during the first half hour incubation were removed while the freshly added mCD was 
able to further extract cholesterol from the system. Interestingly, we observed a 
complete diminishment of the membrane heterogeneity recovery. The membrane 
organization remained in the cholesterol depleted and less heterogeneous state (Figure 
4.5 A). This was more obvious in the percentage change of the 0 value as it kept low 





Figure 4.5 Refreshment with 3 mM mCD or blank imaging buffer after ~30 min of 3 
mM mCD incubation. 
(A) Representative cell change of diffusion coefficient (D, black) and FCS diffusion 
law intercept (0, red) with 3 mM mCD refresh experiment. The fresh 3mM mCD 
medium replaced the original 3 mM mCD after ~30 minutes incubation (33 min in 
this representative one). At least 3 cells were monitored and similar effects were 
observed. (B) Extent of percentage change of D and 0 compared to its value before 
any treatment over time. (C) Distribution of D before treatment (Red bars), 33 min 3 
mM mCD (Blue bars) and refresh with new 3 mM mCD at 60 minutes (Black bars). 
(D) Diffusion law plots before, 33 min and 60 min after the sequential 3 mM mCD 
treatment. (E) GFP-GPI-AP cells were first treated with 3 mM mbCD for 30 minutes. 
The existing mCD-cholesterol containing medium is the replaced with fresh medium 
containing no additional drug. (F) Extent of percentage change of D and 0 compared 
to its value before any treatment at ~30 min and ~60 min. 
At the same time, the average D of GPI-AP increased monotonically (Figure 4.5 A&B), 
which was caused by the continuous extraction of cholesterol from the membrane by 
the additional fresh mCD. This progressive increment of the D was shown to be an 




frequency plot was observed (Figure 4.4 C, inset). At the same time, no recovery of the 
membrane organization was observed as the 0 kept low (Figure 4.4 D). The 
cholesterol-mCD complex formed during cholesterol extraction did not supplement 
cholesterol to the membrane, which was consistent with the permanent cholesterol 
removal from model membrane experiments [317]. 
As a control, the buffer after 30 minutes of mCD treatment was replaced with fresh 
medium without any drug. The recovery of the D and 0 after about 30 minutes was 
observed (Figure 4.5 E). The extent of change was plotted in Figure 4.4 F. The results 
were similar for the 30 min 3 mM mCD treatment and recovery of the D and 0 was 
similar to the continuous incubation experiments (Figure 4.5 F vs Figure 4.4 B). 
This confirms that mCD is saturated with cholesterol after 30 minutes for the CHO 
cell experiments and becomes inactive in the context of cholesterol extraction 
afterwards. Therefore, if longer observation time for cholesterol removal was required 
for cell membrane experiments, an exchange of the mounting medium with fresh 
mCD was required upon mCD saturation. 
In summary, a new membrane state exhibiting less heterogeneity and faster dynamics 
is established with lower cholesterol content by high dose mCD treatment. This new 
membrane state is established no matter in the way of one-step addition of 5 mM or 
two-step addition of a total amount of 6 mM mCD. Therefore, the possible 
explanation to the partial recovery of membrane heterogeneity after high dose mCD 
treatment is the saturation of mCD with the extracted cholesterol. The live cell 
membrane tends to maintain the plasma membrane cholesterol homeostasis, thus 
driving the membrane heterogeneity to a new equilibrium status. The possible way to 
achieve such status can be due to that cells themselves may trigger some specific 




upon external cholesterol extraction perturbations [318]. Therefore, it’s affirmed that 
internal cholesterol/lipid recruitment by the cells will regulate the plasma membrane 
reorganization. Thus, the interesting trend observed upon mCD can be attributed as 
the cell response to extracellular environment stress. In addition, high dose of mCD 
perturbation can probably cause some side effects on the involved cholesterol 
biosynthetic regulating pathways, which results in the uncomplete regain of the 
membrane heterogeneity. In terms of GPI-AP diffusion after cholesterol extraction, 
controversial outcomes have been documented in the literature [319]. The results 
demonstrate that the modulation of lateral mobility and the membrane localization for 
GFP-GPI-AP after mCD treatment is both time and dose dependent for individual cell 
lines. The dependence of incubation time, mCD concentrations as well as cell line 
specificity can possibly be the origin of the discrepancy in many previous studies. 
4.3 Actin-cytoskeleton association of PMT-GFP 
4.3.1 Actin-cytoskeleton compartmentalized marker PMT-GFP 
Plasma Membrane Targeting (PMT) sequence is a short peptide translated by the first 
45 base pairs derived from the N-terminal of the X-linked retinitis pigmentosa protein 
RP2 [320]. It is documented that this RP2 protein will target to the cytoplasmic side of 
the plasma membrane. Previous studies in our lab have revealed the inner leaflet plasma 
membrane localization of PMT-GFP as well as its monomeric status in CHO-K1 cells 
[265, 272]. Other studies adopting imaging method reveal that PMT-GFP is associated 
with the actin cytoskeleton in CHO-K1 and macrophages cells [321].  
The subcellular localization of this PMT-GFP construct by confocal imaging and 
confocal-FCS was first examined. As shown in Figure 4.6 A, it has a predominantly 
membrane localization in CHO-K1 cells similar to previous reports [265, 272]. The 




Under TIRF image, the PMT-GFP distributed homogeneously on CHO-K1 cells 
(Figure 4.6 B, inset). The D and N correlation plot showed random distribution, 
representing its membrane homogeneity above diffraction-limit.  
As shown in Figure 4.6 C, upon cholesterol extraction the distribution shifted to smaller 
value slightly with averaged D decreasing from 0.56 ± 0.24 m2/s to 0.41 ± 0.17 m2/s. 
This small portion of decrease presented as a small shift in the D cumulative frequency 
plot (Figure 4.6 C, inset). This small deduction in D may be induced by the clustering 
of PMT after cholesterol removal or partitioning into the newly-formed solid like 
region as suggested by previous study [306].  
However, the overall membrane organization of PMT-GFP was not altered as the 0 
changed from -0.53 ± 0.03 s before cholesterol depletion to -0.65 ± 0.04 s after 
cholesterol removal (Figure 4.6 D). This clearly showed that PMT-GFP was still 
strongly compartmentalized by the actin cytoskeleton. The cell morphology also 
remained unchanged.  
The actin cytoskeleton disruption effect was subsequently tested. As shown in the 
Figure 4.6 E, the D distribution after actin cytoskeleton disruption did not change from 
0.67 ± 0.20 m2/s (before) to 0.62 ± 0.22 m2/s (after Lat A). The inset of cumulative 
frequency plot also showed marginal change, which further indicated the overall 
unaltered membrane diffusion after cytoskeleton disruption. However, the diffusion 
law intercept 0 increased from -0.63 ± 0.02 s to 0.06 ± 0.02 s (Figure 4.7 F) although 
the cell morphology did not show much difference. The elevation of the intercept 
represented the removal of cytoskeleton compartmentalization effect.  
The results reveal that the diffusion of PMT-GFP on CHO-K1 cells is spatially 
compartmentalized by the actin cytoskeleton meshwork. At the same time, cholesterol-




Cytoskeleton hindered hop diffusion is the main organization principle for PMT-GFP 
membrane sub-resolution localization on live CHO-K1 cells.  
 
Figure 4.6 PMT-GFP in live CHO-K1 cell membrane. 
(A) Normalized representative confocal-FCS measurement in the cytoplasm (Red 
curve) and on the membrane (Green curve) and their corresponding fitting curves 
(Black curves). Inset: Confocal image of CHO-K1 cell transfected with PMT-GFP. The 
expressed PMT-GFP has a predominantly plasma membrane localization on the live 
CHO-K1cell. (B) D vs N correlation plot of PMT-GFP dynamics of ROI from ITIR-
FCS (Red square in the inset TIRF cell image). (C) D distribution before (Red bars) 
and after 3 mM mCD treatment (Black Bars). Inset: D Cumulative frequency plot 
before (Red curve) and after treatment (Black curve). (D) Representative FCS diffusion 
law plot for PMT-GFP transfected CHO-K1 cell plasma membrane before (Red line) 
and after 3 mM mCD (Black line). Inset: TIRF image of PMT-GFP transfected CHO-
K1 cell plasma membrane before and 30 min after mCD treatment. The FCS diffusion 




before (Red bars) and after Lat A treatment (Black Bars). Inset: D Cumulative 
frequency plot before (Red curve) and after Lat A treatment (Black curve). (F) 
Representative FCS diffusion law plot for PMT-GFP transfected CHO-K1 cell plasma 
membrane before (Red line) and after Lat A (Black line). The FCS diffusion law 
intercept 0 value elevates from negative to zero as pointed by the red arrow. Inset: 
TIRF image of PMT-GFP transfected CHO-K1 cell plasma membrane before and after 
10 min Lat A drug treatment. 
In a nutshell, the above studies of various membrane molecules verified the capability 
of ITIR-FCS in probing the membrane dynamics and organization. The live cell 
membrane sub-resolution organization can be recovered by implementing the FCS 
diffusion law analysis into ITIR-FCS. These results show that different sub-resolution 
membrane organization principles rule the membrane molecule behaviour. Free 
diffusion molecule is hardly affected by cholesterol removal or actin cytoskeleton 
disruption. Lipid rafts confinement will be diminished upon depletion of cholesterol 
and the degree of change depends on the remaining membrane cholesterol level. 
Incubation live cells with mCD can extract cholesterol in a time and dose dependent 
manner and strongly alter the dynamics and organization of molecules in the 
cholesterol-containing domains. However, the degree of change needs to be evaluated 
carefully. GPI-AP serves as a good cholesterol-dependent domain marker and almost 
undergoes entire raft confined partitioning on CHO cells. The membrane lateral 
mobility and organization of GPI-AP is not affected by the actin cytoskeleton. At the 
same time, PMT shows completely raft independent diffusion and gets 
compartmentalized by the actin cytoskeleton on CHO cells. The membrane cholesterol 
level contributes little to the PMT membrane lateral mobility and overall localization. 
However, the actin cytoskeleton strongly hinders PMT diffusion and the 
compartmentalization effect can be removed with actin cytoskeleton redistribution. All 
the above observations clearly demonstrate the power of ITIR-FCS in recovering the 
membrane molecule dynamics. With the help of diffusion law analysis, ITIR-FCS is 





5 Membrane dynamics and organization of resting EGFR 
Serving as cell-surface receptor for ligands like EGF, EGFR is a transmembrane 
protein which transduces signals inside cells. Ligand binding is believed to activate 
EGFR while other mechanisms are also reported to influence the EGFR activation such 
as receptor mutations and overexpression [56]. The activation of EGFR provokes a 
large set of intracellular signalling events via several pathways, leading to certain cell 
fates ranging from cell proliferation to apoptosis [15, 322]. Dictated by its 
spatiotemporal dynamics and organization, the activation of EGFR strongly depends 
on its oligomeric-states [323]. It is believed that the distribution of EGFR is 
heterogeneous on the membrane, where monomer, dimer, and oligomers exist as a 
mixture [324]. There is also evidence arguing that before and after ligand binding, the 
localization of EGFR changes dramatically [325].  
Given the diverse membrane structure EGFR resides in, the dynamics and organization 
of EGFR are strongly regulated by its environment. Lipid rafts with specific 
composition were believed to function as the sorting platforms of membrane trafficking 
and signalling [125, 139]. On one hand, the localization of EGFR in the cholesterol 
enriched rafts is reported to promote receptor interaction upon ligand stimulation [326]. 
On the other hand, the full activation of EGFR requires non-raft localization by 
modulation of cholesterol in several cell lines as shown by multiple biophysical studies 
[152, 327-329]. However, as cholesterol depletion is identified to be one major way of 
ligand independent EGFR activation [328], experiments in the aforementioned studies 
inevitably affect the membrane organization of EGFR to some extent. In addition, the 
cell surface organization of EGFR is also closely linked to the actin cytoskeleton 
embedded underneath the cell membrane [330, 331]. Despite the strong evidence 
revealing association between EGFR localization and activation, the role of lipid rafts 





In this chapter, the dynamics and localization of EGFR will be examined at its resting 
state on live cell membranes. The role of cholesterol-dependent domains and the actin 
cytoskeleton will be explored for resting EGFR. 
5.1 EGFR in live cell membranes 
Firstly, the lateral diffusion dynamics of resting EGFR molecule on CHO-K1 cells was 
examined by both confocal-FCS and Imaging-FCS. The confocal-FCS was first 
conducted to determine the expression level of EGFR on CHO-K1 cells. As can be 
seen, the receptors are predominantly localized on the membrane as expected (Figure 
5.1). The number of receptors registered in the region of interest (ROI) was assumed 
to be representative for the total cell membrane surface in all the measurements. In 
addition, CHO cells lack endogenous EGFR and thus the fluorescent receptors are 
assumed to be a good estimation of expressed EGFR on the CHO-K1 cells.  
 
Figure 5.1 Resting EGFR measured by confocal-FCS.  
(A) Image of resting EGFR on live CHO-K1 cells. As shown in the image, most of the 
signal is from the plasma membrane which shows the plasma membrane localization 
of resting EGFR. (B) Representative curve of EGFR confocal-FCS measurements (red 
line) with 2D2p1t fitting (black line). The diffusion time D is an indicator of the 
diffusivity of membrane EGFR while the amplitude of the curve is inversely 
proportional to the number of molecules in the focal volume. Scale bar: 10 µm. 
As shown above, the EGFR-EGFP was mostly localized on the cell membrane at the 
expression level of our experimental conditions. The dominant component on the cell 
membrane was the slow diffusing component with a diffusion time (slow) of 63.6 ± 7.2 




fraction was calculated to be around 60%. The other fraction of the diffusing 
component was much faster with a fast diffusion time (fast) of 0.69 ± 0.19 ms. This is 
on the same order of freely diffusing fluorescent proteins in the cytoplasm [332]. 
Therefor this component was attributed to free diffusing EGFR-EGFP in the cytoplasm 
close to the membrane. The triplet time was measured to be 7.5 ± 2.0 µs which was 
typical for fluorescent proteins. The calculated diffusion coefficient (D) for EGFR-
EGFP diffusing on the plasma membrane (slow fraction) was 0.32 ± 0.04 µm2/s which 
was consistent with previous report (D = 0.38 ± 0.13 µm2/s) [272].  
The range of number of molecules inside the focal volume was determined to be 11.37-
45.22 with an average of 26.69. The surface area illuminated inside the focal volume 
is assumed to be 0.196 µm2 [272]. After the confocal measurements, the cells were 
treated with 10 µM Lat A to bring them into suspension and their radius was measured, 
giving an average value of 17.35 µm and a range of 13.20-23.02 µm. Hence, for all 
experiments the CHO cells were estimated with an expression level of 20,000 ~ 
200,000 EGFR-EGFP/cell. 
The experiments of resting EGFR-EGFP with the same expression level by ITIR-FCS 
at physiological temperature (T = 310 K) were carried out to determine the lateral 
diffusivity of resting EGFR. EGFR-EGFP was expressed homogeneously on the CHO-
K1 cell membrane under TIRF microscope (Figure 5.2 A). The ITIR-FCS measures the 
membrane diffusion over hundreds of contiguous points at the same time and a large 
number of correlation curves were obtained by one measurement as demonstrated 
(Figure 5.2). Two representative curves from the same cell membrane EGFR-EGFP 
measurement were shown (Figure 5.2 E) and the whole set of the measured curves from 





Figure 5.2 Resting EGFR measured by ITIR-FCS. 
(A) The cell image of CHO-K1 EGFR-EGFP. (B) Region of Interest (ROI) composed 
of 2121 pixels registered in the measurement. (C) Diffusion coefficient (D) map after 
FCS fitting. The white pixels are the two pixels not fitted by the program. (D) Number 
of particles (N) map. (E) Two representative curves with the lowest and highest 
amplitude from the entire set of more than hundreds curves were shown with the raw 
data in grey and fitted curves in red. The whole bunch of the raw data (grey) and fitted 
curves (red) were shown in the inset. The large variability was noticed in the shape of 
the curves which is resulted from the heterogeneous membrane environment the 
receptor resides in. Thus the range of D values measured by one measurement spans 
quite wide as shown in F. (F) The distribution of the D obtained from the measurements. 
It spans a wide range from slow as 0.01 µm2/s to fast as 0.86 µm2/s. (G) The scatter 
plot of D and N. No obvious correlation in these two parameters was seen which 
indicate homogeneity of the receptor diffusivity beyond diffraction limit. (H)The 




The averaged value of the diffusion coefficient (D) of EGFR-EGFP was 0.20 ± 0.13 
µm2/s at 310 K (Figure 5.2 F). The large standard deviation (SD) compared to confocal 
measurements is due to the membrane heterogeneity. The D value by ITIR-FCS is 
smaller than that of the value measured by confocal-FCS (D = 0.32 ± 0.04 µm2/s). The 
slightly smaller value for the measured D using ITIR-FCS for other probes on the lipid 
bilayer measurements was reported before [333]. The value D for EGFR-EGFP was 
also smaller compared to the GFP-GPI protein (0.31 ± 0.22 µm2/s) measured by the 
same set-up. This difference of the diffusivity indicates that these two membrane 
proteins are influenced by different membrane environment and EGFR-EGFP possibly 
was more confined compared to GFP-GPI-AP. At the same time, the 0 values of 
EGFR-EGFP were registered to fall in the range of 1.5-2.5 s which were always larger 
than the values registered for GFP-GPI-AP (0.8-1.3 s) on live CHO-K1 cells. As the 0 
values reflect the membrane confinement, the overall domain confinement of EGFR-
EGFP is hence stronger than that of GFP-GPI-AP. In addition, no clear trend of D and 
N is observed (Figure 5.2 G), which indicates the homogeneous distribution of receptor 
beyond the diffraction-limit. 
5.2 EGFR is partially confined in cholesterol dependent domains 
As a relative stronger confinement was registered for the membrane EGFR-EGFP 
compared to the lipid raft marker GFP-GPI-AP, the contribution of cholesterol-
dependent domains (lipid rafts and caveolae) was monitored. The cells expressing 
EGFR-EGFP were incubated with 3 mM mCD to remove cholesterol and ITIR-FCS 
was adopted to monitor the dynamics and localization change of EGFR-EGFP on the 
live cell membrane over time. It was reported that 3 mM mCD is sufficient to deplete 
the cholesterol-containing domains both in COS-7 cells and T cells [228, 316]. And the 
effective function of mCD with this concentration at 310 K was also demonstrated in 
CHO-K1 cells as shown in Chapter 4, which was similar to previous studies. Moreover, 




perturbing conditions was monitored as ITIR-FCS enables diffusion law analysis of 
multiple observation areas with post-acquisition binning.   
No morphological change was observed for the CHO-K1 cell expressing EGFR-EGFP 
before and ~30 minutes post addition of 3 mM mCD (Figure 5.3 A). Within ~30 
minutes of mCD addition the value of D increased from 0.20 ± 0.13 m2/s to 0.28 ± 
0.17 m2/s with an increment of about 40% (Figure 5.3 B). The value D started 
decreasing again to the value of 0.21 ± 0.16 m2/s after ~50 minutes incubation, which 
is close to the initial value. The D distribution of EGFR-EGFP before and ~30 minutes 
after mCD treatment is created by pooling D values of 5 individual cells from 
independent sets (Figure 5.3 D). It is obvious in the cumulative distribution of D that 
overall membrane diffusion increases as the distribution shifted towards the right with 
an unchanged slope after treatment (Figure 5.3 E). At the same time, EGFR-EGFP 
organization became less confined as 0 decreased from the basal value of 1.98 ± 0.72 
s to the lowest value of 0.66 ± 0.14 s at 33 minutes (Figure 5.3 B, red bars). This 
represents a decrease about 65% change from the initial value.  
This is reminiscent of the similar time dependent change of GFP-GPI-AP diffusion 
under identical perturbing conditions observed earlier (Figure 4.4). However, the 
significant difference in the absolute values should be paid attention to. In the case of 
GFP-GPI-AP, the value of 0 is almost zero at ~30 minutes post treatment (from 1.31 
± 0.31 s all the way to 0.17 ± 0.11 s) indicating free diffusion of GFP-GPI-AP, which 
is released from lipid rafts after cholesterol extraction (Figure 4.4 A, red bars). The 
change for EGFR-EGFP confinement on CHO-K1 cells has the same trend of decline 
with cholesterol removal within the first half hour. In contrast, the 0 value remains 
strongly positive (all larger than 0.60 s) instead of the expected value ˂ 0.2 s for free 
diffusion under the same condition, which is clearly different from GFP-GPI-AP. This 




cells. The cholesterol independent confinement of EGFR is either due to its partitioning 
into cholesterol-independent lipid domains or formation of EGFR clusters. On a side 
note, cell-to-cell heterogeneity is a significant factor among all the measurements and 
needs to be taken account for before pooling the single cell data. Hence, single cell data 
analysis should first be conducted to check for cell to cell variation. In addition, cells 
with similar expression levels are applied for conducting the ITIR-FCS measurements. 
 
Figure 5.3 Cholesterol depletion of CHO-K1 expressing EGFR-EGFP. 
(A) TIRF images of the same CHO-K1 cell expressing EGFR-EGFP before and after 
3 mM mCD treatment. (B) Change of diffusion coefficient (D, black) and FCS 
diffusion law intercept (0, red) from one representative cell. We could observe an 
overall faster diffusion and steady disappearance of membrane heterogeneity until 33 
min after treatment (from 0 min before treatment to around half an hour of adding 
mCD). This is the time point where mCD is saturated with the extracted cholesterol 
which is followed by the recovery of membrane heterogeneity (after 33 min). (C) 
Extent of change of D (black bars) and 0 (red bars) compared to the value before 




treatment (Number of ACFs = 2205 and Number of cells = 5). (E) Cumulative 
distribution of the histograms before and after 3 mM mCD treatment.  The shift of the 
D is an overall change. (F) Representative FCS diffusion law plots for the same cell 
before and after 3 mM mCD treatment.  
The change of D and 0 for EGFR-EGFP was plotted to show the variation of response 
from individual cells post mCD incubation (Figure 5.4). The change of the D value 
varies in the extent but all show a rise as the D distribution all shifts to the right (Figure 
5.4 A). Moreover, the 0 showed a big drop, which represented less confinement after 





Figure 5.4 Cell to cell variability after mCD incubation. 
(A) The D distribution of individual CHO-K1 cell expressing EGFR-EGFP after 





Moreover, it was noted that 0 for both EGFR-EGFP and GFP-GPI-AP recovered to 
about 70% of the basal value after prolonged incubation with mCD. In this context, 
the decrease of 0 value was found to depend on the incubation time and concentration 
of mCD as shown earlier (Chapter 4.2.2).  
Therefore, a significant amount of EGFR-EGFP resides in cholesterol-containing 
domains where GFP-GPI-AP exclusively partitions into. Another fraction of EGFR is 
trapped by cholesterol-independent domains which can be either other lipid domains 
or protein clusters. Earlier studies have suggested that in absence of ligand EGFR, 
clusters exist on the membrane for A431 cell line, SKBR3 breast cancer cells and CHO 
cells [4, 48, 334]. In NIH 3T3 cells, Hofman et al. also showed that EGFR resides in 
cholesterol-independent GM1 domains in the resting state [335]. In addition, GM3, 
which is demonstrated to have a higher affinity for EGFR than GM1 [336], may also 
form clusters to trap membrane EGFR. Therefore, the origin of the cholesterol-
independent part of 0 can be both dynamic formation of EGFR clusters and partitioning 
into cholesterol-independent lipid domains. Such cholesterol independent trapping of 
signalling molecules in protein clusters is documented in the previous report for T-cell 
receptors in the activated state [337].  
5.2.1 Cholesterol-dependent confinement of EGFR-EGFP 
The origin of cholesterol dependent trapping of EGFR on the plasma membrane may 
rise from its localization in cholesterol-containing domains such as lipid rafts or 
caveolae. Biochemical studies showed that in HEp-2 and A431 cells, 40% of EGFR is 
localized in the lipid rafts together with GPI-AP and pacental alkaline phosphatase 
(PLAP) while only 5-10% is in the caveolae [338]. However, in both MA104 cells and 
Rat-1 cells, the resting EGFR was reported to enrich in caveolae membrane fractions 
with high amount (60.5% for MA104 and 48.6% for Rat-1) by membrane fractionation 




which lack endogenous EGFR transfected with EGFR were also reported to show 
abundant enrichment of EGFR in the caveolae [341]. It was also reported by FLIM-
FRET experiments that EGFR in resting state co-localizes with GM1, but not with GPI-
AP, in HER14 cells [335]. The authors found that GPI-AP co-localizes with GM1 in a 
cholesterol dependent manner implying that EGFR partitions into cholesterol-deficient 
GM1 domains. However, the co-localization between caveolae and EGFR was not 
explored in that study. A recent study also reported that in mouse neural stem cells 
(NSCs) GD3 is co-localized with EGFR in the microdomain structure and their 
interaction plays important role in EGFR endocytosis and recycling which is closely 
related to its cell-fate determination [342]. A clear picture of cholesterol-dependent and 
cholesterol-independent confinement for EGFR on live cell membrane is still lacking 
due to many factors, such as variation between cell lines and limitation of techniques. 
In order to test the confinement of the cholesterol-containing domains for EGFR-EGFP, 
experiments on Jurkat cells which lack caveolae was performed [343]. The hypothesis 
for this experiment is based on the change of confinement originated from cholesterol-
containing domains which are categorized into two species rafts and caveolae. On a 
side note, caveolae are considered as a subset of lipid rafts containing cholesterol in 
some literature [344, 345] but these two distinct microdomains rich in cholesterol and 
sphingolipid differ in stability as well as shape [346]. Especially regarding the proteins 
content in these two microdomains, caveolae are known for caveolin association [347] 
while lipid rafts are enriched with GPI-APs [346]. Hence, in this thesis the term lipid 
raft referring to the rafts portion exclude the caveolae structure was used unless 
otherwise stated. 
If the cholesterol-dependent fraction of EGFR is exclusively located in caveolae, 
cholesterol depletion from Jurkat cells would not lead to any change in the EGFR-
EGFP confinement as no caveolae are present in Jurkat cells. While the same treatment 




confinement was expected to be removed similar to the case of CHO-K1 cells. First, 
experiments to check for the cholesterol-dependent confinement of GPI-AP on Jurkat 
cells were conducted. 
Surface coating is required for Jurkat cell attachment. This additional cell attachment 
procedure is demonstrated not to alter the diffusion of membrane proteins [267]. 
Detailed protocol for Jurkat cell measurements is described in chapter 2.  
The results for the GFP-GPI-AP on Jurkat cells are depicted in Figure 5.5. Only fully 
attached cells on the pre-coated glass were taken for measurements in imaging buffer 
without serum. To avoid the effect of transient attachment of peripheral cell part 
observed for some cells, most of the measurements were taken close to the centre of 
the cell.  
 
Figure 5.5 3 mM mCD treatment in live Jurkat cells expressing GFP-GPI-AP. 
(A) Brightfield image for the Jurkat cell attach to the coverglass. (B) TIRF image for 
the same cell. Large patch of basal membrane is attached to the glass surface. The TIRF 
image remains unchanged throughout the whole incubation time. (C) The D and 0 
value for GFP-GPI-AP before treatment and after mCD incubation for 30 minutes. 
(D) Representative diffusion law plots for the same cell expressing GFP-GPI-AP 
before and after mCD treatment. The same mCD incubation experiments were 




The value of D increased from 0.42 ± 0.23 m2/s to 0.52 ± 0.22 m2/s after mCD 
treatment (Figure 5.5 C). The absolute D value is slight different between the Jurkat 
cell and CHO-K1 cell lines, which is expected. But the same increase trend in D is 
observed after cholesterol removal. At the same time, the diffusion law analysis 
revealed that 0 changed from 1.09 ± 0.17 s to 0.28 ± 0.12 s for GFP-GPI-AP on Jurkat 
cells after mCD treatment. One representative set of the diffusion law plot is depicted 
in Figure 5.5 D, which is taken from the same cell before and after mCD treatment. 
Similarly for GFP-GPI-AP on CHO-K1 cells, the fall in the absolute value of 0  close 
to 0.1 s is an indicator of free diffusion of GFP-GPI-AP after cholesterol removal on 
Jurkat cells. 
Following the same strategy, measurements of EGFR-EGFP in Jurkat cells were 
carried out. The cell attachment and morphology did not change much before and after 
mCD treatment (Figure 5.6 A&B). The value of D increased from 0.23 ± 0.16 m2/s 
to 0.51 ± 0.39 m2/s (Figure 5.6 C). This increase in D is similar to what was observed 
for GFP-GPI-AP on Jurkat cells after drug treatment. Similarly, for EGFR-EGFP, the 





Figure 5.6 3 mM mCD treatment in live Jurkat cells expressing EGFR-EGFP. 
(A) TIRF Image for EGFR-EGFP on Jurkat cells. (B) TIRF Image for EGFR-EGFP on 
Jurkat cells The after treatment. (C) The D and 0 value for EGFR-EGFP before and ~ 
30 minutes after mCD treatment. (D) Representative diffusion law plots for the same 
cell before and after mCD treatment. The same mCD incubation experiments were 
repeated at least three times and each individual cell showed the same trend. Scale bar: 
10 m. 
The relative decrease of 0 of EGFR-EGFP was comparable for CHO-K1 (~ 65%) and 
Jurkat cells (~ 56%). At the same time, 0 for GFP-GPI-AP on Jurkat cells decreases to 
values close to 0.2 s which was set as threshold value used as free diffusion in this 
study [279]. This is also similar to the observation on CHO-K1 cells. The above results 
indicate that on Jurkat cells in absence of caveolae almost the entire cholesterol-
dependent fraction of EGFR is located in lipid rafts. Therefore, the cholesterol-
dependent confinement of EGFR on CHO-K1 cells is unlikely to originate from 
localization in caveolae. This is different to EGFR organization in HER14 cells where 
in the resting state it is excluded from lipid rafts [335]. Thus localization of EGFR 
depends on the cell type and availability of various types of cholesterol-containing 
domains. Nevertheless, a significant fraction of cholesterol-independent confinement 
of EGFR is common in both CHO-K1 and Jurkat cells while GFP-GPI-AP confinement 
exclusively depends on cholesterol. Similarly, the degree of confinement (0 value) of 
EGFR-EGFP is higher than that of GFP-GPI-AP. This is also reflected in their 
respective lateral dynamics as D of GFP-GPI-AP is larger than that of EGFR-EGFP in 
resting cells. 
5.3 EGFR-EGFP organization depends on actin cytoskeleton 
Another important role in plasma membrane organization is played by the actin 
cytoskeleton. It has been proposed that the interaction between cytoskeleton and 
membrane/lipid rafts play pivotal roles in regulating many membrane protein signalling 
and function [348]. Since EGFR is involved in cell migration and adhesion, it is 
somewhat expected that cytoskeletal elements will play an active role in EGFR 




Hence, the role of the actin cytoskeleton on EGFR organization was studied by 
inhibiting actin polymerization. As shown in the Chapter 4, 3 M Lat A incubation was 
enough to change the microscopic cytoskeleton structure and lead to its strong 
rearrangement from attaching to the membrane.  
 
Figure 5.7 Lat A treatment in live CHO-K1 cells expressing EGFR-EGFP. 
(A) TIRF images of the same cell expressing EGFR-EGFP before and after 
cytoskeleton disruption. (B) Distribution of D before and 15 min after Lat A treatment 
(Number of ACFs = 2205 and Number of cells = 5). (C) The cumulative distribution 
of the D histograms before (Red curve) and after (Black curve) treatment. (D) 
Representative FCS diffusion law plots for untreated (Red line) and treated (Black line) 
cells. (E) Cell images after Lat A treatment. Microscopic clusters can be observed in 
about 20% of the cells after cytoskeleton disruption. 
After addition of Lat A microscopic clusters of EGFR-EGFP was observed in ~20% of 
cells (Figure 5.7 E). The average D of EGFR-EGFP increased slightly from 0.20 ± 0.13 
m2/s to 0.26 ± 0.28 m2/s, which is consistent with the results observed by SPT 




interesting phenomenon. The fraction of slow diffusing species (D < 0.1 m2/s) 
increased while the species exhibiting intermediate diffusivity (D = 0.1-0.5 m2/s) 
decreased moderately. At the same time, the fast diffusing species (D > 0.5 m2/s) also 
increased slightly after Lat A treatment. The redistribution of the diffusivity was more 
obvious in the cumulative distribution of D (Figure 5.7 C). 
The increase in the population of fast diffusing species is ascribed to the release of the 
cytoskeleton bound EGFR after treatment. This portion of released EGFR from the 
cytoskeleton can diffuse at a faster rate after treatment. On the other hand, the increase 
in the slow diffusive fraction results from EGFR clustering after Lat A treatment. This 
argument is further confirmed by the emerging microscopic clustering observed in ~20% 
of the cells after treatment in TIRF imaging. As proposed in the literature, the 
probability of receptor clustering is dependent on its concentration and the meshwork 
density [35, 352]. At low receptor concentration, which is the case here, the 
cytoskeleton compartments inhibit receptors from clustering. Once the actin 
cytoskeleton polymerization close to plasma membrane is inhibited, the receptors 
diffusing on the membrane are spatially less constrained and exhibit a higher tendency 
to cluster. Hence, in absence of the meshwork hindering effect from the cytoskeleton, 
EGFR is able to form microscopic clusters on the plasma membrane in some of the 
cells after Lat A treatment. The different cluster formation is mainly due to the cell to 
cell variability. 
The 0 value increased from 1.57 ± 0.11 s to 2.46 ± 0.10 s after cytoskeleton disruption, 
with an increment of about 55% (Figure 5.7 D). This is reminiscent of what was 
observed for diffusion law analysis of PMT-GFP in CHO-K1 cells (increase from 
negative to zero). At the same time, a negligible effect on D and 0 was observed upon 
the same treatment on either DiI-C18 stained cells (Figure 4.1 E&F&H) or GFP-GPI-




 The elevation of the 0 after Lat A treatment confirms the influence of the cytoskeleton 
meshwork on EGFR organization. A similar phenomenon is also observed for other 
transmembrane proteins such as dipeptidyl peptidase IV (DPPIV-GFP) on live COS-7 
cells [290] and NKp46 receptor on hypo-responsive natural killer (NK) cells [294].  
The above results suggest that EGFR lateral dynamics and organization in the resting 
state is dictated by its confinement in membrane domains and compartmentalization by 
the actin cytoskeleton. The cholesterol-dependent confinement on CHO-K1 cells 
originates mainly from lipid rafts, with little contribution of caveolae inferred from the 
Jurkat cell measurements. The cholesterol-independent transient trapping of EGFR is 
identified to be either cholesterol-deficient lipid domains or EGFR nanosclusters. 
Earlier studies have revealed that EGFR binds to gangliosides such as GM3 through 
carbohydrate to carbohydrate interactions [353], which can potentially be one of the 
sources of cholesterol-independent trapping of the receptor. Another possibility which 
should be considered for the cholesterol-independent confinement is the interaction of 
EGFR with chathrin-associated protein complex AP2 which has been addressed in the 
literature [354, 355]. Despite different sources contributing to the EGFR membrane 
confinement, the effect of the domain confinement on the CHO-K1 plasma membrane 
is more significant than for the lipid raft marker GFP-GPI-AP. The domain 
confinement is considered to play an important role in the EGFR spatial organization. 
However, the effect of cytoskeleton compartmentalization of EGFR should be noted as 
another important factor regulating the EGFR membrane distribution. The actin 
cytoskeleton disruption is shown to strongly alter the receptor dynamics and 






6 Ligand bound EGFR  
Binding by its cognate ligand EGF will induce the conformational transitions of the 
extracellular domain and release the self-inhibitory tether of EGFR [21, 22], which will 
facilitate its oligomerization and phosphorylation. Ligand binding is believed to be one 
of the main mechanisms of the receptor activation. Large microscopic clusters which 
amplify EGFR signalling are also shown to form after EGF binding [51]. A growing 
body of evidences suggests that the ligand induced activation of EGFR happens at the 
plasma membrane [85]. The major internalization pathway after EGFR activation is 
clathrin mediated endocytosis (CME) which is thought to have the most efficient 
endocytosis rate [72]. It was reported earlier that depending on the ligand dose, ligand-
bound EGFR internalizes via different endocytosis routes [83]. At high dose of EGF 
stimulation, CME and non-clathrin mediated endocytosis (NCE) became the two major 
internalization pathways where NCE is reported to attenuate EGFR signalling [83, 356]. 
Previous studies have also shown that EGF binding promotes the membrane 
redistribution of EGFR as ligand-bound EGFR will move out from the lipid rafts [324]. 
More ligand-bound EGFR was reported in CCPs after EGF stimulation [60]. This 
suggests that ligand binding, activation and internalization of EGFR are closely 
coupled with its localization on the membrane [357, 358].  
With different concentrations of ligand treatment, EGFR is reported to be activated on 
the membrane with changes of its oligomerization states and localization [57]. More 
and more experimental evidence shows that localization of EGFR in membrane 
domains play complex roles in EGFR signalling [359, 360]. At physiological dose of 
EGF stimulation, a distinctive pool competent for signalling of endocytic EGFR was 
proposed as phosphorylated EGFR trafficked with the characteristic of lipid rafts 
through intracellular compartments [361]. Further investigation suggested that plasma 
membrane EGFR in DRMs accounts for signalling while caveolae deficient lipid rafts 




[360]. However, depletion of cholesterol leading to the increment of intrinsic EGFR 
tyrosine kinase activity was also reported, which was interpreted as the suppression 
effect of lipid rafts on the binding and kinase activity of EGFR [362].  
Similar studies based on binding analysis demonstrate that increased binding of EGF 
after cholesterol depletion is caused by the alteration of available EGFR number of 
copies [358]. The negative regulating function of the non-caveolae lipid rafts is 
proposed for EGFR signalling in a manner of sequestering the EGFR in the ligand 
inaccessible state [358]. As the above mentioned studies present the ambiguity of the 
role of lipid rafts in EGFR signalling, the exact functioning mechanism of lipid rafts in 
EGFR signalling is still under debate. The experimental difficulties which arise from 
the nanoscopic size of the membrane domains or deleterious effects of chemical 
treatments can partially explain the contradictory role of lipid rafts in promoting or 
suppressing EGFR signalling. However, more systematic studies with more 
physiological relevance and less perturbation are required in order to reveal the 
relationship of EGFR membrane localization, endocytosis and activation.  
Previous chapter has revealed the EGFR membrane distribution which is partially 
trapped by cholesterol dependent domains and hindered by actin cytoskeleton at its 
resting states. Regarding the controversial role of lipid rafts in EGFR activation, we 
move on to study the dynamics and localization of EGFR after ligand stimulation. 
Time-lapse confocal imaging was performed to monitor ligand-induced EGFR 
clustering and endocytosis [363, 364]. In parallel, TIRF imaging and ITIR-FCS were 
employed in tandem to elucidate the state of EGFR diffusion and organization above 
and below the resolution limit upon low and high doses of EGF stimulation. The 
contribution of cholesterol-dependent domains and the actin cytoskeleton in EGF 
induced modulation of EGFR dynamics was also studied. In addition, the temperature 
effect on EGFR endocytosis and clustering was also examined as some studies have 




6.1 Dose dependence of EGFR ligand binding 
6.1.1 Low and high dose EGF stimulation 
Previous studies by Scatchard analysis have reported two distinct populations of EGFR 
with different affinities for EGF on intact EGFR-expressing cell plasma membrane. 
The low-affinity class which accounts for 95-98% of the membrane receptors is 
initially proposed to be the monomeric EGFR with the tethered and autoinhibited 
configuration [14]. Subsequent studies modify this model into the argument that the 
low-affinity EGFR represents the interconverting tethered and extended dimerizing 
receptor [367]. Recent progresses by Pike’s and Lemmon’s groups showed that 
negative cooperativity of the receptor-ligand interaction result in the concavue-up 
Scatchard plot. The lower affinity Kd =2-5 nM EGFR represents the majority of the 
receptors on the plasma membrane while the significantly higher affinity receptor with 
Kd =10-100 pM represents only small fraction of the membrane receptors [368]. It is 
believed that this heterogeneity in binding affinities also reflects the pre-existing 
equilibrium of EGFR monomers and dimers which will ultimately affect the receptor 
activation [369]. The initiation of distinct signalling pathways induced by high- and 
low-affinity interactions between EGFR and EGF has been reported before [370].  
Kd [nM] 
EGF concentration 
1.56 nM (10 ng/mL) 15.6 nM (100 ng/mL) 
0.01 99% 100% 
0.1 94% 99% 
2 40% 88% 
5 22% 75% 
Table 2 Calculation of ligand-bound EGFR with different Kds and ligand 
concentrations. 
For the total receptor concentration, we assumed 0.6 nM as determined from the cell 
number per sample dish (1-2 million), the numbers of receptor per cell (20,000 – 




affinities of the receptor according to Klein [26] are Kd = 10-100 pM and Kd = 2-5 nM, 
respectively. For the high affinity receptors (Kd = 10-100 pM) which represent a 
fraction of only 2-5% of all receptors, both low (1.56 nM) and high (15.6 nM) doses of 
EGF show similar binding behaviours with EGFR. For the low affinity receptor (Kd = 
2-5 nM) the bound fraction changes from ~22-40 to ~75-88% when changing from1.56 
to 15.6 nM 
Studies demonstrated that low and high concentration EGF stimulation triggered 
different endocytosis pathways for EGFR. Calculation determining the ligand 
concentration for stimulation was carried out based on previous results [75, 83]. The 
two doses (10 and 100 ng/mL of EGF) used in this thesis for EGFR stimulation 
represent low and high dose ligand concentrations, respectively [371]. The binding 
portions of both high- and low-affinity classes corresponding to two ligand 
concentrations were listed (Table 2). 
6.1.2 EGFR imaged at low and high doses EGF stimulation 
Two different doses of EGF stimulation are employed to stimulate the EGFR on live 
cells. In the imaging experiments, EGFR internalization is used to indicate the efficient 
receptor activation by EGF. 
As can been seen in Figure 6.1, both ligand stimulations induced efficient membrane 
receptor internalization within minute. The clustering of EGFR on the membrane can 
be seen from confocal images. It is obvious that the amount of EGFR clusters after the 
10 ng/mL EGF stimulations was less compared to the 100 ng/mL EGF stimulations on 
the membrane (Figure 6.1 A 10 min vs B 10 min). In addition, throughout the whole 
monitoring period the intracellular fluorescence was observed while the membrane 
fluorescence did not change significantly for 10 ng/mL EGF stimulation (Figure 6.1 A 
13 min, 20 min and 30 min). This can probably attribute to the dynamic recycling of 




time, the TIRF images after the two doses of EGF stimulation were also taken and the 
analysed results were presented in Figure 6.2. In the TIRF images it also was observed 
that membrane fluorescence was similarly maintained after 10 ng/mL EGF stimulation 
(Figure 6.2 A). This retention in the membrane fluorescence corroborates well with the 
confocal imaging results. 
After addition of 100 ng/mL EGF, macroscopic EGFR-EGFP clusters were formed on 
the plasma membrane (Figure 6.1 B). The clustered fluorescence signal was 
internalized (Figure 6.1 B, 13-20 minutes) and gradually disappeared over time (Figure 





Figure 6.1 Endocytosis of EGFR-EGFP after 10 and 100 ng/mL EGF. 
(A) CHO-K1 cells expressing EGFR-EGFP with 10 ng/mL EGF stimulation. The time 
stamp indicates the time point after addition of EGF in the culture medium. The images 
were taken with one-minute interval and tracked up to half an hour. The 6th image is 
the enlargement of the green square from the 13 min image. (B) CHO-K1 cells 
expressing EGFR-EGFP with 100 ng/mL EGF stimulation. The cell images were taken 
every 1 minute and tracked up to half an hour. The 6th image is the enlargement of the 
green square from the upper panel image at 13 min. (C) CHO-K1 cells expressing GFP-




tracked up to half an hour. Representative cell images were shown for certain time 
points. Scale bar: 10 m. 
be the endocytosed EGFR in endosomes or multivesicular bodies. In the later time 
points the disappearance for the EGFR signal could highly be due to the receptor 
degradation in the intracellular part. Earlier studies also reported the degradation of 
EGFR in lysosomes in a similar time scale [72].  
In parallel with the confocal imaging results, a significant drop of membrane 
fluorescence signal was also observed in the TIRF images (Figure 6.2 B). The 
permanent reduction of membrane fluorescence and gradual fading of intracellular 
fluorescence correspond well to the proposed degradation of the internalized EGFR 
[83].  
As a control, GFP-GPI-AP expressing cells incubated with 100 ng/mL of EGF were 
also monitored. After EGF treatment, no intracellular fluorescence was observed which 
suggested no endocytosis of GFP-GPI-AP was triggered by EGF stimulation. No 
clusters of GFP-GPI-AP on the membrane were observed as expected (Figure 6.1 C). 
At the same time, the membrane fluorescence of GFP-GPI-AP showed marginal 
change which also showed no endocytosis happened after EGF stimulation (Figure 6.2 
E&F). In parallel, TIRF imaging for both the GFP-GPI expressing and DiI-C18 stained 
cells were also conducted with 100 ng/mL EGF incubation. As shown in Figure 6.2, 
for both cases the fluorescence intensity distribution showed marginal change after 
EGF stimulation. 
No fluorescence reduction observed for GFP-GPI and DiI-C18 on CHO-K1 cells 
indicates that both two fluorescent molecules maintain on the membrane without 
endocytosis or other signal loss. This is somehow expected as both molecules do not 
possess any EGF interacting domains. Hence, EGF addition to CHO-K1 cells without 
expressing EGFR will not cause much membrane perturbation. Although previous 




methods adopted here cannot resolve any changes below the optical resolution on the 
membrane. This result also rules out the possibility that other membrane proteins’ 
interaction with EGF will trigger certain cell functions, which may affect membrane 
GPI proteins behaviours.  
Hence, EGF binding to EGFR induces microscopic clusters formation on the 
membrane which are subsequently internalized and further sorted inside cells. The 
clustering and sorting of EGFR is ligand dose dependent. The confocal imaging results 
indicate different mechanisms regulating the membrane EGFR behaviour and bring up 
the requirement of a closer look at membrane EGFR dynamics and localization below 





Figure 6.2 Membrane fluorescence intensity change of EGFR-EGFP after 10 and 100 
ng/mL EGF. 
(A) TIRF images of EGFR-EGFP expressing CHO-K1 cells at resting state and 20 min 
after stimulation with 10 ng/mL EGF. (B) Fluorescence intensity histograms of EGFR-
EGFP expressing CHO-K1 cells before and after EGF stimulation with 10 ng/mL. (C) 
TIRF images of EGFR-EGFP expressing CHO-K1 cells at resting state and 20 min 
after stimulation with 100 ng/mL. (D) Fluorescence intensity histograms of EGFR-
EGFP expressing CHO-K1 cells before and after EGF stimulation with 100 ng/mL. (E) 
TIRF images of GFP-GPI expressing CHO-K1 cells before and 20 min after EGF 
stimulation with 100 ng/mL. (F) Fluorescence intensity histograms of GFP-GPI 
expressing CHO-K1 cells before and 20 min after EGF stimulation with 100 ng/mL. 
(G) TIRF images of DiI-C18 stained CHO-K1 cells before and 20 min after EGF 
stimulation with 100 ng/mL. (H) Fluorescence intensity histograms of DiI-C18 stained 
CHO-K1 cells before and 20 min after EGF stimulation with 100 ng/mL. 




Both 10 ng/mL and 100 ng/mL EGF stimulation will efficiently induce the activation 
and endocytosis of EGFR which are closely related to the membrane dynamics of 
EGFR. The change of membrane diffusion and heterogeneity of the remaining EGFR 
after EGF stimulation is next monitored with ITIR-FCS. 
After low dose 10 ng/mL of EGF stimulation, the D value remained unchanged with 
average value of 0.20 ± 0.13 m2/s before and 0.21 ± 0.13 m2/s (Figure 6.3 A). The 
distribution of the diffusion coefficient showed no shift over the whole ROI (Figure 6.3 
C). The 0 remained at the same level with value of 1.69 ± 0.12 s before and 1.64 ± 0.10 
s after 10 ng/mL EGF stimulation (Figure 6.3 E). Thus, membrane dynamics and 
confinement of EGFR does not change much at low dose EGF stimulation. However, 
EGFR internalization post 10 ng/mL EGF stimulation is active as shown in the previous 
section which hints at the receptor recycling. By continuous replenishment of the 
recycled EGFR to membrane, the cells can maintain the overall equilibrium of the 
plasma membrane without changing membrane dynamics and heterogeneity [72].  
When the 100 ng/mL EGF was added, the average D increased from 0.20 ± 0.13 m2/s 
to 0.27 ± 0.17 m2/s at about 20 min after stimulation. A clear shift in the D distribution 
was shown (Figure 6.3 B). The average D after 100 ng/mL EGF stimulation was very 
similar to the value after cholesterol removal (0.28 ± 0.17 m2/s for mCD and 0.27 ± 
0.17 m2/s for 100 ng/mL EGF). However, the 0 remained unaltered after 100 ng/mL 
EGF stimulation (1.85 ± 0.12 s before and 1.93 ± 0.08 s after) (Figure 6.3 F), which is 





Figure 6.3 The Dynamics and organization of EGFR after EGF stimulation. 
(A) D distribution before (Red bars) and after (Black bars) stimulation of 10 ng/mL 
EGF (Number of ACFs = 2205 and Number of cells = 5). (B) D distribution before 
(Red bars) and after (Black bars) stimulation of 100 ng/mL EGF (C) Cumulative 
frequency of D distribution before (Red bars) and after (Black bars) stimulation of 10 
ng/mL EGF (D) Cumulative frequency of D distribution before (Red bars) and after 
(Black bars) stimulation of 100 ng/mL EGF (E) FCS diffusion law plot before and 20 
min after 10 ng/mL EGF stimulation for one representative cell. (F) FCS diffusion law 
plot before and 20 min after 100 ng/mL EGF stimulation for one representative cell. 
After 100 ng/mL EGF stimulation, a small but significant time dependent change of D 
of EGFR-EGFP was recorded (Figure 6.4). The D value increased with time (Figure 
6.4 A), where the largest value registered in the representative cell by 35% at 22 min 
(Kolmogorov-Smirnov [KS] test p < 0.001). However, the diffusion law intercept 0 
remained positive with marginal change after 100 ng/mL EGF stimulation (Figure 6.4 
B). The trend of the temporal change of D was similar to that of mCD treatment while, 
it significantly differed for 0 (Figure 4.3 D vs Figure 6.4). Therefore, as expected, it is 
not a common mechanism that modifies EGFR-EGFP diffusion on the membrane upon 






Figure 6.4 Time dependent modulation of EGFR-EGFP on CHO-K1 cells. 
(A) Time dependent change of the diffusion coefficient D (Black bars) and diffusion 
law intercept 0 (Red bars) over time for one representative cell. (B) The percentage of 
change of D (Black bars) and 0 (Red bars) post 100 ng/mL EGF stimulation. The same 
treatment was repeated at least three times for different cells and the same trend was 
observed.  
When a closer look in the D distributions (both histogram and cumulative) of the EGFR 
after mCD (Figure 5.3 D & E; Figure 6.5 Green) and 100 ng/mL EGF treatments 
(Figure 6.4 B & D; Figure 6.5 Black) is taken, an interesting observation can be seen. 
There was a striking drop on the fraction of slow diffusing particles (D < 0.1 m2/s) 
after EGF stimulation in a similar fashion to that after mCD treatment (Figure 6.5 
Green and Black). However, the fast diffusing fraction in the case of EGF stimulation 
did not increase to the same extent compared to the mCD treatment (Figure 6.5 Black 
vs Green). In both cases, the cumulative distribution right shifted from that of the 
resting state. But the slope of the cumulative plot did not change for the mCD 
treatment as opposed to the case of EGF stimulation where the slope became steeper 
(Figure 6.5 Black vs Green). Therefore, mCD treatment causes a global change in 
EGFR diffusion while the slow diffusing fraction on the membrane surface disappears 





Figure 6.5 The distribution of D of EGFR-EGFP after different treatments. 
Histogram distribution of EGFR-EGFP at resting (red) and with drug treatment of 3 
mM mCD (green), 3 M Lat A (blue), 100 ng/mL EGF (black) and 10 ng/mL EGF 
(cyan). (B) Cumulative frequency of D distribution corresponding to resting (red) and 
with drug treatment of 3 mM mCD (green), 3 M Lat A (blue), 100 ng/mL EGF 
(black) and 10 ng/mL EGF (cyan). 
 
Figure 6.6 Raft marker (GFP-GPI-AP) and free diffusion marker (DiI-C18) with 100 
ng/mL EGF stimulation. 
(A) D distribution of GFP-GPI-AP expressed CHO-K1 before and after treatment. (B) 
FCS diffusion law plots of GFP-GPI-AP expressed CHO-K1 before and after treatment. 
(C) D distribution of DiI-C18 labelled CHO-K1 before and after treatment. (D) FCS 
diffusion law plots of DiI-C18 labelled CHO-K1 before and after treatment. For each 





At the same time, the cells expressing GFP-GPI-AP and stained with DiI-C18 were also 
monitored after 100 ng/mL EGF stimulation as a control. As shown in Figure 6.6 A, 
the D distribution of GFP-GPI-AP did not change after 100 ng/mL EGF addition with 
the averaged value 0.31 ± 0.22 m2/s before and 0.32 ± 0.22 m2/s after treatment. 
Similarly, the 0 value changed from 1.15 ± 0.07 s before to 1.24 ± 0.07 s after (Figure 
6.6 B), which also showed no prominent change in sub-resolution domain organization. 
Similar effects were also observed for DiI-C18 diffusion and organization, which were 
depicted in Figure 6.6 C and D. This confirms that on CHO-K1 cells, EGF has no 
influence on the free diffusion as well as GFP-GPI-AP containing cholesterol-
dependent domains.  
In addition, previous studies suggested that the EGFR signalling pathways such as 
STAT pathway was activated by EGF stimulation with the promotion of cytoskeleton 
[372]. EGF was also reported to regulate the cytoskeleton structure to modulate certain 
cell functions in many cell lines [373, 374]. Hence, the effect of EGF stimulation on 
the cytoskeleton organization was examined with stably transfected Lifeact cells as 
shown in Figure 6.7.  
No obvious microscopic change was observed for both doses stimulation. This is 
somehow expected as CHO cells lack endogenous EGFR. These imaging results 
indicate that both low and high dose stimulation of EGF in this set of experiments 





Figure 6.7 Cytoskeleton change after 10 & 100 ng/mL EGF probed by Lifeact cells. 




6.2 EGFR membrane diffusion, confinement, and internalization in the 
ligand-bound state 
6.2.1 EGFR membrane diffusion and endocytosis in the ligand-bound 
state 
Both high and low doses EGF stimulation will induce the membrane EGFR endocytosis. 
When the remaining EGFR is monitored, different membrane dynamics are observed 
at the two different doses. The relationship between EGFR membrane status and its 
internalization modes is further investigated in the ligand-bound state. 
The D distribution of EGFR-EGFP following EGF stimulation can be linked to the 
mode of endocytosis. The major route of receptor internalization is clathrin mediated 
endocytosis (CME). In this mechanism, the receptor is transported via CCPs into early 
endosomes (EEs) followed by late endosome localization. The fate of the receptor 
whether gets degraded at the lysosome or recycles back to the membrane is decided at 
the late endosome [59, 72, 83]. In contrast, cholesterol-containing domains involved in 
non-clathrin mediated endocytosis (NCE) is reported earlier [76]. As a result, 
cholesterol-containing domains disappear from the membrane after high dose EGF 
stimulation, which is also consistent with the previous study [75]. Since EGFR is 
partially localized in cholesterol-dependent domains as shown in Chapter 5, NCE of 
the receptor changes its membrane diffusion. But if cholesterol-dependent domains do 
not participate in the internalization, as in the case of CME, EGFR diffusion will remain 
unaffected.  
In this context, the NCE was tested by monitoring endocytosis of GFP-GPI-AP and 
EGFR-mRFP co-transfected cells at a given EGF dose. The cells expressing similar 
level of GFP-GPI-AP and EGFR-mRFP were monitored over time. After 10 ng/mL 
EGF treatment, the fluorescence of EGFR-mRFP but not of GFP-GPI-AP was observed 
in the cytosol on the co-transfected cells (Figure 6.8A). This implies that cholesterol-




ng/mL EGF stimulation condition. Therefore, the possibility of NCE which involves 
the cholesterol-containing domains is ruled out to be the internalization pathway here. 
Sigismund et al. reported that the EGFR undergoes CME and is recycled to the 
membrane after low dose of ligand stimulation [83]. Persistent intercellular 
fluorescence signal since its first appearance and unchanged membrane fluorescence 
as observed in the confocal imaging experiments suggest receptor recycling to the 
membrane after internalization. The D and 0 values for EGFR after 10 ng/mL EGF 
stimulation registered by ITIR-FCS experiments are unchanged as shown earlier 
(Figure 6.3 A&E), which can be explained as the trapping sites are not involved in the 
endocytosis. 
Moreover, both green and red fluorescence in endocytosed clusters of GFP-GPI-AP 
and EGFR-mRFP co-transfected cells were observed after 100 ng/mL EGF addition 
(Figure 6.8 B). The inset clearly shows the co-localization of EGFR-mRFP and GFP-
GPI in the EEs. The endocytosis of GFP-GPI-AP confirms that the cholesterol-
dependent domains are endocytosed and thus NCE involving cholesterol-dependent 
domains is the process initiated by the high dose EGF stimulation. Note that in absence 
of EGFR CHO-K1 cells expressing GFP-GPI-AP alone does not endocytose after 100 
ng/mL EGF treatment (Figure 6.1 C). In addition, the significant portion of intracellular 
EGFR-mRFP signal which does not co-localize with GFP-GPI-AP suggests that CME 





Figure 6.8 Endocytosis of GFP-GPI-AP and EGFR-mRFP by two-colour confocal 
imaging. 
(A) Results show that only EGFR-mRFP is endocytosed after 10 ng/mL EGF 
stimulation (B) Both proteins are present in the endocytosed clusters after 100 ng/mL 
EGF stimulation. This implies that cholesterol-dependent domains are involved in the 
endocytosis process at high dose stimulation. 
Interestingly, as revealed by ITIR-FCS measurements the average membrane diffusion 
of the EGFR-EGFP increased after 100 ng/mL EGF stimulation. The D distribution 
after 100 ng/mL stimulation shows that slow diffusing (D < 0.05 m2/s) fraction of 
EGFR disappeared while the fast diffusing fraction remained unaffected (Figure 6.3 D; 




the removal of more ordered and viscous (less fluid) cholesterol-containing domains 
during NCE. In addition, fluorescence signal from the membrane did not recover after 
prolonged incubation while the internalized clusters that were observed after 100 
ng/mL EGF stimulation (Figure 6.1 B) gradually disappeared over time suggesting 
degradation of internalized EGFR. This matches well with literature, which states that 
about 40% of EGFR is endocytosed via NCE after stimulation with high dose of EGF 
and the majority degrades over time [83, 375, 376]. The completion of the 
internalization process takes about 15 minutes after ligand stimulation has been shown 
by a recent study [377]. This is about the time when the maximum diffusivity of the 
EGFR on the membranes was observed in my experiments after EGF stimulation, 
inferring the disappearance of the cholesterol-containing domains to the highest extent 
(Figure 6.4 B). Therefore, one of the internalization pathways of EGFR after 
stimulation with 100 ng/mL EGF is NCE which involves the cholesterol containing 
domains. Abulrob et al. also reported similar endocytosis and degradation of the 
intermediate size EGFR containing domains while monomers of EGFR will recycle 
back to the membrane [378].  
In addition, another interesting observation in the organization of EGFR-EGFP should 
be noted here. The 0 value of EGFR-EGFP did not change much after 100 ng/mL EGF 
stimulation. Therefore, the fraction of membrane area that can trap EGFR remain the 
same although cholesterol-containing domains are partially removed during 
endocytosis. It is known that EGF binding will induce the EGFR clustering and EGFR 
signalling is regulated by the dynamic clustering of ligand-bound EGFR [51, 379]. 
Sergeev et al. reported that the binding of EGF increases the number and size of EGFR 
clusters [380]. In addition, EGF was also reported to introduce large domains by 
coalescing various membrane domains [335, 381]. The existence of these larger 
nanoclusters/domains will therefore compensate the loss of confinement due to the 




The relationship between EGFR clustering and EGF stimulation will be further 
discussed in the following sections.  
Overall, the interaction of EGF with membrane EGFR is strongly dependent on EGF 
concentration. At low dose of 10 ng/mL EGF stimulation, EGFR internalizes probably 
via CME with an unchanged membrane diffusion and confinement. At high dose of 
100 ng/mL EGF stimulation, EGFR undergoes both CME and NCE, which leads to a 
time-dependent increase of its membrane diffusion. In parallel, the remaining EGFR 
on the membrane assembles into nanoclusters with larger size and density.  
6.2.2 Membrane organization principles in regulating EGFR membrane 
distribution and endocytosis 
As cholesterol containing domains have been demonstrated to play important role in 
the EGFR internalization, the effects of EGF on EGFR organization were next 
investigated when the receptor is released from cholesterol-dependent domains.  
The CHO-K1 cells expressing EGFR-EGFP were first incubated with 3 mM mCD for 
30 minutes. At this time point when the maximum effect of mCD in terms of D and 
0 was observed as shown earlier, 10 ng/mL of EGF was added to the system. Not much 
microscopic clusters on the membrane was observed. When ITIR-FCS measurements 
were taken to monitor the confinement change reflected by 0, an interesting change 
trend was observed (Figure 6.9 A). The values of 0 first dropped from 2.14 ± 0.17 s 
for to 1.18 ± 0.15 s for the mCD incubated cells. This was consistent with previous 
results under cholesterol depletion condition. When measurements were taken at the 
homogeneous membrane part on the cells after EGF addition, interestingly, the 0 value 
at this condition increased significantly up to 3.00 ± 0.17 s (Figure 6.9 E). The high 
value of 0 after EGF stimulation can be due to the existence of nanosclusters [57, 380]. 
However, the D value for this set of experiments changed from 0.20 ± 0.15 m2/s 




to 0.25 ± 0.20 m2/s after longer incubation with 10 ng/mL EGF. This reduction in 
value with longer incubation of EGF can both result from simultaneous recovery of 
membrane heterogeneity by cell intrinsic response and the stronger confinement from 
the clusters induced by EGF. However, the change of D value after treatment is not as 
strong as change of 0, which serves as a good indicator for sub-resolution membrane 
organization.  
 
Figure 6.9 Two doses of EGF on the diffusion and heterogeneity of EGFR-EGFP on 




(A) D (Red bars) and 0 (Black bars) value plot with different treatment. 3 mM mCD 
for 30 min followed by 10 ng/mL EGF for 20 min on the EGFR-EGFP expressing 
CHO-K1 cells. (B) D (Red bars) and 0 (Black bars) value plot with different treatment. 
3 mM mCD for 30 min followed by 100 ng/mL EGF for 20 min on the EGFR-EGFP 
expressing CHO-K1 cells. (C) D (Red bars) and 0 (Black bars) value plot with different 
treatment. 3 mM mCD for 30 min on the GFP-GPI expressing CHO-K1 cells and 
refresh with medium. (D) D (Red bars) and 0 (Black bars) value plot with different 
treatment. 3 mM mCD for 30 min on the EGFR-EGFP expressing CHO-K1 cells and 
refresh with medium. (E) Representative FCS diffusion law plots for resting EGFR-
EGFP (Red line), 30 min after 3 mM mCD (Black line) and 20 min after adding 10 
ng/mL EGF (Blue line). (F) Representative FCS diffusion law plots for resting EGFR-
EGFP (Red line), 30 min after 3 mM mCD (Black line) and 20 min after adding 100 
ng/mL EGF (Blue line). (G) Representative TIRF images of EGFR-EGFP clusters after 
3 mM mCD + 100 ng/mL EGF treatment. Measurements were repeated at least three 
times and more than 1323 ACFs were analysed at each state of drug treatments. 
In contrast, when 100 ng/mL EGF stimulation was applied on cholesterol-depleted cells, 
microscopic EGFR clusters were observed on the membrane from several minutes up 
to hours (Figure 6.9 G). In general, these clusters are randomly distributed over the cell 
surface while in some cases they are more populated in the cell periphery (Figure 6.9 
G first and third cell images). This cell periphery localization of the clusters could be 
due to better access of the EGFR molecules along the cell boundary [260]. However, 
the specific curvature dependent interaction of EGF with the peripheral EGFR reported 
by previous study cannot be ruled out here [382]. The similar cell surface distribution 
of EGF induced EGFR clusters which are predominantly abundant at the cell periphery 
is also reported on live A431, HeLa and COS-7 cells, respectively [79, 260, 325].  
For the cells deficient of cholesterol stimulated with 100 ng/mL EGF, the D value 
measured from regions devoid of clusters before any treatment was 0.21 ± 0.13 m2/s 
and increased to 0.32 ± 0.26 m2/s after cholesterol removal (Figure 6.9 B). With 
longer time incubation, the D value 0.34 ± 0.27 m2/s remained similar to the 
cholesterol removal state. However, the FCS diffusion law analysis again gave a much 
larger positive intercept (Figure 6.9 B). The 0 value changed from the resting 
membrane 2.04 ± 0.08 s to cholesterol removal with value of 1.16 ± 0.04 s, and 




than resting states indicates a larger surface coverage of the nanoscopic clusters 
compared to the basal state.  
As shown in Chapter 4, the membrane heterogeneity will recover after certain time of 
mCD incubation (~ 30 min). This membrane recovery effect should be considered for 
membrane EGFR confinement. The GFP-GPI as a lipid raft marker can probe the 
reoccurrence of this cholesterol-dependent confinement. As a control, the cells 
expressing GFP-GPI were first incubated with mCD and replaced with fresh culture 
medium upon the maximal removal effect was achieved (~30 min). The results (Figure 
6.9 C) clearly demonstrated that the recovery of membrane heterogeneity after 
perturbation would not go beyond its resting state. Nevertheless, serum-starved EGFR-
EGFP expressing CHO-K1 cells were incubated with mCD for 30 minutes followed 
by washing out of mCD with serum-free medium that did not contain EGF. The 
recovery of 0 was observed as expected, but does exceed the basal value for the 
untreated plasma membrane (Figure 6.9 D). No substantial change in the D of EGFR 
was observed (Figure 6.9 D). Therefore, EGFR molecules that remained in the non-
cholesterol domains after mCD treatment would have moved to somewhat larger 
domains after EGF stimulation to exhibit an unchanged D and an augmented 0. This 
argument was further supported by the 100 ng/mL EGF stimulation results as 
microscopic clusters were observed.  
The internalization of EGFR under cholesterol depletion was also examined by 
confocal imaging. The membrane EGFR-EGFP almost maintained the same after 
mCD treatment for all the cells tracked (Figure 6.10). For those cholesterol depleted 
cells, no intracellular fluorescence was observed at both low and high dose EGF 
stimulation. In addition, after EGF stimulation, the inhomogeneous fluorescence 
distribution was noticed for both doses. Those bright spots visualized on the membrane 




microscope. This observation clearly indicates that the internalization of EGFR on 
CHO-K1 cells is impaired after cholesterol depletion at both 10 and 100 ng/mL EGF 
stimulation. Similar observation is also reported previously on 3T3 cells. It is 
demonstrated that treatment of mCD increase approximately 40% of the EGF surface 
binding [362]. 
 
Figure 6.10 No endocytosis of EGFR-EGFP on cholesterol depleted membrane 
stimulated by 10&100 ng/mL EGF. 
(A) Confocal images of EGFR-EGFP expressing CHO-K1 cells after cholesterol 
depletion followed by 100 ng/mL EGF treatment. (B) Confocal images of CHO-K1 
expressing EGFR-EGFP cells after cholesterol depletion followed by 100 ng/mL EGF 
treatment. Endocytosis of EGFR-EGFP at both low dose and high dose of EGF 
stimulation was impaired after cholesterol depletion. Scale bar: 10 m. 
The above results are consistent with the work of Saffarian et al., who reported EGFR 
clustering on the membrane after cholesterol depletion [38]. The strong effect of 
cholesterol containing domains on EGFR internalization was asserted by the above 
observation. It was proposed earlier that NCE internalization of EGFR after EGF 
stimulation will attenuate EGFR signalling [383]. Ligand-independent EGFR 
activation was observed for cholesterol depleted HaCaT cells [328]. As demonstrated 
earlier, cholesterol containing domains will accommodate EGFR in its resting state. 
Taken together, these results imply that the cholesterol containing domains on CHO-




As a control, the cytoskeleton structure with Lifeact cells after cholesterol depletion 
followed by EGF stimulation was also examined (Figure 6.11). The microscopic 
structure of cell cytoskeleton is not altered by the treatment. Any possible changes in 
the actin organization during the internalization process were probed. In both cases, no 
microscopic changes in cytoskeletal organization were observed. Therefore, 
involvement of the actin cytoskeleton on ligand induced EGFR endocytosis and its 
impairment after cholesterol depletion is not associated with macroscopic actin 
reorganization. 
Overall, the results in this section demonstrate that EGFR membrane organization and 
internalization behaviour post EGF stimulation strikingly differ in resting and 
cholesterol-depleted CHO-K1 cells. Thus cholesterol depletion followed by EGF 
stimulation has two effects on EGFR-EGFP expressing CHO-K1 cells. On one hand, 
cholesterol removal severely impaired the internalization of EGFR at both ligand doses 
stimulation. On the other hand, a stronger confinement of EGFR on the membranes 






Figure 6.11 Cytoskeleton change treated with 3 mM mCD followed by 10 & 100 ng/mL EGF stimulation probed by Lifeact cells. 
(A) Lifeact with 3 mM mCD followed by 10 ng/mL EGF. (A) Lifeact with 3 mM mCD followed by 100 ng/mL EGF. The microscopic organization of actin 




It’s well established that both high and low affinity EGFR exist on the cell surface 
simultaneously [26, 367]. From the above results, the relationship between the two 
different binding affinities EGFR species with their membrane organization can be 
heuristically commented on. EGFR molecules in the cholesterol-containing domains 
form clusters and internalize upon EGF stimulation while the ones in the cholesterol 
independent domains remain unclustered. These EGFR molecules located in non-
cholesterol domains are supposed to only interact with EGF to form clusters when 
membrane is devoid of cholesterol-enriched domains. Therefore, the cholesterol 
dependent EGFR molecules tend to show stronger affinity for EGF than their non-
cholesterol domain counterpart. This implies that the EGFR membrane localization 
will strongly affect its ligand binding affinity, which has a huge implication on EGFR 
signalling as reported earlier [370]. The previous simulation study has also 
demonstrated that heterogeneity in the EGFR density due to its localization will result 
in the different ligand binding affinities [357, 385]. This computational result leads to 
the same conclusion as the experimental results shown in this section. Both EGFR 
cooperativity by its own configuration [26] and the physical-chemical interaction of 
EGFR with other domain components [386] can be the driving force for the high-and-
low affinity ligand binding behaviors. However, the detailed study on the nature of 
differential affinity of membrane EGFR is beyond the scope of this study. Nevertheless, 
this perception sets strong notion that membrane domains act as EGFR signalling 
platforms. The relationship between the EGFR membrane localization and ligand 
binding can be studied in the future. 
6.2.3 The actin cytoskeleton in the internalization of ligand-bound EGFR 
The results in the previous chapter demonstrate that strong compartmentalization of 
EGFR is resulted from its association with actin cytoskeleton at its resting state. 
Previous study has also reported that dynamic cortical actin cytoskeleton 




relationship between cytoskeleton and EGFR is more complex when the cytoskeleton 
redistribution after EGFR activation is taken into account [388]. 
Hence, TIRF imaging was apply to investigate the role of actin cytoskeleton in EGFR 
endocytosis. As demonstrated in the previous chapter, Lat A took function quite fast 
and the maximal effect was achieved after 10 minutes’ incubation. The cells expressing 
EGFR-EGFP was first incubated with 3 M Lat A for 15 minutes, followed by EGF 
stimulation for 20 minutes. Lat A treatment, as stated earlier, induced clustering of the 
EGFR-EGFP on the plasma membranes of about 20% of the cells. The mechanism for 
the cytoskeleton disruption induced clustering was elaborated earlier. Briefly, the 
cytoskeleton compartments inhibit the clustering of EGFR on the membrane and 
disruption of cytoskeleton increases the interaction of EGFR molecules [352]. 
Computational studies have generated insightful knowledge into the mechanism of 
these complex processes regarding its spatial organization [35]. 
Interestingly, for those homogeneous cell membranes after Lat A treatment, 
microscopic clusters started to emerge after EGF stimulation for both doses.  
The same cell tracked with ITIR-FCS was first incubated with Lat A and exhibited 
similar as what was observed before (Figure 6.12 A). At about 15 min after Lat A 
treatment, 10 ng/mL EGF was added into the system to stimulate the cytoskeleton 
disrupted cells. Surprisingly, microscopic clusters started to emerge a few minutes after 
EGF addition. Images of the same cell tracked were shown and microscopic clusters 
started to be visualized from 3 min onwards (Figure 6.12 A). After about 10 min 
incubation, more than 80% of cells exhibit plasma membrane clustering of EGFR-
EGFP and the representative cell images were presented in Figure 6.12 B. The same 
results were observed for 100 ng/mL EGF treatment (Figure 6.12 C&D). 
Moreover, the endocytosis of EGFR on cytoskeleton disrupted cells was also examined 




more spherical (Figure 6.13), which used as the criterion in Kusumi’s lab for 
reorganization of cytoskeleton [389]. The membrane localization of EGFR was not 
altered by the cytoskeleton reorganization (Figure 6.13 C). The 100 ng/mL EGF was 
added when the maximal effect of Lat A took place. Continuous monitoring of receptor 
endocytosis was conducted and no EGFR-EGFP vesicles were observed in the 
intracellular part, which was clearly different from the 100 ng/mL EGF stimulation 
(Figure 6.1 B).  
These results corroborate well with the TIRF images, indicating that the EGFR 
endocytosis is inhibited after cytoskeleton perturbation. Similar results of actin 






Figure 6.12 Two doses EGF stimulation on EGFR-EGFP in the actin cytoskeleton 
disrupted cells. 
 (A) Representative TIRF images of one cell expressing EGFR-EGFP at resting state 
(first image), after 3 M Lat A for 15 min (second image), add 10 ng/mL EGF for 3 
min (third image) and  add 10 ng/mL for 10 min (fourth image). After Lat A treatment, 
the cell TIRF image remains homogeneous similar to the resting state, from 3 min 
onwards, microscopic clusters start to be visible after 10 ng/mL EGF treatment. (B) 
Representative TIRF images of cells expressing EGFR-EGFP after 3 M Lat A + 10 
ng/mL EGF. About 80% cells show microscopic clusters all over the cell. (C) 
Representative TIRF images of one cell expressing EGFR-EGFP at resting state (first 
image), after 3 M Lat A for 15 min (second image), add 100 ng/mL EGF for 5 min 
(third image) and add 10 ng/mL for 10 min (fourth image).  After Lat A treatment, the 
cell TIRF image remains similar to its resting state, after adding 100 ng/mL EGF for 5 
min, microscopic clusters were seen on the membrane. (D) Representative TIRF 
images of cells expressing EGFR-EGFP after 3 M Lat A + 100 ng/mL EGF. Almost 
all cells present with microscopic clusters on the membrane. 
 
Figure 6.13 No endocytosis for EGF stimulation on EGFR-EGFP in the actin 
cytoskeleton disrupted cells. 
(A) Resting CHO-K1 cells expressing EGFR-EGFP. (B) Cells incubate with 3 M Lat 
A for 10 min (C) Cells incubate with 3 M Lat A for 25 min (D) Cells incubate with 3 
M Lat A for 25 min and then add 100 ng/mL EGF for 5 min. (E) Cells incubate with 
3 M Lat A for 25 min and then add 100 ng/mL EGF for 10 min. (F) Cells incubate 
with 3 M Lat A for 25 min and then add 100 ng/mL EGF for 18 min. 
In addition, the role of actin cytoskeleton in the interaction between GFP-GPI-AP 
expressing cells and EGF was also tested. As shown earlier (Figure 6.6), EGF addition 
did minimal change to the GFP-GPI-AP membrane dynamics which indicated little 
effect of EGF on GFP-GPI-AP expressing cells. The GFP-GPI-AP expressing cells was 
first incubated with Lat A for 15 min and stimulated with 100 ng/mL EGF for 20 
minutes. TIRF images were taken at each step of the treatments. No microscopic 




GFP-GPI-AP is earlier shown to be unaffected by the perturbation of actin organization. 
And no interaction between GPI-AP and EGF is also demonstrated. Although some of 
the previous studies have reported that GPI-AP is also modulated by actin [392, 393], 
no microscopic changes were observed for such modulation in the experiments in this 
study.  
 
Figure 6.14 No change for GFP-GPI-AP in cytoskeleton disrupted cells with 100 
ng/mL EGF stimulation. 
No microscopic clusters on CHO-K1 cells expressing GFP-GPI-AP after Lat A 
treatment and stimulated by 100 ng/mL EGF. 
Overall, both cholesterol and cytoskeleton play important roles in the membrane 
redistribution and endocytosis of ligand bound EGFR. Removal of either cholesterol 
containing domains or cytoskeleton undermines EGFR endocytosis and allows EGFR 
clusters to remain on the membrane for a prolonged duration. Hence, the coordination 
of cholesterol-containing domains and the cytoskeleton is necessary for EGFR 
endocytosis after EGF stimulation.  
The results hitherto clearly show that the clustering of EGFR on the membrane is 
mediated by both cholesterol and cytoskeleton. At the same time, ligand concentration 
also modulates the EGFR clustering on live cell membrane. The factors affecting the 
EGFR membrane clustering will be discussed in the next section in a more detailed 
manner.  
6.3 Clustering of ligand bound EGFR 
6.3.1 Ligand Dose dependeny of EGFR clustering 
By membrane perturbations, microscopic clusters are observed, which ascertains the 




is also shown to induce cluster formation at both 10 and 100 ng/mL dose. The ligand 
induced clusters range in sizes from nanoscopic to microscopic. Ligand binding 
induced receptor clustering is well documented in literature [56, 57, 334, 378]. EGFR 
clustering is believed to play important role in EGFR signalling and further studies 
unravelling the clustering control factors are carried out. 
For the ligand induced microscopic clustering, an even higher EGF stimulation with 
500 ng/mL was applied. The membrane dynamics of the EGFR-EGFP with 500 ng/mL 
EGF stimulation were monitored and one representative TIRF cell image was shown 
(Figure 6.15 A). As can be seen, microscopic clusters were observed 10 min after 500 
ng/mL EGF stimulation. With longer time incubation, the clusters gradually vanished 
along with the decrease of membrane fluorescence. This may be due to the receptor 
endocytosis and degradation at high dose similar to the 100 ng/mL EGF stimulation. 
However, microscopic clusters stayed longer in the membrane in this scenario 
compared to 100 ng/mL EGF stimulation. The microscopic clusters were visible on the 
membrane even after 30 min post stimulation. This can be the saturation of membrane 
internalization cargo as well as the continuous formation of EGFR clusters on the 
membrane [59, 61]. This point is further supported by FCS measurements results 
(Figure 6.15 B). The ITIR-FCS measurements were conducted on the homogeneous 
membrane, with the microscopic clusters typically present as immobile with lifetime 
in minute scale.  
The D distribution for EGFR-EGFP shifted to the slower side with longer incubation. 
The average D value changed from 0.18 ± 0.13 m2/s before 500 ng/mL treatment to 
0.12 ± 0.11 m2/s 10 min after 500 ng/mL EGF stimulation and further decreased to 
0.10 ± 0.08 m2/s 20 min after 500 ng/mL EGF stimulation. This decrease in D was 
more obvious in the cumulative frequency distribution plot (Figure 6.15 C). As can be 




500 ng/mL stimulation. At the same time, the fast diffusing (D > 0.5 m2/s) fraction 
almost vanished completely. To better visualize the change of D histogram, the D 
histogram distributions were plotted by lines between points (Figure 6.15 D). After 20 
min of incubation, the diffusion of EGFR on the membrane was about two times slower 
than the resting state. The 0 before treatment was about 2.2 ± 0.2 s, within the typical 
intercept range for resting EGFR on the membrane. The intercept increased to 4.7 ± 
0.3 s 10 min after the 500 ng/mL EGF addition and further increased to 6.5 ± 0.3 s 20 
min after treatment. This is mainly due to the receptor clustering on the membrane. 
This argument is confirmed by both microscopic clustering imaged and nanoscopic 
clusters registered by the diffusion law analysis. Hence, 500 ng/mL EGF stimulation 
strongly induce the receptor cluster formation, even nanoscopic clusters present in large 
quantity for the optically homogeneous membrane.  
Interestingly, the formation of microscopic clusters on the membrane was observed for 
almost all the cells after 10 min of 500 ng/mL EGF treatment (Figure 6.16 A). . For 
most of the cells, the clusters were randomly distributed all over the cells. As many of 
the clusters stay longer on the membrane, the endocytosis of EGFR was examined by 
confocal imaging to check whether internalization of EGFR would be affected by this 
clustering or not. The 500 ng/mL EGF stimulation still induced efficient EGFR 
internalization but with a slower rate compared to 100 ng/mL EGF stimulation (Figure 
6.16 B). This slower endocytosis rate is probably due to the involvement of NCE 
pathways in high dose stimulation [75]. With the increase of EGF concentration, the 
contribution of NCE increases, which is reported to take place in a slower rate 
compared to the CME [59, 74]. It’s highly likely that CME saturation takes place when 
a large portion of EGFR is activated by the high amount of EGF. The contribution of 
slower NCE increases with the higher EGF concentration, reducing the apparent EGFR 




intracellular signal were also noticed for 500 ng/mL stimulation, which is mainly due 
to the degradation of EGFR after high dose stimulation [83, 383]. 
 
Figure 6.15 ITIR-FCS on 500 ng/mL EGF stimulation with EGFR-EGFP. 
(A) TIRF images of CHO-K1 cells expressing EGFR-EGFP stimulated with 500 
ng/mL EGF. One representative cell result was shown here. Membrane clusters were 
observed at 10 min and gradually internalized over time. Some clusters remained on 
the membrane even longer than half an hour. (B) TIRF-FCS on the receptor diffusion 
coefficient. The D histogram for EGFR-EGFP before 500 ng/mL treatment (Red bars), 
10 min after 500 ng/mL stimulation (Black bars) and 20 min after 500 ng/mL 
stimulation (Blue bars). (C) Cumulative frequency plot for the D with 500 ng/mL 
stimulation. Before treatment (Red curve), 10 min after 500 ng/mL stimulation (Black 
curve) and 20 min after 500 ng/mL stimulation (Blue curve). (D) Histogram 
distributions were plotted by lines between points to show the shift of the D distribution. 
Before treatment (Red curve), 10 min after 500 ng/mL stimulation (Black curve) and 
20 min after 500 ng/mL stimulation (Blue curve). (E) Diffusion law plots for the 
membrane heterogeneity after 500 ng/mL EGF treatment. Before treatment (Red line), 




stimulation (Blue line). The same experiments were repeated at least three times and 
the same trend was observed. 
Hence, the possibility of microscopic clusters formation is closely related to the ligand 
concentration. The endocytosis of EGFR-EGFP process will be initiated at both low 
and high dose EGF stimulation while the rate is determined by the ligand concentration. 
The high dose ligand stimulation can induce microscopic clusters on the cell membrane 
and prolonged membrane localization. The prolonged clustering is probably related to 
the attenuation of EGFR signalling at high concentration EGF stimulation [394]. 
 
Figure 6.16 Imaging on clusters of 500 ng/mL EGF stimulation with EGFR-EGFP. 
(A) TIRF images of CHO-K1 cells expressing EGFR-EGFP after about 10 min with 
500 ng/mL EGF stimulation. More than 80% cells were observed with microscopic 
clusters on the membrane. (B) Confocal Images of CHO-K1 cells expressing EGFR-
EGFP stimulated with 500 ng/mL EGF. The high dose stimulation also leads to EGFR-
EGFP endocytosis.  
6.3.2 Temperature in ligand-bound EGFR clustering and endocytosis 
Another important factor regulating the membrane EGFR behaviour is temperature. 
Previous study has demonstrated the temperature dependence of EGFR signalling and 
the kinetic models were simulated [395]. The clustering properties of EGFR are 
expected to be modulated by the temperature as previous studies suggested [56, 396, 
397]. Thus, the effect of temperature on the ligand-bound EGFR clustering and 





At 298 K the microscopic clusters were observed with 100 ng/mL EGF stimulation in 
(Figure 6.17 A). At about 10 min after EGF stimulation, microscopic clusters emerged 
on the membrane. More interestingly, the clusters observed at 10 minutes (indicated by 
the arrow in Figure 6.17 A) were not at the same place 10 minutes later. More 
microscopic clusters were observed at 20 min (Figure 6.17 B). 
As earlier results have shown, clustering on the membrane will be induced by EGF 
stimulation at physiological temperature, with clusters in various sizes both below and 
beyond optical resolution. At sub physiological temperature 298 K, microscopic 
clusters were observed on the membrane for longer time. This leads to the conclusion 
of increased sizes in receptor clusters and slower endocytosis rates at sub physiological 
temperature. The similar observation of temperature dependent EGFR clustering has 
been reported earlier [365]. Previous studies have proposed that the EGFR clusters on 
the membrane are affected by the lipid phase transition since EGFR is modulated by 
specific lipids compositions [56]. The observation of the temperature dependent EGFR 
clustering is in accordance with the reported lipid phase separation in the temperature 
range from 277 K to 310 K [341]. However, the exact mechanism for the microscopic 
clusters observed at 298 K is not clear yet. 
Coban et.al reported that the membrane bound receptors will be rapidly depleted at 
physiological temperature after EGF stimulation [366]. This is consistent as what is 
observed in the previous low and high doses of EGF stimulation experiments as no 
large microscopic clusters are observed under TIRF microscope. Lowering down the 
temperature as a strategy to slow down the cell ligand-induced ErbB receptor 
internalization process is also documented in the literature [366]. Earlier studies have 
shown that clusters of ErbB2 receptors will increase both in size and density over a 
period up to 2 hours when change temperature from physiological temperature to room 




promoted but not CCPs budding at low temperature [398]. So the microscopic clusters 
may be both EGFR high order oligomers and EGFR assemble into the CCPs. 
In addition, two possibilities can be brought up to explain the changes of observed 
clusters over time on the membrane. First, the clusters at 20 min (Figure 6.17 A) can 
be the newly formed clusters while the clusters at 10 min on the membrane have been 
endocytosed. If this is the case, microscopic clusters inside the intracellular side were 
expected after 10 min of stimulation at 298 K. Another possibility is the lateral 
movement of the clusters formed on the membrane, together with the increased sizes 
and number of clusters. Little endocytosis of membrane receptors is expected.  
Regarding the microscopic clusters observed over time on the plasma membrane, the 
change of ligand bound EGFR endocytosis under this scenario is examined. CHO-K1 
cells expressing EGFR-EGFP have no obvious microscopic changes at 298 K after the 
100 ng/mL EGF stimulation (Figure 6.17 C). This indicates that the ligand induced 
endocytosis is strongly impaired at 298 K compared to 310 K. Although for other cell 
lines like A431, U343 and SKOV3 cells, the internalization rate and the degree of 
internalization are reported to show little difference at room temperature and at 310 K 
[399]. The difference may stem from the different cell lines as well as the particular 
tyrosine kinase inhibitors (TKIs) used in that study. The cellular context is shown to 
play important roles in the EGFR signalling interaction including ligand-EGFR 






Figure 6.17 Temperature effect on EGFR with low temperature (T = 298 K) and 
physiological temperature (T = 310 K) with 100 ng/mL EGF stimulation. 
(A) CHO-K1 cells expressing EGFR-EGFP with 100 ng/mL EGF stimulation at T = 
298 K. The same cell was tracked and clusters were observed 10 min after stimulation. 
The clusters stayed on the membrane longer than 10 min. Arrow points to the different 
clusters observed at different time points. (B) TIRF images of CHO-K1 cells 
expressing EGFR-EGFP after 100 ng/mL EGF stimulation at T = 298 K. Clusters were 




EGFP cells after 100 ng/mL EGF stimulation. Incubate the cells at T = 298 K for up to 
half an hour and no obvious endocytosis is observed inside the cells but clusters on the 
membrane. (D) The same cell incubated at T = 298 K were warmed up to T = 310 K 
and monitored over time. The warm up procedure took about 8-10 min. During this 
process, no obvious endocytosis was observed. When the temperature increased up to 
T = 310 K, the clusters started internalized after about 5 min incubation. (E) 
Enlargement of the green square in the upper panel to show the intracellular signal. The 
same temperature and ligand treatment experiment was repeated at least twice and 
repeated results were obtained. 
More interestingly, the EGFR-EGFP endocytosis procedure was restored when the 
temperature increased to physiological temperature level (Figure 6.17 D). When the 
cells were gradually warmed up to physiological temperature, the microscopic 
internalized signal was observed in the intracellular part. The plasma membrane EGFR-
EGFP internalization was observed after 10 min incubation at 310 K. This reversible 
endocytosis for the EGFR was a strong evidence for the temperature dependent effect 
in receptor endocytosis. Early study has claimed that all endocytosis will be effectively 
reduced at 277 K (4 °C). The inhibition is reversible simply by restoring the 
temperature back to physiological temperature. A similar temperature reversible 
phosphorylation effect was also reported for other tyrosine kinase [401].  
Taken together, the EGFR clustering and endocytosis can be drastically altered by the 
incubation at non-physiological temperature (T = 298 K in this case) with ligand 
stimulation. The EGFR membrane clustering is closely related to its endocytosis. 
Different EGFR membrane clustering status may have huge implications in the EGFR 
activation and endocytosis.  
Overall, the EGFR membrane distribution and activation after ligand stimulation is 
intensively investigated in this chapter. The results indicate that the ligand stimulation 
induced EGFR redistribution and endocytosis are dose dependent. Low dose EGF 
stimulation will not affect the EGFR membrane diffusion and overall confinement. The 
EGFR internalization after low dose EGF stimulation is mainly through CME and 
recycling of receptors back to membrane is observed. High dose EGF stimulation leads 




involvement of NCE after high dose EGF stimulation has been registered. Both 
cholesterol removal and actin cytoskeleton disruption will strongly impair EGFR 
endocytosis. Ligand stimulation after cholesterol removal or cytoskeleton disruption 
will induce various sizes of receptor clusters on the membrane, which ranges from 
nanoscopic to microscopic.  
The EGFR clustering modulated by EGF is also strongly affected by temperature. 
Nonphysiological temperature may heavily impair the effective EGFR endocytosis 
after ligand stimulation and cause the receptor clusters retention on the membrane. 
Altogether, the effective EGFR signalling requires proper receptor membrane 





7 Conclusion and Outlook 
7.1 Conclusion 
7.1.1 ITIR-FCS diffusion law validated in live cell membrane 
The development of ITIR-FCS, a quantitative imaging method, enables measuring 
plasma membrane dynamics and organization with single molecule sensitivity in a 
multiplexing form. Implementation of FCS diffusion law analysis into the ITIR-FCS 
measurements further facilitates in exploring the membrane sub-resolution 
organization.  
In chapter 4, membrane dynamics and organization are investigated employing 
different membrane probes, which exhibit their identical membrane diffusion 
behaviours. The membrane non-raft marker DiI-C18 freely diffuses on the CHO-K1 cell 
membrane. The lateral mobility and membrane partitioning of DiI-C18 are not altered 
by either cholesterol depletion or the actin cytoskeleton disruption on live CHO-K1 
cells.  
The raft marker GFP-GPI-AP diffuses slower than the free diffusion marker and 
exhibits large confinement. It partitions into cholesterol-containing domains and the 
confinement can be almost completely removed with cholesterol depletion. However, 
the membrane heterogeneity modulated by cholesterol removal is strongly dependent 
on the concentration of mCD and time of incubation. The different concentration of 
mCD (3 and 5 mM) incubation reaches maximum cholesterol removal effect at 
different time points. The membrane fluidity change by the mCD incubation is 
reflected by the marker mobility D and the percentage of D change. The membrane 
heterogeneity change is probed by the diffusion law intercept 0 and the maximum 
effect of mCD induced cholesterol depletion is noted as the largest deduction at the 
respective time point. Following the saturation of cholesterol removal, the membrane 
heterogeneity will gradually recover presumably by replenishing the cholesterol from 




controversial results which employ mCD to deplete cholesterol from cell membrane. 
At the same time, both the lateral mobility and membrane confinement show marginal 
change after the actin cytoskeleton disruption. This indicates that GFP-GPI-AP is not 
affected by actin cytoskeleton disruption while control Lifeact cell experiments have 
clearly shown the effect of actin cytoskeleton reorganization.  
Another membrane probe PMT-GFP is associated with actin cytoskeleton in CHO-K1 
cells and its diffusion is strongly hindered by the cytoskeleton compartmentalization. 
The meshwork confinement is not affected by the raft depletion but diminished upon 
actin cytoskeleton disruption. This confirms the role of actin cytoskeleton 
compartmentalization for PMT-GFP, which is not accessible by TIRF imaging directly. 
In a nutshell, these results have demonstrated that Imaging FCS can not only obtain the 
dynamics of membrane molecules on live cell membrane but also probe the molecule 
membrane localization by diffusion law analysis.  
7.1.2 EGFR cell membrane organization at its resting and ligand bound 
states 
The dynamics and organization of EGFR-EGFP at its resting and activated states on 
live on CHO-K1 plasma membranes were intensively explored in the following two 
chapters. Investigation and quantification of the EGFR at its resting state and ligand 
bound state is achieved by ITIR-FCS. The EGFR dynamics and organization was 
compared with the aforementioned free diffusion marker DiI-C18 and cholesterol-
dependent domain marker GFP-GPI-AP. With the help of well-established FCS 
diffusion law analysis, the EGFR sub-resolution nanoscale membrane organization is 
recovered.  
At resting state, EGFR is partly trapped by cholesterol dependent domains and hindered 
by the actin cytoskeleton. With the removal of cholesterol from the membrane, EGFR 




AP which shows almost entire confinement from cholesterol dependent domains, 
EGFR is still partially confined after cholesterol removal which can stem from 
cholesterol independent domains such as GM3 domains and receptor nanoclusters. The 
role of caveolae in the cholesterol dependent confinement of EGFR has also been tested. 
The results reveal that caveolae is not necessary for the confinement of EGFR on CHO-
K1 cells. The diffusion of EGFR is strongly regulated by the cholesterol level, which 
affects the membrane organization tremendously. The results have also revealed that 
EGFR is coupled to cytoskeleton at its resting state. The disruption of cytoskeleton 
plays a significant role in EGFR clustering.  
Stimulation by its cognate ligand EGF leads to the activation of EGFR, which changes 
EGFR dynamics and localization on the membrane. Interestingly, different 
concentrations of ligand stimulate EGFR into distinct dynamics in the membrane as 
well as different endocytosis pathways. At low dose (10 ng/mL) stimulation, both the 
diffusion and confinement of EGFR in the membrane remain unchanged while EGFR 
may be internalized mainly by the clathrin mediated endocytosis (CME) pathway. 
While at high dose (100 ng/mL) stimulation, the lateral mobility of EGFR in the 
membrane increases while the overall confinement keeps similar. Under this situation, 
non-clathrin mediated endocytosis (NCE) which involves the cholesterol-containing 
domains contributes a large portion to the EGFR internalization while the CME still 
functions in receptor endocytosis. The remaining EGFR on the membrane forms 
clusters, which can even grow into microscopic clusters with higher EGF stimulation 
(500 ng/mL). The ligand stimulation experiments affirm that EGFR organization in the 
membrane is modulated by its ligand concentration.  
Cholesterol and the actin cytoskeleton play significant roles in the membrane clustering 
of ligand-bound EGFR. The depletion of cholesterol from cell membrane greatly 
impairs EGFR endocytosis, which induces EGFR to form clusters under ligand 




nanoscopic to microscopic and get retarded in the membrane for long time. The 
disruption of actin cytoskeleton promotes EGFR cluster formation. The endocytosis of 
EGFR is hampered with the actin cytoskeleton disruption as receptors remain in the 
membrane with formation of microscopic clusters all over the membrane.  
Clustering and endocytosis of ligand-bound EGFR are also modulated by temperature. 
Sub-physiological temperature will impair the EGFR endocytosis and allow the 
receptor stay longer on the membrane. As the endocytosis is an active process which 
requires ATP, it will be significantly reduced at temperature so that bigger and 
prolonged EGFR clusters can appear. Moreover, the inhibition of endocytosis by low 
temperature is reversible when the temperature is warmed up back to physiological 
temperature.  
Overall, this study addresses how different membrane organizational principles 
contribute to EGFR localization and ligand binding on the plasma membranes. The 
results also reveal the link between EGFR endocytosis and modulation of membrane 
diffusion, confinement, and clustering after EGF binding. 
7.2 Outlook 
The development of advanced bioimaging techniques such as ITIR-FCS allows 
monitoring and quantifying EGFR dynamics on live cell membranes as well as its 
subsequent endocytosis process. A number of future directions to fully reveal the 
EGFR activation and signalling can be explored based on the current results.  
The overall EGFR membrane dynamics and organization revealed in this study address 
the potential of bioimaging methods in describing cell signalling pathways 
quantitatively, although the quantification of EGFR endocytosis process is still lacking. 
Previous work in our lab have obtained the quantitative information about the 
interaction between EGFR and its downstream phosphotyrosine binding (PTB) domain 




recruitment of PTB to membrane EGFR and results in the full binding of EGFR and 
PTB. However, this work is still based on confocal set-up and limited to one-point 
measurement. Recent technique development in our lab has demonstrated the 
capability of dual colour ITIR-FCCS in monitoring the EGFR membrane complexes. 
The membrane interaction of EGFR with other molecules like its downstream 
signalling adapters proteins can be quantified by the ITIR-FCCS. The first step in this 
kind of studies can be achieved by measuring the spatial interaction maps of EGFR and 
PTB to reveal the membrane heterogeneity effect in the EGFR-PTB interaction.  
The colocalization of EGFR with other membrane components both before and after 
ligand binding is the exploration that should be done in the future. It is believed that 
the localization of EGFR in lipid rafts functions as EGFR signalling platforms by 
concentrating the receptors and promoting its interaction with many downstream 
signalling molecules [398]. Current results have revealed that cholesterol dependent 
domains are involved in EGFR endocytosis only at high concentration ligand 
stimulation. The contribution of other endocytosis membrane components like CCPs 
in EGFR endocytosis is believed to play an important role in the EGFR activation and 
endocytosis. Ligand induced dynamic redistribution of EGFR at different 
concentrations also needs to be quantified to better understand activation and 
endocytosis of EGFR. 
It has been reported that the EGFR activation is regulated by the interaction between 
membrane lipids and EGFR both from the extracellular domain [336] and intracellular 
region [29]. A recent simulation study has provided new insights into the interaction 
between phosphatidylinositol-4,5-bisphosphate (PIP2) and the JM region of EGFR 
[402]. The coordination of membrane environment with EGFR dynamics should be 
elucidated to reveal the membrane organization principles in regulating the EGFR 




primary knowledge to dictate its correlation with EGFR. Primary results have partially 
revealed the PIP2 membrane dynamics and localization in my most recent experiments.  
Emergence of super-resolution techniques provides the possibility of imaging the 
membrane molecule below the optical resolution limit. The comprehensive EGFR 
clustering issue can be further resolved by super-resolution approach. The involvement 
of membrane organization principles in EGFR clustering can be investigated by SMLM 
imaging. The resting EGFR in the membrane is supposed to be the mixture of monomer, 
dimer and high-order oligomers[38]. The primary results of EGFR clustering imaging 
have shown significant improvement in the image resolution (Figure 7.1 A c&d, e&f). 
The mean-shift analysis for resting EGFR showed the clusters size spanned a 
distribution from 23-125 nm, which was consistent with the reported basal membrane 
cluster size in COS-7 cell line [261]. The expression levels were not related to the 
cluster sizes and distribution as only marginal shift on the cluster distribution between 
the low and high expression cells (Figure 7.1 B).  
But more systematic experiments and robust analysis are required in the super-
resolution microscopy application in resolving membrane EGFR cluster size and 
distribution problems. The number of EGFR clusters, cluster size, shape and other 
parameters can be extracted. The regulation of EGFR cluster formation by different 





Figure 7.1 EGFR imaged by SMLM and mean-shift cluster analysis. 
(A) (a) TIRF images of EGFR-EGFP using 488 nm illumination. (b) SMLM images of 
Alexa 647-EGF antibody labelling. (c)Enlargement of the region in the green square 
from a. (d) Enlargement of the region in the green square from b, same region as c. (e) 
Enlargement of the region in the green square from c.(f) Enlargement of the region in 
the green square from d, same region as e. Scale bar is labelled on each image 
accordingly. (B) Region of interest from f green square regions marked with H and L, 
corresponding to the high and low expression cell. The histogram of the cluster 
distribution by mean-shift analysis on the low and high expression cell region is 
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